On quantifying quality of care by Varewyck, Machteld
FACULTY OF SCIENCES
On Quantifying Quality of Care
Machteld Varewyck
Proefschrift voorgedragen tot het behalen van de graad van
Doctor in de Statistische Data-Analyse
Academiejaar 2015-2016
Promotoren:
Prof. dr. Els Goetghebeur
Prof. dr. Stijn Vansteelandt
Vakgroep Toegepaste Wiskunde, Informatica en Statistiek
Faculteit Wetenschappen, Universiteit Gent
Krijgslaan 281, B-9000 Gent
Research funded by a Ph.D. grant of the Agency for Innovation by Science and
Technology (IWT)
Cover art by Preben Bonte and Maarten Varewyck
Contents
Dankwoord vii
1 Introduction 3
1.1 A Global Need for Quantifying Performance . . . . . . . . . . . . . 3
1.2 Riksstroke, the Swedish Register for Stroke . . . . . . . . . . . . . . 5
1.3 Statistical Issues when Quantifying Performance . . . . . . . . . . 6
1.3.1 Deciding on the indicator of interest . . . . . . . . . . . . . . 7
1.3.2 Deﬁning the causal inference framework . . . . . . . . . . . 8
1.3.3 Two summary measures for performance . . . . . . . . . . 11
1.3.4 Outcome regression modeling to adjust for patient mix . . 15
1.3.5 Benchmarking and reporting . . . . . . . . . . . . . . . . . . 19
1.3.6 A note of caution . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.4 Technical Motivation and Outline . . . . . . . . . . . . . . . . . . . 24
2 On Shrinkage and Model Extrapolation in the Evaluation of Clinical
Center Performance 29
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2 Proﬁling Center Performance: Framework . . . . . . . . . . . . . . 32
2.2.1 Direct versus indirect standardization . . . . . . . . . . . . . 32
2.2.2 Decision criterion for labelling centers . . . . . . . . . . . . 33
iii
2.3 Regression Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.3.1 Normal mixed effects model . . . . . . . . . . . . . . . . . . 35
2.3.2 Reducing shrinkage . . . . . . . . . . . . . . . . . . . . . . . 37
2.3.3 Accounting formodel extrapolation: Doubly robust PSmethod 38
2.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.4.1 Simulation study application . . . . . . . . . . . . . . . . . . 40
2.4.2 Analysis of the Swedish Stroke Register . . . . . . . . . . . . 43
2.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.A Technical Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . 50
2.A.1 Firth correction . . . . . . . . . . . . . . . . . . . . . . . . . . 50
2.A.2 Fixed effects logistic regression: Asymptotic variance . . . . 51
2.A.3 Doubly robust PS method: Asymptotic variance . . . . . . . 52
2.B Additional Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
2.B.1 Simulation study application . . . . . . . . . . . . . . . . . . 54
2.B.2 Analysis of the Swedish Stroke Register . . . . . . . . . . . . 59
3 On the Practice of Ignoring Center-Patient Interactions in Evaluating
Hospital Performance 73
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.2 Setting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.2.1 Nature of Interactions . . . . . . . . . . . . . . . . . . . . . . 76
3.2.2 Direct and Indirect Standardization . . . . . . . . . . . . . . 77
3.2.3 Ignoring interactions . . . . . . . . . . . . . . . . . . . . . . . 78
3.3 Asymptotic Bias Calculation . . . . . . . . . . . . . . . . . . . . . . . 78
3.4 Simulation Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
3.5 Data Analysis: Riksstroke . . . . . . . . . . . . . . . . . . . . . . . . 85
3.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
3.A Asymptotic Bias Calculation . . . . . . . . . . . . . . . . . . . . . . . 94
3.A.1 Direct standardization . . . . . . . . . . . . . . . . . . . . . . 94
3.A.2 Indirect standardization . . . . . . . . . . . . . . . . . . . . . 97
3.A.3 Model-based estimators when comparing risks . . . . . . . 99
3.B Decision Criterion for Labelling Centers . . . . . . . . . . . . . . . 100
3.C Additional Results on Simulation Study and Data Analysis . . . . . 101
iv
4 Cost-efﬁcient Variable Selection for Clinical Registers with Missing Co-
variate Values 113
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
4.2.1 Deﬁning the error functions . . . . . . . . . . . . . . . . . . 116
4.2.2 Search methods for cost-efﬁcient variable selection . . . . 118
4.3 Two Case Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
4.3.1 Subset selection for RAND data . . . . . . . . . . . . . . . . . 122
4.3.2 Subset selection for Riksstroke . . . . . . . . . . . . . . . . . 126
4.4 Analytical Reﬂections on the Inclusion of Covariates . . . . . . . . 128
4.4.1 A covariate with measurement error . . . . . . . . . . . . . . 129
4.4.2 A covariate with missing values . . . . . . . . . . . . . . . . . 130
4.4.3 Comparing the added value of consciousness and NIHSS . 133
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
4.A Analytical Reﬂections on the Inclusion of Covariates . . . . . . . . 138
4.B Additional Figures and Tables . . . . . . . . . . . . . . . . . . . . . . 141
5 The R package RiskStandard 149
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2 Implemented R-Functions . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.1 standardizeRisks() . . . . . . . . . . . . . . . . . . . . . . . . 151
5.2.2 labelCenters() . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
5.2.3 plotRisks() . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
5.2.4 plotCenterLabels() . . . . . . . . . . . . . . . . . . . . . . . . 156
5.2.5 funnelPlot() . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
6 Conclusion and Future Research 159
6.1 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
6.2 Future Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
6.2.1 Instrumental variable analysis . . . . . . . . . . . . . . . . . 162
6.2.2 On the methods in this thesis . . . . . . . . . . . . . . . . . . 164
6.2.3 Assessing differences in patient-mix . . . . . . . . . . . . . . 166
6.2.4 Longitudinal analysis . . . . . . . . . . . . . . . . . . . . . . 167
v
6.2.5 Mediation analysis . . . . . . . . . . . . . . . . . . . . . . . . 169
7 Samenvatting 171
8 Summary 175
Bibliography 179
vi
Dankwoord
Tijdens mijn doctoraat heb ik het voorrecht gehad om niet één, maar wel twee
promotoren te hebben die tot de top behoren in hun vakgebied. Dat de lat
daardoor hoog werd gelegd, daar ben ik nu oprecht dankbaar voor.
Els, je hebt een belangrijke rol gespeeld in het sturen van mijn jonge loopbaan.
Je wist me te motiveren voor maatschappelijk belangrijke thema’s tijdens mijn
bachelor- en masterthesis. Tijdens dit doctoraat bracht je opnieuw boeiende
onderzoeksvragen aan en kon ik op je steun en gedrevenheid rekenen bij het
beantwoorden ervan. Bedankt voor de vele uren die je in mij en in dit werk hebt
geïnvesteerd.
Stijn, bedankt voor je eindeloze geduld bij het uitwerken van kleine en grote
problemen. Als ik door het kluwen van statistische formules soms de uitweg niet
meer zag, kon ik altijd bij jou terecht. Het vertrouwen dat je toonde in een goede
aﬂoop heeft me doen volhouden tot de eindmeet.
Marie, thank you for providing me access to the Riksstroke data and to initiate
me into this brilliant register. Although the answers to our research questions
sometimes yielded surprising results, you never doubted my statistical knowl-
edge but instead helped explaining the underlying mechanisms. Tack!
I would also like to thank all members of the examination committee: Marie
Eriksson, Els Goetghebeur, Tom Loeys, Sharon-Lise Normand, Rosanna Over-
holser, Olivier Thas, Herman Van Oyen and Stijn Vansteelandt. You made me
realize how easily the bigger picture fades into the background when working
on one topic for four years. I highly appreciate your constructive and insightful
vii
comments to this thesis.
Naast mijn promotoren hebben ook de andere leden van onze onderzoeks-
groep me vaak geïnspireerd en gemotiveerd tijdens dit doctoraat. In het bijzonder
wil ik Karel bedanken, nog zo een krak in zijn vak! Tijdens onze opleiding hebben
we vaak samen gezwoegd op examens en het herwerken van papers. Ik wil je
graag bedanken voor je hulp bij het doorgronden van statistische mysteries,
maar ook voor je luisterend oor en je schouderklopjes. Onze wegen gaan nu een
andere richting uit, maar ik wens je veel succes en denk maar niet dat je nu aan
mij zal ontkomen! Bart VR, het is altijd ﬁjn om te kunnen terugvallen op een
collega met zoveel ervaring. Door onze gemeenschappelijke Zweedse uitdaging
hadden we vaak boeiende discussies. Dankzij de aanwezigheid van Bart, Johan,
Jozeﬁen, Karel en Sjouke hebben de vele conferenties me niet alleen op statistisch
vlak iets bijgebracht. Ook al heb ik veel bureaugenoten versleten, ze mochten
er stuk voor stuk wezen. Bedankt Jan, Lizzy, Peter, Koen, Jens en Pieter om de
soms lange dagen iets korter te maken en de soms grote frustraties iets kleiner te
maken. Jan, je liet me vanaf de eerste dag thuis voelen op ons bureau en al was je
parcours soms onvoorspelbaar, ik ben supertrots op jou. Daarnaast wil ik ook
alle andere TWIST-leden bedanken. Catherine, jij bent de grootste ‘welbevinden
op het werk’-heldin die ik ken. De spelletjesavonden, weekends en barbecues
zorgen ervoor dat iedereen zich hier thuis voelt. Als ik ooit een wedding-planner
nodig heb, weet ik je te vinden! Virginie, bedankt voor je onuitputtelijke energie,
je talloze mailtjes en natuurlijk een dikke dankjewel voor je vastberadenheid
om me van straat te helpen. Charlotte, onze middagpauzes waren altijd veel te
snel om, net als ons tweejaarlijks stoffenjacht-avontuur. Herman, JAMES is echt
supercool, bedankt om hem draaiende te krijgen op mijn computer. Bedankt
ook sportieve vrienden voor al dat badmintongeweld, wat zweet mocht zeker
niet ontbreken in een opleiding als deze.
Ook buiten het werk stonden er vrienden klaar voor wat ontspanning nu en
dan. Bedankt Elke, Frauke, Jolijn, Nathalie en Sara om geduldig naar een geschikt
moment te zoeken zodat iedereen mee kon op vrijgezellen, naar de kerstmarkt
of een Lokers etentje. Lotte, bedankt voor de warme omhelzingen als het even
moeilijk ging, maar ook voor de spontane afspraakjes die altijd een groot feest
werden. Stijn, bedankt voor de vele jog-zondagen zodat we met een fris hoofd
viii
aan de nieuwe week konden beginnen. De muzikanten van het GUHO, bedankt
om het stof van mijn dwarsﬂuit te blazen en me te laten meegenieten van jullie
prachtige orkest en de onvergetelijke concerten.
Liefste mama en papa, duizendmaal dank om bij te springen als het on-
verwachts druk, moeilijk of spannend werd. Dat ik altijd op jullie kan reke-
nen is zodanig vanzelfsprekend geworden dat het veel te weinig wordt gezegd,
dankjewel! Bedankt om me zoveel te leren naast mijn studies en me te steunen
in alles wat ik doe. Bedankt Matthias en Ellen, Maarten en Evi voor de gezellige
familiemomenten en jullie interesse in mijn onderzoek. Bedankt ook aan jul-
lie kroost die me elke keer weer doet beseffen wat echt belangrijk is. Bedankt
lieve Preben, om mij geduldig te laten uitrazen na een werkdag, om me plat te
knuffelen als ik te veel pieker en om een unieke covertekening te maken. Ik ben
helemaal klaar voor een nieuw avontuur, samen met jou!
Machteld Varewyck
December 2015
ix

Glossary of Acronyms
CC Complete cases
CI Conﬁdence interval
DSR Directly standardized risk
FE Fixed effects
ISR Indirectly standardized risk
MAR Missing at random
MCAR Missing completely at random
ME Mixed effects
MI Multiple imputed
PS Propensity score
RE Random effects
SMR Standardized mortality risk
1

1CHAPTER 1
Introduction
1.1 A Global Need for Quantifying Performance
Improving the quality of health care has been captivating people for ages, just as
it did Florence Nightingale, a great pioneer in statistics:
“In 1855, Florence Nightingale tabulated the death rates from leg amputation
of English soldiers who participated in the Crimean War. She observed that after
accounting for the level of amputation above or below the knee, soldiers operated
on in large hospitals were more likely to die than those operated on in small
hospitals. She identiﬁed the causes of this unexpected ﬁnding as poor sanitation
and the rapid spread of infection from patient to patient in large hospitals. She
pleaded with English royalty to do something about the sanitary conditions of
English ﬁeld hospitals.” (from Keeler et al. (1992))
More than a century later, there continues to be great interest in characteriz-
ing hospitals that experience a better or worse outcome than expected and to
use this information in some way to improve health care: For example, giving
feedback to hospitals can help target interventions such as continuing education
for the personnel, government agencies on the other hand can make evidence-
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based decisions on public expenditure, while public reporting may guide patients
in their hospital choice (Normand et al., 1997). Implications may thus be far-
reaching whereby criticism of hospitals may damage staff morale and public
conﬁdence or even lead to closure (Black, 2010). For example, in the United
Kingdom (UK), reports on poor performance led to the dissolution of the Mid
Staffordshire NHS Trust and transferring services to other health trusts 1. In the
United States (US), St. Mary’s Medical Center in Florida permanently closed its
pediatric cardiothoracic surgery program after exceedingly high mortality rates
had been published 2.
Measuring hospital performance is not a new activity, neither is it a local
phenomenon. Several initiatives have been set up, nationally (e.g. National
Health Service in the UK 3) and internationally (e.g. the PATH project in Europe
4), all sharing the goal to improve health care. In its recommendations, the World
Health Organization (WHO) European Region stated that by the year 2010 all
countries should have a nationwide mechanism for continuous monitoring and
development of the quality of care for at least ten major health conditions (World
Health Organization and others, 2003). Results on hospital performance have
been published since the mid-1980’s in the United States and since 1999 in the
United Kingdom. In the last 10 years, many other countries have introduced
various forms of hospital performance measurement. In Belgium, the Flemish
government has the authority for health care and public welfare. Recently a
website was launched to compare the quality of Flemish hospitals 5, where in a
ﬁrst phase most reports are on breast cancer treatment. Not only the quality of
hospitals is increasingly monitored, also other public institutions such as nursing
homes, universities and schools can learn from each other (Leckie and Goldstein,
2009; Spiegelhalter, 2005a). The social relevance and broad applicability only
emphasize the importance of accurate data analysis that allows for making fair
comparisons. Although we will focus on hospital performance, this speciﬁc
context is exemplary rather than restrictive.
1http://www.bbc.com/news/uk-england-stoke-staffordshire-23508096
2http://edition.cnn.com/2015/08/17/health/st-marys-medical-center-investigation
3http://www.nhs.uk
4http://www.pathqualityproject.eu
5http://www.zorgkwaliteit.be
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1.2. Riksstroke, the Swedish Register for Stroke
Quantifying a hospital’s performance by its crude observed mortality rate
is naive and may be highly misleading. Indeed, a hospital may show a high
mortality rate because it mostly treats severely ill patients and not because it
has poor quality of care. In Section 1.3 we brieﬂy explain the standard statistical
methods to handle this and other challenges when quantifying performance.
Some of their drawbacks motivate the developments we present in the following
chapters. Before discussing analysis methods, we introduce Riksstroke, the
Swedish register for stroke patients, which will be analyzed in the following
chapters and illustrate the discussed methods.
1.2 Riksstroke, the Swedish Register for Stroke
Patient attributes may partly explain differences in hospital outcomes. Not
accounting for these differences between patients at hospital admission would
result in unfair comparisons, which is clearly not a good idea. So, for reliable
assessment of hospital performance, accurate registration of patient data is
the basis (Brookhart et al., 2010). Efforts towards more systematic and accurate
registration have been facilitated by digitization (Iezzoni, 1997). Electronic health
records for example allow to share patient data across different health care
settings. Sweden has been a pioneer with a strong tradition in high-quality
registers. One of these is Riksstroke, the national register for stroke patients that
will be analyzed throughout this thesis.
Riksstroke, the Swedish quality register for stroke care, aims to monitor and
improve hospital performance and ultimately to ensure the best possible care
for stroke patients (Asplund et al., 2011). It is one of the world’s largest stroke
registers. It is estimated to cover between 80% and 90% of the total stroke popu-
lation with considerable variation in coverage between hospitals and over the
years since 2001. A detailed analysis of Riksstroke data quality showed that data
entry errors were marginal: A 95% consistency rate was noted upon comparing
the diagnosis stated in Riksstroke with the medical chart.
We consider different subsets of the data across the chapters, either because
the data were updated with the most recent records or new patient characteristics
5
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had only recently been measured. In general, we restrict our analysis to the
ﬁrst registered stroke for adult patients (≥ 18 years), treated in one of the 90
Swedish hospitals between 2001 and 2012. We consider patients diagnosed
with ischemic stroke (ICD-10 I63), intracerebral haemorrhage (ICD-10 I61) or
unspeciﬁed acute cerebrovascular event (ICD-10 I64). This dataset contains
249 414 patients. Although the sample size is large, the number of registered
patients per hospital can be problematically small e.g. for year-speciﬁc analysis.
Using personal identiﬁcation numbers, records in Riksstroke are linked with the
register from Statistics Sweden so that a wide range of information is available
on the patient’s background (e.g. age, yearly income, education level), medical
treatments during the hospital stay (e.g. stroke unit care, thrombolysis) and
patient’s follow up (e.g. 30-day mortality, living conditions at 3 and 12 months).
Generally speaking, the register shows limited differences in patient mix across
hospitals (see Chapter 2), because no strong regional differences in patient
characteristics are present and stroke is an acute disease so that patients are
mostly treated in the nearest hospital.
Analytical reports on process and outcome quality indicators are accessible
for the public on the Riksstroke website: http://www.riksstroke.org/eng/.
To facilitate data interpretation, background information on the hospitals is
presented, such as patient characteristics and coverage of the total stroke pop-
ulation. Key quality indicators in Riksstroke are also presented in a report on
the quality of Swedish healthcare produced annually by the National Board of
Health and Welfare and the Swedish Association of Local Authorities and Regions.
Participating hospitals have access to reports presenting their own data in more
detail and in comparison with national data. A range of reports are thus provided,
each adapted to the stakeholders’ interest and background knowledge.
1.3 Statistical IssueswhenQuantifyingPerformance
The assessment of hospital performance concerns many different stakeholders
such as hospitals and clinicians, government and health insurers, and last but
not least, the patients and their support group. They may all have different moti-
6
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vations for learning about hospital performance such as reducing the workload,
identifying hospitals that need extra investments or improving patient satisfac-
tion. To perform a proper statistical analysis and come to relevant reporting,
close collaboration with the target audience is thus needed. In our case, frequent
consultations with Marie Eriksson, a member of the Riksstroke statistics team,
and visits from/to Sweden were arranged to gain insight in the Swedish register
Riksstroke.
1.3.1 Deciding on the indicator of interest
Hospital performance cannot be captured in one number, so a range of indica-
tors are used that are thought to be related to the given care level. Untimely death
is often used in this context, because it is easily measured, of undisputed impor-
tance and encountered across hospitals (Lilford and Pronovost, 2010). However,
in settings where all hospitals are expected to have similarly high or low death
risks it is certainly not the ideal indicator. For example when patients go to the
hospital for end-of-life care, everyone is expected to die within a short time span
so that quality of life may be a better indicator of good hospital performance.
Also when (almost) no deaths are observed within a relatively short time frame,
e.g. for 1-day surgical procedures or chronic diseases, patient satisfaction is
probably a more relevant outcome measure. Outcome indicators are frequently
criticized as they do not directly point to how, if so, the given care could be im-
proved (Freeman, 2002). Still, hospitals can utilize them for internal evaluation
and start searching for reasons that may explain differences between their and
other centers’ outcome indicators and what they can learn from it.
Besides outcome indicators, which assess whether the given care is effective,
process indicators assess whether patients get the care they need as indicated
in guidelines, e.g. ‘Is blood pressure measured daily?’ (Campbell et al., 2000).
These process indicators are more direct measures of quality of care, although
it is not always obvious which guidelines have to be met, e.g. Is it necessary to
measure blood pressure daily? For further discussion on when to best use which
type of indicator, we refer to Lilford et al. (2004), Mant (2001) and Campbell et al.
(2000). In either case, it is important to focus on one department or disease of
7
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the hospital at a time, rather than aiming to evaluate the hospital as a whole. This
because differences in the quality of care within hospitals are often much larger
than differences between hospitals (Jha et al., 2005).
Of course, multiple outcome indicators or a combination of outcome and
process indicators will provide better insight in the quality of care. Anyhow, some
selection is required as too many indicators may complicate the interpretation
and increase the maintenance cost (Freeman, 2002). We will focus on 30-day
mortality following a speciﬁc disease (e.g. stroke), denoted by Y (1= death,0=
survived), but the methods we will discuss are also applicable for other outcome
indicators.
Example 1.1
On the Flemish website for hospital comparisons (www.zorgkwaliteit.be)
concerning breast cancer treatments, both process indicators (e.g. percent-
age breast saving surgery) and outcome indicators (e.g. 5-year survival
probability) are reported per hospital, see also Figure 1.1.
1.3.2 Deﬁning the causal inference framework
In general, a comparison of crude mortality risks between hospitals can only
be fair if their patient mix (e.g. age, initial disease severity) is very similar. Only
then can higher observed mortality risks effectively be attributed to worse quality
of care. In practice, however, this is very exceptional, so that other statistical
measures are needed that do account for baseline differences in patient mix
among hospitals. The causal effect of a hospital on the outcome indicator will
be our target focus: It expresses the differences in mortality risk that cannot be
explained by differences in patient mix, but by differences in hospitals. This
effect is represented by the arrow from the hospital centerC to the outcome Y
below:
patient mix L
centerC 30-day mortality Y
8
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Figure 1.1: Hospital quality of care assessment in Flanders: 5-year survival probability
following breast cancer, controlled for age and disease stage.
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In order to capture the causal center effect it is important to control for the
differences in patient mix L (DeLong et al., 1997; Austin et al., 2003). In a causal
inference setting, this is better known as controlling for confounding.
In fact, many possible confounders may exist, some of the most common
are age, gender, initial disease status, smoking status, whether the patient has
diabetes or any other chronic disease. However, only those patient characteris-
tics (i.e. confounders) that were actually measured can be incorporated in the
outcome regression model. To estimate the causal center effect we will there-
fore assume that the measured patient characteristics are sufﬁcient to adjust
for confounding of the center-outcome effect (Hernán and Robins, 2006b). This
assumption of ‘no unmeasured confounding given the measured variables’ states
that patient outcomes are conditionally exchangeable within levels of L. More
speciﬁcally, it is assumed that for patients with the same baseline characteris-
tics, the mortality risk of those treated under the care level of center A, had they
been treated under the care level of center B, would have been the same as the
observed mortality risk in center B. Expert knowledge is needed to identify the
potential confounders already at the design stage of the study, although full reg-
istration may still be limited, not only by lack of information but also by budget
and workload constraints. This assumption may be violated when important
confounders are not measured. For example, patient’s socioeconomic status is
rarely measured although it has recently been shown to affect the mortality risk
of stroke patients in Sweden (Lindmark et al., 2014) and it is not unlikely to also
inﬂuence at which hospital the patient is actually treated as wealth may differ
between geographical regions.
Two other assumptions for causal inference are the ‘stable unit treatment
value assumption’ (SUTVA) and the positivity assumption. Let Y (c) indicate the
potential outcome for a given patient if treated at the care level of center c . Then,
the SUTVA states that a patient’s potential outcome Y (c) at care level c does
not depend on other patients’ given care level (Hernán and Robins, 2006b). For
Riksstroke the interaction between patients is minimal: We restrict our analysis
to the ﬁrst registered stroke for patients. If not, the potential outcome for a single
patient with a second stroke may depend on the given care level for his/her ﬁrst
stroke, e.g. if repeated thrombolysis treatments are not recommended. Another
10
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possible source for violation of the SUTVA assumption are infectious diseases, e.g.
if a patient at a given center has the ﬂu, other patients who would be treated at
that center may get infected, thereby affecting their potential outcome. The posi-
tivity assumption states that for each value of the covariates L in the population
and for any center c, the probability that some patients with L experienced the
care level at center c is positive (Hernán and Robins, 2006b). This assumption can
be assessed empirically by investigating how patient-mix differs across centers.
For Riksstroke, it will be shown (see Chapter 2) that differences in patient-mix
across centers are limited, in favor of the positivity assumption. If on the other
hand, patient mix would differ across centers, e.g. people in northern Sweden
are older than in the southern regions, it is still likely that a patient from northern
Sweden is treated at a hospital in the south, because he/she works there or is on
vacation while having an acute stroke. In other settings or for other diseases this
assumption may be violated e.g. when some centers are not permitted to treat
patients who need advanced care.
1.3.3 Two summarymeasures for performance
Although the causal hospital effect is our main focus, it is not an intuitive mea-
sure of e.g. the number of additional deaths compared to the national average.
In the ﬁeld of health services research, these hospital effects will therefore be
communicated through directly and indirectly standardized risks, which are the
most commonly used summary measures for performance (Keiding and Clayton,
2014).
To illustrate the two standardization techniques, we introduce a simple exam-
ple in Table 1.1. We consider 3000 patients who were treated in one of 3 hospitals
and 30-day mortality was registered as outcome quality indicator. The patient
mix across hospitals only differs by patient’s baseline disease severity, which is
either low or high. It can be seen that hospital 1 and 2 have the same severity-
speciﬁc mortality risks, respectively 1% for patients entering with low risk and
10% for those with high risk. However, hospital 1 shows a much higher crude
mortality risk (9.1%) than hospital 2 (1.9%). This is because hospital 1 treated
relatively more patients at high baseline risk than hospital 2, resulting in a larger
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number of observed deaths. So the observed difference in crude mortality risks
is not due to a worse care level but due to a different patient mix. In contrast,
hospital 2 and 3 have the same patient mix, so pairwise comparisons between
their crude mortality risks are fair.
Baseline disease severity Total ˆISR ˆDSR
Low High
Hospital 1 0.93 4.3%
No. patients 100 900 1000
Deaths 1 (1%) 90 (10%) 91 (9.1%)
Hospital 2 0.84 4.3%
No. patients 900 100 1000
Deaths 9 (1%) 10 (10%) 19 (1.9%)
Hospital 3 1.32 5.7%
No. patients 900 100 1000
Deaths 18 (2%) 12 (12%) 30 (3.0%)
Overall
No. patients 1900 1100 3000
Deaths 28 (1.5%) 112 (10.2%) 140 (4.7%)
Table 1.1: Toy example comparing the crude, directly and indirectly standardized mor-
tality risks of three hospitals.
Direct standardization (Nicholl et al., 2013; Bos et al., 2005) aims to infer the
potential full population risk for each hospital: the risk that would be realized if
all patients under study were to experience the care level of that given hospital,
irrespective of where they were actually treated. This is illustrated in Figure 1.2b,
where the care level of hospital 1 is extrapolated to the patients of the other
centers under study, to estimate the directly standardized risk of center 1. For
the example in Table 1.1, the directly standardized risk (DSR) for hospital 1 is
simply calculated as:
ˆDSR1 = 0.01× (100+900+900)+0.10× (900+100+100)
3000
= 0.01×0.63+0.10×0.37
= 4.3%, (1.1)
12
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(a) Observed data.
(b) Directly standardized risk
of center 1.
(c) Indirectly standardized risk
of center 1.
Figure 1.2: Sample of three centers with a different mix of patients having good health
condition on admission (yellow smiling face) and poor health condition on admission
(green sad face).
and this is the same for hospital 2, reﬂecting similar care delivered at these two
centers. Only hospital 3 has a larger estimated DSR than the overall mortality
risk of 4.7%. Direct standardization thus applies for each hospital the same set of
weights (resp. 0.63 for the low and 0.37 for the high risk group), but applies the
hospital’s severity-speciﬁc risks. The DSR is therefore insensitive to differences in
the hospitals’ distribution of baseline disease severity. It is sometimes criticized
as not evaluating the hospitals on the patients they actually treated. For example,
hospital 1 mostly treated patients at high risk, although for ˆDSR1 in (1.1) most
weight is given to its mortality risk for patients with low baseline disease severity.
Formally, the directly standardized risk for center c is denoted by E {Y (c)}, where
E {·} refers to the expected value over all patients under study. Given the DSRs,
we can easily make pairwise comparisons either among different centers, with
past performance or with the overall mortality risk E(Y ).
In contrast, indirect standardization (Shahian et al., 2001; Campbell et al.,
2012) focuses on what a center achieves for its own patient mix (Figure 1.2c). In
general, a risk ratio or risk difference is calculated between the observed and
expected risk (e.g. the risk when the average of all observed care levels would
apply) for each center. For example, when the indirectly standardized risk (ISR)
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is calculated as the ratio of observed and expected mortality risk, we obtain for
hospital 1 in Table 1.1:
ˆobserved risk1 = 0.01×100+0.10×900
1000
= 9.1%
ˆexpected risk1 =
(0.01+0.01+0.02)/3×100+ (0.10+0.10+0.12)/3×900
1000
= 9.7%
ˆISR1 = 9.1
9.7
= 0.93, (1.2)
stating that the observed mortality risk in hospital 1 is better than the expected
mortality risk if its patients were to experience the average of all observed care
levels. Similarly, hospital 2 has an ISR smaller than 1, contrary to hospital 3 which
has a worse care level than expected. Note that even though hospital 1 and 2
perform equally well for each patient type, their estimated ISRs differ because
their patient case-mix differs. Comparing two hospitals based on their ISRs can
thus only be fair if their patient distributions are very similar. What indirect
standardization actually aims to answer is: “How would the risk in a given center
change if its patients were to experience the average risk across all centers?”. The
observed risk in center c can formally be denoted by E {Y |C = c}= E {Y (c)|C = c}
and the expected risk bym−1
∑m
c∗=1E {Y (c
∗)|C = c}, wherem denotes the number
of hospitals under study.
In summary, direct and indirect standardization are each others mirror-
image: For direct standardization, the hospital of interest provides the risks
and the total study population provides the weights. For indirect standardiza-
tion, the population of observed centers provides the risks and the hospital of
interest provides the weights. So, the different standardizations may yield dif-
ferent results, because they intend to answer different research questions and
pursue different standards. For example, given direct standardization a hospi-
tal may show a smaller mortality risk than the overall mortality risk, while this
hospital may have an ISR larger than 1, indicating worse performance than the
expected mortality risk for its patient mix. This emphasizes the importance of
transparency to the end user (Manktelow et al., 2014), otherwise such ‘conﬂicting’
results may strengthen the myth that statistics can prove anything.
14
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For both standardization methods, caution is needed when some patient-
groups are almost empty or have close to zero events, because then results may
be unstable. For example, when hospital 1 in Table 1.1 had 0 instead of 1 observed
death for its low risk patients, ˆDSR1 would drop from 4.3% to 3.7% while ˆISR1
would hardly change (still 0.93). At the same time, the ˆDSR for the other hospitals
would not change, while the estimated ISRs would increase: for hospital 2 from
0.84 to 0.97 and for hospital 3 from 1.32 to 1.53.
Example 1.2
• Traditionally indirectly standardized measures are used for national
hospital performance evaluations, e.g. in the UK (Clinical Indicators
Team, 2015) and the US (Ash et al., 2012). This is indeed the most
relevant measure to judge a hospital’s performance on its own patient
mix or for yearly evaluations, where the latter should ideally come
with a careful description of changes in patient mix over time.
• Recently, the usefulness of direct standardization in this context has
been recognized (Nicholl et al., 2013), e.g. in Figure 1.1 directly stan-
dardized 5-year survival probabilities are reported. It is a valuable
measure for example when hospitals vary in approach and one wishes
to choose one approach for implementation across all hospitals. The
given care level can then be extrapolated to a broader set of patients
through direct standardization.
A further discussion of when to best use which standardization is given in
Chapters 2 and 3.
1.3.4 Outcome regressionmodeling to adjust for patientmix
The arithmetic approach we used in the previous section to estimate the DSR and
ISR has some practical limitations: Calculations become complicated when the
number of patient characteristics is large. Moreover, patient attributes that were
measured on a continuous scale (e.g. age) have to be categorized (e.g. 10-year age
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groups), reducing their informative value. We have also shown that the calculated
standardized risks may become unstable when the observed number of deaths is
small for some patient subgroups. In each of these situations outcome regression
modeling can help estimate the directly and indirectly standardized risks.
A simple regression model for a patient’s outcome Yi (e.g. patient satisfaction
score) given his/her agei and at which hospitalCi (1 or 2) he/she was treated, is:
E(Yi |agei ,Ci )=β agei +ψ1I (Ci = 1)+ψ2I (Ci = 2), (1.3)
where I (Ci = 1) is 1 if the i -th patient was treated at hospital 1 and 0 otherwise,
similarly for I (Ci = 2). Under the ‘no unmeasured confounders’ assumption the
model parameters (β,ψ1,ψ2) can be interpreted as the causal effect of respec-
tively age, the care level of hospital 1 and the care level of hospital 2 on the patient
satisfaction. In Chapter 2 and Chapter 3 or in Roalfe et al. (2008) it is explained
how the directly and indirectly standardized risks can be calculated based on
outcome regression models. For the simple model in (1.3), a possible way to
calculate the indirectly standardized risk (as a ratio of observed and expected
risk) for hospital 1 is:
ˆISR1 =
1
n1
∑n1
i=1Yi
1
n1
∑n1
i=1
(
β agei + ψ1+ψ22
) , (1.4)
where n1 is the number of registered patients in hospital 1.
The limitations of the arithmetic approach can be overcome by using out-
come regression modeling: The outcome model can include whatever type of
patient characteristic, such as binary (e.g. smoking status), categorical (e.g. edu-
cation level) or continuous covariates (e.g. age). Neither is the outcome format
limiting, even though we formulated a regression model for a continuous out-
come, statistical models exist for binary outcomes (e.g. logistic regression for
30-day mortality, Agresti (2002)) or survival outcomes (e.g. Cox proportional
hazards model for time to death, Collett (2015)). For a large number of patient
characteristics p and a general number of centers m, the simple outcome regres-
16
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sion model in (1.3) can easily be extended:
E(Yi |Li ,Ci )=
p∑
j=1
β j Li j +
m∑
c=1
ψc I (Ci = c), (1.5)
where Li = (Li1, . . . ,Lip) is the vector of confounders for patient i . However, the
important challenge is to accurately estimate the model parameters (β1, . . . ,βp ,
ψ1, . . . ,ψm).
Given a sample of n patients, the model parameters can be estimated for
example via maximum likelihood estimation (Neter et al., 1996), which is a
widely-used method and implemented in most statistical software programs.
When the number of hospitals under study m is large, many hospital effects
ψc (c = 1, . . . ,m) need to be estimated. Moreover, due to a limited sample size, the
number of registered patients may be small for some hospitals so that estimating
hospital effects may become impossible or hold unstable and inaccurate results
(Peduzzi et al., 1996). Especially the smallest hospitals may suffer from this lack of
information. Excluding those hospitals is not an option as smaller hospitals have
shown lower care levels in some settings e.g. due to a smaller learning effect for
surgical procedures (Silber et al., 2010; Kressner et al., 2009). Currently, the most
popular solution is the mixed effects model (Ohlssen et al., 2007a; Mohammed
et al., 2012). It assumes ﬁxed effects for the patient characteristics as before, but
normal random effects for the hospital, i.e. the hospital effects are assumed to
follow a normal distribution: ψc ∼ N (μ,σ2). Then, only two parameters (μ,σ)
need to be estimated instead of m separate hospital effectsψc(c = 1, . . . ,m). To
estimate the effect of one speciﬁc hospital, information from all other hospitals
under study is borrowed, namely via μ and σ. However, this approach may
shrink the hospital effect towards the ‘average’ hospital effect μ (Kalbﬂeisch and
Wolfe, 2013; Ash et al., 2012), especially for the smallest hospitals, as they put
less weight in estimating μ and σ. For example, in Figure 1.3 we plot a histogram
of hospital effects ψc (c = 1, . . . ,m) together with a normal distribution curve
having sample mean 0.05 and sample variance 1.19. It is clear that when the
hospital effects are drawn from the approximating normal distribution, this
results in an accurate estimate for most hospital effects, but the percentage of
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Figure 1.3: The distribution of the hospital-speciﬁc effectsψc (c = 1, . . . ,m) form = 200
hospitals and an overlaying normal distribution function.
hospitals with an effect in the tails will be smaller than the observed percentage.
Thus, outlying (good or bad) performance may be masked which is of course
undesirable. An alternative method to estimate the hospital effects is via Firth
corrected maximum likelihood estimation (Firth, 1993), which does not assume
a normal distribution for the hospital effects, but instead a distribution that has
heavier tails, allowing for more substantial deviations from the ‘average’ hospital
effect. This method builds upon ordinary maximum likelihood estimation, but
is developed to reduce bias on the parameter estimates and has shown to ﬁx
convergence problems even when only few events are observed in some patient
subgroups. Its use in the context of assessing hospital performance will therefore
be investigated in Chapter 2.
Example 1.3
• In the US, the Centers for Medicare and Medicaid Services estimate
the expected risk based on a mixed effects model with ﬁxed patient ef-
fects and random hospital-speciﬁc effects (without including hospital
18
1
1.3. Statistical Issues when Quantifying Performance
attributes such as volume) (Ash et al., 2012).
• In the UK, the Health and Social Care Information Centre reports that
the expected risk is based on a ﬁxed effects model with patient effects
and without hospital-speciﬁc effects (Clinical Indicators Team, 2015).
1.3.5 Benchmarking and reporting
Given the estimated standardized risks, we also need to be aware of their preci-
sion: If the average mortality risk is 20%, a standardized mortality risk of 25%
is in general more worrisome for a hospital with 400 registered patients than
for a hospital with 100 registered patients. This source of uncertainty on the
estimated standardized mortality risks (SMR) can be expressed through its vari-
ance, whereby smaller hospitals will have a larger variance. We can then easily
construct a conﬁdence interval for each hospital’s SMR. Traditionally 95% conﬁ-
dence intervals are used, which express a range of values (e.g. 22% to 28%) that
you can be 95% certain contains the true hospital’s SMR, which is unknown. So, if
we would be able to take 100 data samples, then on average 95 of the constructed
conﬁdence intervals will contain the true SMR.
Funnel plots are used in an increasing number of applications to provide a
graphical representation of hospital performance (Spiegelhalter, 2005a; Camp-
bell et al., 2012). Examples are given in Figure 1.1 and Figure 1.4, where the
hospital performance measure (e.g. in Figure 1.1 estimated 5-year survival proba-
bility) is plotted against a measure for its precision (e.g. the number of registered
patients), a horizontal line is drawn at the average (e.g. 81.5%) and thresholds
indicate for which hospitals the performance measure is signiﬁcantly different
from that average. Over-dispersion may dilute this plot, i.e. when the variabil-
ity in hospital performance measures is so large that it cannot be attributed to
chance and a few divergent institutions (Spiegelhalter, 2005b). Then the majority
of hospitals lies outside the threshold values, which makes the labeling useless.
Several methods exist to temper over-dispersion, from ad-hoc methods that
cluster the hospitals in more homogeneous groups, to more advanced meth-
ods that estimate an over-dispersion factor which expands the control limits
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Figure 1.4: Summary Hospital-level Mortality Indicator (SHMI) funnel plot for the period
January 2014 until December 2014.
(Spiegelhalter, 2005b).
Alternatively, a range of clinical equivalence can be deﬁned (Normand et al.,
1997), for example in Figure 1.5 the clinical equivalence limits are set at 0.8 and
1.2 times the average mortality risk Eˆ(Y ). Then, for hospitals with an estimated
SMR outside the clinical equivalence zone, we aim to express how certain we
are about the estimated SMR and whether its true SMR is expected to exceed
the clinical equivalence limits. Therefore, a hospital is labeled as having high
mortality risk if (the lower limit of) its 50% conﬁdence interval exceeds the upper
clinical boundary, similarly for low mortality risks. Taking into account the
magnitude of effect is especially important because e.g. large hospitals tend to
have very narrow conﬁdence intervals which are virtually guaranteed to exclude
the average risk even though such differences may not be clinically relevant.
When taking into account a clinical equivalence range, the level of conﬁdence
should accordingly be decreased (e.g. from 95% to 50%), otherwise hardly any
hospital would be labeled as having outlying performance, so that the labeling
20
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Figure 1.5: A hospital is labeled as having low (blue) or high (red) mortality risk if the
50% conﬁdence interval (CI) for its directly standardized risk respectively exceeds the
clinically relevant boundaries 20% lower or higher than the overall mortality risk of 8%.
would again become useless.
The chosen values for the statistical and clinical relevance determine how
much priority is given to avoiding Type I and Type II errors. A Type I error is made
if a hospital with acceptable performance is labeled as having low/high mortal-
ity risk. On the other hand, Type II errors occur when hospitals with low/high
mortality risk are not detected as such. When reports are openly published, Type
I errors may be more harmful than Type II errors, because wrongly labeling a
center as having high mortality risk may lead to unjust negative advertising. A
smaller percentage of Type I errors may then be obtained by either construct-
ing wider conﬁdence intervals or widening the clinically meaningful interval.
However, these actions will increase the percentage of Type II errors. If results
are used for internal evaluation in hospitals, the stakeholders can decide to set
the benchmarking values so that the percentage of Type II errors is small and
hospitals with deviating performance have a high probability to be detected as
such.
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Example 1.4
• In the US, comparative performance information in the form of ‘report
cards’ (e.g. http://www.valleyhealthlink.com/usnews) has been
published for the public for over a decade (Normand and Shahian,
2007; Mannion and Goddard, 2003).
• In the UK, annual reports on hospital performance include funnel
plots, for example Figure 1.4.
1.3.6 A note of caution
Statistical inference is inextricably connected with uncertainty. Clinical regis-
ters naturally do not record all patients in all hospitals, due to time and cost
constraints or on explicit request of the patient (e.g. privacy concerns). So in
practice results are mostly based on a sample of n patients, where these results
may still pertain to the whole patient population if this sample was randomly
chosen, but not if for example (some) hospitals systematically avoid registering
older patients with higher mortality risk.
Precision is decreased and bias may be induced when there are missing data
(Rubin, 1976), e.g. when for some patients it is registered whether they smoke
or not, while for others this is unknown. In Chapter 4 we discuss both complete
case analysis and multiple imputation to handle missing data, comparing cur-
rent practice and statistical preference (White and Carlin, 2010). To perform a
complete case analysis, one assumes that the reason why values are missing is
independent of the observed and unobserved data. In practice this assumption
is rarely met and may then yield biased results for hospitals with a selective
subset of complete records (Knol et al., 2010). Multiple imputation (Schafer,
1999) on the other hand assumes that given the observed data, the missingness
mechanism is independent of the unobserved data, for example when age is
more often missing for females whereby gender is completely observed. Missing
values for age are then ﬁlled in, based on a parametric model that predicts age
values in function of the observed data. So, whether imputed values for age are
22
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unbiased, strongly relies on the correctness of the assumed parametric model.
Special awareness is needed when the missing at random assumption is not
met, for example when age is more often missing for older patients (Sterne et al.,
2009). A sensitivity analysis may then explore how strongly results vary under
the different missingness mechanisms (Robins et al., 2000).
In addition, benchmarking hospital performance is not a ‘hard’ science:
Different techniques will give different results. Crossing a threshold should
therefore not indicate high or low ‘quality’ but it may be useful to investigate
reasons for the apparent discordance (Spiegelhalter, 2005b). Of course it would
be pointless to collect and analyze all these data if no action follows. However,
caution is needed when doing so. It has been shown, e.g. by Lilford et al. (2004)
and Freeman (2002), that when results are used for funding or could even lead to
closure, they often stimulate perverse reactions. One way is through data gaming,
i.e. manipulating the data registration on purpose to upstage performance
results, for example by keeping patients wait in ambulances to decrease the
registered time between hospital admission and treatment start (Shaw et al.,
2015). Another example is given in Figure 1.6 where some of the increasing trend
in deaths coded as palliative will be due to an increasing accuracy of coding
over the years, but it is highly likely that there is also an element of data gaming.
Adverse reactions could even lead to worse clinical practice itself, e.g. when
the number of surgical interventions for high-risk patients is reduced to avoid
in-hospital deaths.
So, not only should there be paid close attention to developing valid statistical
analysis but also to developing an organizational environment that encourages
the constructive use of such information (Mannion and Goddard, 2003). Hos-
pitals can use health outcomes data to evaluate how they are doing compared
to their peers. This gives them a unique opportunity to learn from one another,
to investigate and discuss its performance and next take whatever action seems
necessary to improve the way they provide care. In this way, performance moni-
toring can indeed have a major beneﬁcial effect on quality of care and patient
outcomes (Gross et al., 2001): In Mehta et al. (2007) it is claimed that monitoring
quality of care is likely to achieve larger reductions in death than any individual
new therapy or drug.
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Figure 1.6: The percentage of deaths coded as palliative from ﬁnancial year 2006/07 to
2012/13.
We can conclude with a citation from Lilford and Pronovost (2010): “The
science still needs to mature, not only to improve the measurement of quality,
but also to learn how to use the (inevitably imperfect) measurements so that they
do more good than harm.”
Example 1.5
In the UK, the Clinical Indicators Team (2015) remark that the reported
standardized risks require careful interpretation and should be used in con-
junction with other indicators and information from other sources (e.g.
patient feedback, staff surveys and other similar material) that together form
a holistic view of trust outcomes.
1.4 Technical Motivation and Outline
Having argued that hospital evaluations need careful statistical analysis which
face many challenges, we give an overview of the statistical techniques in this
thesis. We will focus on some deﬁciencies in the current methodology and
evaluate the properties of candidate approaches in the following chapters.
Clinical registers often contain some hospitals with a small number of reg-
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istered patients. It has been repeatedly shown that the popular mixed effects
model may pull the performance of these hospitals towards the average, inﬂating
the Type II error of not detecting outlying performance (Normand et al., 1997;
Ash et al., 2012). Therefore we evaluate in Chapter 2 to which amount Firth
corrected estimates (Firth, 1993) may avoid such shrinkage and moreover reduce
bias on the estimated directly standardized risk. A second concern we handle is
the risk of model extrapolation when estimating e.g. the directly standardized
risk, because it requires predicting for each patient how he/she would fare if the
care level of a given hospital c applied, which is not observed. This is especially
problematic when the patient mix differs substantially across hospitals, as il-
lustrated at the top of Figure 1.7, where the smallest hospital suffers most from
extrapolation. Standard regression methods may then hold biased results and
underestimated uncertainty (Rubin, 1997). We investigate whether and how this
could be remedied by weighting patients by the reciprocal of the probability to be
treated in the observed hospital (Shahian and Normand, 2008). If this probability
is extremely small, the end user will be warned for strong extrapolation through
inﬂated variance estimates.
Common adjustments for differences in patient mix assume that the effect of
the hospitals’ care level on the outcome is constant over patient characteristics
(Ohlssen et al., 2007b; Shahian and Normand, 2008). For example in model (1.3)
the hospital effects ψ1 and ψ2 are assumed to be independent of the patient’s
age. This is violated when e.g. hospital 1 is specialized in care for the elderly, so
that older patients receive much better care in hospital 1 compared to hospital
2, while for younger patients the care level is very similar in both hospitals.
A visualization of the outcome regression models in such a situation is given
in Figure 1.7 and will be discussed in more detail in Chapter 3. The topic of
that chapter is to assess how common practice of ignoring such interactions
may impact the bias and precision of directly and indirectly standardized risks,
depending on the patient distribution across hospitals and the hospital size.
This may help justify the common practice, especially in situations where it is
simply prohibitive to allow for these interactions in the model because sufﬁcient
information is lacking in small hospitals, see for example Ash et al. (2012).
By adjusting for all potential confounders, outcome regression models aim to
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Figure 1.7: Extrapolation for the directly and indirectly standardized risk considering 2
centers (small or large center size). The 30-day mortality risk is estimated based on an
outcome regression model without interaction between center and patient’s age, while
the true model includes a different center effect on 30-day mortality for varying ages.
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come as close as possible to the true causal effect of hospitals on mortality (Green-
land, 2008; Brookhart et al., 2010). However, registering all potential confounders
is practically limited by the measurement time/cost and the perverse effect
of more missing values (Shahian et al., 2007). Moreover, estimation strategies
may no longer converge when too many covariates are included (Vansteelandt
et al., 2010). In Chapter 4 we investigate the use of stochastic search algorithms
(De Beukelaer et al., 2015) to ﬁnd the subset of confounders that minimizes the
cross-validated error on the estimated individual or standardized risk. In doing
so, we give the covariates a cost proportional to the measurement/registration
effort or to the percentage of missing values, because missing values may imply
serious loss of efﬁciency and even induce bias if the missingness assumption
is not fulﬁlled (Sterne et al., 2009). We will also provide analytical guidelines
that may help decide for which amount of missingness it is still beneﬁcial to in-
clude a more informative covariate, rather than its surrogate which is completely
observed.
We have also been working on a user-friendly R-package ‘RiskStandard’ that
implements the estimation of the directly and indirectly standardized risks based
on (Firth corrected) logistic regression models with ﬁxed effects for the hospital
and patient characteristics. The package allows for labeling hospitals based on
these estimated risks, where the statistical and clinical signiﬁcance levels are
deﬁned by the user. The implemented plot functions may help visualizing the
quality of care in hospitals. This package is documented in Chapter 5 and can
be downloaded from www.cvstat.ugent.be.
27

2CHAPTER 2
On Shrinkage and Model Extrapolation
in the Evaluation of Clinical Center Performance
This chapter is based on the following paper: Varewyck, M., Goetghebeur, E.,
Eriksson, M., and Vansteelandt, S. (2014). “On shrinkage and model extrapolation
in the evaluation of clinical center performance," Biostatistics, 15(4): 651-664.
Summary
We consider statistical methods for benchmarking clinical centers based on a
dichotomous outcome indicator. Borrowing ideas from the causal inference
literature, we aim to reveal how the entire study population would have fared
under the current care level of each center. To this end, we evaluate direct
standardization based on ﬁxed versus random center effects outcome models
that incorporate patient-speciﬁc baseline covariates to adjust for differential
case-mix. We explore ﬁxed effects regression with Firth correction and normal
mixed effects regression to maintain convergence in the presence of very small
centers. We moreover study doubly robust ﬁxed effects regression to avoid
outcome model extrapolation. Simulation studies show that shrinkage following
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standard mixed effects modeling can result in substantial power loss relative to
the considered alternatives, especially for small centers. Results are consistent
with ﬁndings in the analysis of 30-day mortality risk following acute stroke across
90 centers in the Swedish Stroke Register.
2.1 Introduction
In recent years, the interest in proﬁling hospital performance has grown among
different stakeholders including government and health insurers, hospitals and
clinicians, and last but not least the patients. Health care quality thus deserves
careful statistical analysis yielding relevant and relatively simple measures with
clear interpretation for hospital evaluation.
In this article, we focus on statistical methods to estimate center performance
on a binary quality indicator such as 30-day mortality. Causal inference methods
will be adopted to adjust for measured confounding by differential patient mix
(e.g. initial disease status, age). This is important (DeLong et al., 1997; Austin
et al., 2003) as centers treating more severely ill patients tend to have higher
mortality irrespective of treatment quality. Most literature uses indirect standard-
ization to adjust for patient mix (Spiegelhalter, 2005a; Shahian and Normand,
2008). This involves contrasting the observed average quality outcome in each
center with what it would have been for their patients if ‘the average level of
care over all centers’ applied. This is particularly helpful for policy makers when
deciding where to best spend resources for quality improvement. However, when
centers are expected to provide good health care on the overall patient popula-
tion, directly standardized outcomes may be of greater interest. This potential
full population risk in each center will be our focus. It makes us consider how
the entire study population would have fared under the current level of care of
each center.
Random effects models which incorporate patient-speciﬁc baseline covari-
ates are routinely applied for indirect standardization (Ohlssen et al., 2007a), and
can also be used for direct standardization. The main advantage of these models
is that they severely reduce the effective model dimension, thereby avoiding
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problems of overﬁtting. However, two main shortcomings deserve more in depth
study: shrinkage and model extrapolation. First, estimates for small centers
may shrink severely toward the population mean, resulting in bias and power
loss for these centers (Normand et al., 1997). This is a major concern because
the quality of care in small centers is sometimes questioned, in view of their
potentially more limited surgical experience or medical infrastructure (Saposnik
et al., 2007). Fixed effects models are no viable substitute in settings encounter-
ing many centers with often small numbers of registered patients, where this
method suffers from bias and convergence problems (Neyman and Scott, 1948).
In this article, we will investigate whether this limitation can be overcome via
the Firth correction for ﬁxed center effects models (Firth, 1993). Second, when
case-mix differs severely between centers, results from the default ﬁxed and
random effects models can become very sensitive to model misspeciﬁcation
which is hard to detect (Rubin, 1997). We aim to overcome this using doubly
robust methods (Robins et al., 2007) that build on a ﬁxed center effects model
(with Firth correction) but utilize inverse weighting by the so-called propensity
score (Shahian and Normand, 2008), which is the probability of being treated in
the observed center based on patient characteristics.
These statistical methods will be compared in terms of their support for
correct detection of low and more importantly high risk centers. For this purpose,
we will adapt the decision criterion suggested by Normand et al. (1997) to the
framework of direct standardization. Speciﬁcally, we will seek solid statistical
evidence of a clinically relevant difference between the potential full population
risk from a given center and the observed population risk.
Comparisons are made in two case studies: a simulation study on quality
insurance for rectal cancer treatment in Belgium and an analysis of quality of
care data from the Swedish Stroke Register (Asplund et al., 2011). They reﬂect
markedly different settings with chronic versus acute illness, with major versus
more limited differences in case-mix, with small versus larger center sizes, and
with a limited versus rich set of patient covariates.
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2.2 Proﬁling Center Performance: Framework
Throughout the paper, C is a random variable indicating in which center the
patient was actually treated (C = 1, . . . ,m) and L denotes the vector of patient-
speciﬁc baseline characteristics such as gender and initial disease status. The
methods below focus on 30-day mortality Y , but can easily be extended to a
continuous or categorical outcome.
2.2.1 Direct versus indirect standardization
Direct standardization aims to infer the potential full population risk for each
center c : the risk that would be realized if all patients under study were to experi-
ence the care level of that given center c , irrespective of where they were actually
treated. We denote this by E {Y (c)}, where Y (c) indicates the potential outcome
for given patient if treated at the care level of center c. A main feature of direct
standardization is that the patient mix used for comparison is a common set of
subjects. As such, center comparisons are based on their current performance in
the extended patient population, where the extent of extrapolation from each
center’s own patient population depends on how case-mix differs between cen-
ters. This approach may thus evaluate a center’s performance based on patients
it is not likely to treat.
In contrast, indirect standardization focuses on what a center achieves for its
own patient mix. For instance, the frequently used standardized mortality ratio
(SMR) takes the ratio of the center’s observed risk and the expected risk if these
patients would experience the average care level across all centers where center
performance levels were uniformly distributed, i.e.
SMR= E {E(Y |L,C = c)|C = c}
m−1
∑m
c∗=1E {E(Y |L,C = c∗)|C = c}
= E {Y (c)|C = c}
m−1
∑m
c∗=1E {Y (c∗)|C = c}
, (2.1)
(DeLong et al., 1997; Shahian and Normand, 2008). When a difference is taken
instead of a ratio, the name ‘excess risk’ is used (Goetghebeur et al., 2011). Indirect
standardization thus aims to answer the question: ‘How would the risk in a given
center change if its patients were to experience the average risk across all centers?’.
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Mortality risk (no. patients) Indirect stand. Direct stand.
L = low L = high SMR Excess Risk
center 1 1% (900) 10% (100) 0.8382 −0.0037 0.0670
center 2 1% (100) 10% (900) 0.9349 −0.0063 0.0670
center 3 2% (100) 12% (900) 1.1301 0.0127 0.0833
Table 2.1: Artiﬁcial example comparing center performance based on indirect and direct
standardization. For the three centers patient-speciﬁc mortality risks and patient mix
(no. patients) are given per level of the covariate L, indicating low or high baseline
severity.
Such contrast with the average risk across all centers can be limiting when this
reference deviates from what is ideally targeted.
Direct and indirect standardization extrapolate observations to a general
population or a general care level respectively. This may result in different
comparisons, as illustrated in Table 2.1 where centers 1 and 2 have the same
patient-speciﬁc mortality risks, but differ in patient mix. Following indirect stan-
dardization, these centers are classiﬁed as having different performance because
their patient mix differs. Results moreover depend on whether indirect stan-
dardization is based on SMRs or excess risks, because small absolute differences
can result in large relative differences and vice versa. Therefore, when indirectly
standardized outcomes are of interest we would recommend excess risks em-
phasizing the possibly large extrapolation of center performance. The directly
standardized risks on the other hand detect equal quality of care in centers 1
and 2, because of their equal patient-speciﬁc mortality risks. They also allow
for direct comparison with the overall risk of 7.02%, but may involve serious
extrapolation when the patient population of that center differs substantially
from the overall population.
2.2.2 Decision criterion for labelling centers
In Section 2.3, we will compare statistical methods for direct standardization in
terms of correctly detecting low and more importantly high risk centers. There-
fore, following a proposal ﬁrst introduced in a Bayesian context (Normand et al.,
1997), we will classify a center as low/high risk if the data provide sufﬁcient
33
Chapter 2. On Shrinkage and Model Extrapolation
2
evidence that the potential risk E {Y (c)} exceeds a benchmark relative to the pop-
ulation average risk E(Y ). For this purpose, we will develop estimators Eˆ {Y (c)}
for the potential risk E {Y (c)} (see Section 2.3) and then classify a center as low
risk if
Eˆ {Y (c)}+ zk × sd
(
Eˆ {Y (c)}
)< (1−λ) E(Y ) (2.2)
or as high risk if
(1+λ) E(Y )< Eˆ {Y (c)}− zk × sd
(
Eˆ {Y (c)}
)
. (2.3)
Here, λ expresses a clinically meaningful tolerance level (e.g. 20%) indicating
how much the center-speciﬁc potential risk is allowed to depart from the current
population average risk E (Y ). The latter can be estimated by the sample average
of observed risks or be replaced by a reference standard if objective benchmarks
(e.g. national guidelines) are available. In practice such envisaged reference is
likely to steer the choice of λ once E (Y ) is known or has been estimated. Further,
zk is the k×100th percentile of the standard normal distribution, so k (e.g. 0.75)
expresses the degree of statistical evidence required before ﬂagging a center as
low/high risk.
The previous criterion has close links to the often used frequentist criterion
(DeLong et al., 1997) whereby a center c is classiﬁed as low/high risk if the
estimated 95% conﬁdence interval for its potential full population risk excludes
the population average risk E(Y ):
E(Y ) ∉ [Eˆ {Y (c)}± z0.975× sd(Eˆ {Y (c)})] . (2.4)
See Shahian and Normand (2008) for a related Bayesian criterion. This corre-
sponds with (2.2) and (2.3) if λ= 0 and k = 0.975. A key drawback of this criterion
is that it disregards clinical signiﬁcance. In particular, large centers are virtually
guaranteed to exclude the population average risk and thus will nearly always be
labelled statistically signiﬁcant low/high risk centers.
Pure ranking based on the estimated potential risk is dangerous as it is oblivi-
ous to a clinical appreciation of differences between centers as well as to uncer-
tainty. Large differences in ranks may correspond with small clinical differences
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and vice versa. Moreover, uncertainty around the ranking is often substantial
(especially for small centers) and conﬁdence intervals may tend to overlap for
different centers (Spiegelhalter, 2005a). Although ranking based on the estimated
probability of exceeding performance can be considered (Normand et al., 1997),
we believe its inherent property of masking the size of differences in center per-
formance demands careful interpretation involving additional information; it
will therefore not be considered in this paper.
2.3 RegressionMethods
We will now discuss different methods to estimate the potential full population
risk E {Y (c)} in each center c = 1, . . . ,m. Let n be the total sample size. Through-
out we assume that the patient-speciﬁc covariates L are sufﬁcient to adjust for
confounding of the center-outcome effect, so that Y (c)⊥⊥C |L for all c (Hernán
and Robins, 2006b). Under this assumption, we have that
E {Y (c)}= E {E(Y |L,C = c)}. (2.5)
2.3.1 Normalmixed effects model
We will ﬁrst focus on outcome regression models which postulate that in each
center c:
E(Y |L,C = c)= expit(L′β+ψc)= f (L,c;β,ψ), (2.6)
whereψ = (ψ1, . . . ,ψm) are the center effects. For convenience, we here constrain
the effects β of patient-speciﬁc covariates on outcome to be equal across all
centers, but this can in principle be checked (size permitting) or relaxed by
including interactions with center. Once estimates (βˆ ,ψˆ) for (β,ψ) have been
obtained, it follows from (2.5) that the potential full population risk can be
estimated as (Hernán and Robins, 2006b):
Eˆ {Y (c)}= 1
n
n∑
i=1
expit
(
L′i βˆ + ψˆc
)= 1
n
n∑
i=1
f (Li ,c;βˆ ,ψˆ). (2.7)
The evaluation of center performance is often based on Bayesian normal
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mixed effects models (ME). These augment model (2.6) with a normal random
effects distribution
ψc ∼N (μψ,σ2ψ), c = 1, . . . ,m, (2.8)
which assumes centers to be exchangeable in the sense that any a priori infor-
mation on the relative ordering or grouping of center effects is ignored (Ohlssen
et al., 2007a). Here, μψ is the common mean and σψ the standard deviation of
the center effectsψc , which we assume to have independent hyperpriors. More-
over, assuming that the center effects are a priori independent of the effects of
patient characteristics, the joint posterior distribution of this two-level Bayesian
approach is of the form:
p(β,ψ,μψ,σ
2
ψ|y,L,C)∝
n∏
i=1
p(yi |β,ψ,L,C)p(ψ|μψ,σ2ψ)p(β)p(μψ)p(σ2ψ). (2.9)
This posterior is estimated using a Markov chain Monte Carlo (MCMC) algorithm,
which provides values for the model parameters (β,ψ) in each step. These are
subsequently used to evaluate (2.7), thereby enabling us to estimate the posterior
distribution of E {Y (c)}.
An advantage of the Bayesian over a frequentist approach based on empirical
BLUPs (Robinson, 1991) is that by using MCMC algorithms one can directly
obtain posterior estimates and variances of even complicated transformations
such as (2.7) without the need for large sample justiﬁcations, provided a sufﬁ-
cient number of MCMC iterations are run (O’Brien and Dunson, 2004). Prior
information can be incorporated in Bayesian models through an informative
prior distribution. When no such information is available, a normal distribution
with large variance as non-informative prior on center level may still be hard to
justify as the center effects could follow a longer-tailed distribution such as the
Student’s t or even an asymmetric distribution. In particular, choosing a normal
prior may shrink estimated center effects towards the center population mean
μψ, especially for very small centers (Normand et al., 1997). Severe shrinkage
may be problematic when reporting individual feedback to the centers, because
identiﬁcation of centers with deviating performance is especially important. The
amount of shrinkage is related to the choice of prior, but judging the plausibility
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of a normal prior is difﬁcult because it refers to center effects on the logit scale.
2.3.2 Reducing shrinkage
Clustered normalmixed effects model.
The mixture model of Ohlssen et al. (2007a) forms a ﬁrst approach considered
to reduce shrinkage. This involves assigning the m centers to a chosen number
K <m of clusters with each their own normal random effects distribution. The
model for the center level effects thus becomes
ψc ∼N (μk ,σ2k) with unknown probability pk , k = 1, . . . ,K .
It thus assigns each center c to cluster k with probability pk and subsequently
draws a random center effect from the normal distribution of the ‘cluster k
population’ with cluster mean μk and variance σ
2
k within the cluster. In this
process, we let each center have an a priori equal probability of belonging to
each cluster without the size or performance of the clusters being predeﬁned.
When a priori knowledge of clustered center performance is available (e.g. when
large centers are expected to have better facilities resulting in better performance
(Saposnik et al., 2007)), it can be incorporated by giving centers a larger prior
probability for speciﬁc clusters.
Fixed effects logistic regressionmodel with Firth correction.
Shrinkage can alternatively be reduced using maximum likelihood estimation
for the ﬁxed effects (FE) logistic regression model (2.6). However, because of
overﬁtting the resulting estimator (2.7) may behave erratically when there are
centers with few events: besides convergence problems, there may be substantial
ﬁnite sample bias and large variance (Peduzzi et al., 1996). The ME approach
of Section 2.3.1 accommodated this by imposing a normal distribution on the
center effects. Here, we will consider the Firth corrected FE method instead.
Firth correction (Firth, 1993) reduces the O(n−1) bias of ordinary maximum
likelihood estimators to the orderO(n−2) by maximizing the penalized likelihood
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function
L∗(β,ψ)= L(β,ψ)|I (β,ψ)|1/2, (2.10)
instead. Here, |I (·)| denotes the determinant of the Fisher information matrix
of (β,ψ) and L(·) is the ordinary likelihood function. Since |I (β,ψ)|1/2 equals
Jeffreys’ invariant prior, Firth correction is equivalent with penalization of the
likelihood by Jeffreys’ prior (Kosmidis and Firth, 2009), suggesting that Firth
corrected maximum likelihood estimates are also subject to shrinkage. However,
Jeffreys’ prior is invariant under reparameterization and has the key feature of be-
ing non-informative. The latter, coupled with its deﬁning bias reduction property,
implies that it may result in less shrinkage compared to the use of a normal prior.
There is evidence that it may also perform better in terms of other properties
such as ﬁniteness of the estimator and coverage of conﬁdence intervals (Kos-
midis and Firth, 2009). We will investigate this in our setting through simulations
in Section 2.4. In the Appendix (Section 2.A.1 and 2.A.2), we give additional detail
on the Firth correction and show how to estimate the asymptotic variance of the
resulting estimate of E {Y (c)}.
2.3.3 Accounting formodel extrapolation: Doubly robustpropen-
sity scoresmethod
All previous methods suffer from a risk of extrapolation as they require predicting
for each patient how he/she would fare if the care level of a given center c
applied. When case-mix differs across centers, especially when there are strong
confounders, such extrapolation may not be justiﬁed. Even models that seem
to ﬁt the observed data well may then be misspeciﬁed and imply serious model
extrapolation, resulting in bias and underestimated uncertainty (Rubin, 1997).
This is illustrated in the Appendix (Figure 2.4) where we consider two centers
with strongly differential case-mix: one center has patients older than 60 and the
other does not. We ﬁnd strong model extrapolation that may not get reﬂected
in standard errors, so the user is left without warning (Rubin, 1997). Similar
concerns are warranted for standard indirect standardization methods as these
extrapolate stratum-speciﬁc center effects to the patients of each given center.
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Inverse probability weighting via propensity scores (PS) avoids extrapolation
by not relying on outcome models. For a given patient i the PS are deﬁned as the
vector of probabilities to belong to each given center c on the basis of his/her
baseline characteristics Li . In practice, such PS can be estimated by ﬁtting a
multinomial regression model:
P (Ci = c|Li )= g (Li ,c;γ,δ)=
⎧⎪⎪⎨
⎪⎪⎩
1
1+∑mj=2 exp(L′iδ j+γ j ) c = 1
exp(L′iδc+γc )
1+∑mj=2 exp(L′iδ j+γ j ) c 	= 1,
(2.11)
whereCi indicates the center where patient i was treated. Parameter estimators
(γˆ, δˆ) can be obtained via maximum likelihood, so by solving the following set of
estimating equations
1
n
n∑
i=1
(
1
Li
){
I (Ci = c)− g (Li ,c; γˆ, δˆ)
}= 0 c = 2, . . . ,m. (2.12)
We can now estimate E {Y (c)} as in (2.7), but using a weighted regression to
ﬁt the ﬁxed effects model (2.6), with weights equal to one over the PS of the
observed center g (Li ,Ci ; γˆ, δˆ). That this works can be seen because the weighted
regression of the FE model sets
1
n
n∑
i=1
⎛
⎜⎜⎜⎜⎜⎝
Li
I (Ci = 1)
...
I (Ci =m)
⎞
⎟⎟⎟⎟⎟⎠
1
g (Li ,Ci ; γˆ, δˆ)
{
Yi − f (Li ,Ci ;βˆ ,ψˆ)
}= 0. (2.13)
This enables us to rewrite
Eˆ {Y (c)} = 1
n
n∑
i=1
f (Li ,c;βˆ ,ψˆ)
= 1
n
n∑
i=1
[
f (Li ,c;βˆ ,ψˆ)+ I (Ci = c)
g (Li ,c; γˆ, δˆ)
{
Yi − f (Li ,c;βˆ ,ψˆ)
}]
(2.14)
= 1
n
n∑
i=1
[
I (Ci = c)Yi
g (Li ,c; γˆ, δˆ)
+
{
1− I (Ci = c)
g (Li ,c; γˆ, δˆ)
}
f (Li ,c;βˆ ,ψˆ)
]
.(2.15)
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These expressions show how the resulting estimator of E {Y (c)} is doubly robust,
i.e. unbiased (in large samples) if either the outcome or the PS model holds, but
not necessarily both (Robins et al., 2007). Indeed, the second term in (2.14) and
(2.15) has population mean zero if respectively the outcome or the PS model is
correctly speciﬁed. Furthermore, the remaining term has mean E {Y (c)} under
those respective assumptions. This double robustness property is attractive
because it allows for misspeciﬁcation of the FE model if the PS is modelled
correctly. It thus in particular offers partial protection against false omission
of interactions between center and patient characteristics. When patient mix
is drastically different between centers, the resulting lack of information gets
exhibited in large standard errors.
Small centers can give problematically small estimated PS values, especially
when its patient case-mix is very different from that of other large centers. We
therefore stabilize the PS for each center by dividing all estimates g (Li ,c; γˆ, δˆ)
by the proportion of patients at that center. This stabilization does not affect
the consistency nor the double robustness property of Eˆ {Y (c)}. These properties
are also not affected by applying the Firth correction when ﬁtting the outcome
model (2.6) by weighted regression, because this is a ﬁnite-sample correction. In
the Appendix (Section 2.A.3) we give details on how the asymptotic variance of
Eˆ {Y (c)} is estimated.
2.4 Results
2.4.1 Simulation study application: Belgian Colorectal Cancer
register
The Belgian cancer register collected data on colorectal cancer diagnosis and
follow-up between 2006 and 2010. This fairly young register with voluntary
participation has a national coverage of about 30%. We will consider a total
of 2355 patients treated in 63 centers and examine a binary outcome quality
indicator with 22% events on average. Causal inference methods on this dataset
were introduced by Goetghebeur et al. (2011), with descriptive statistics showing
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substantial heterogeneity in case-mix.
We will compare the performance of the normal ME, clustered normal ME,
Firth corrected FE and doubly robust PS methods (Section 2.3) via simulation
experiments that reﬂect the structure of these data. Comparisons are based
on the power and type I error of center classiﬁcation following the proﬁling
technique described in section 2.2.2 with λ= 20% and k = 0.75. For example, the
Power to detect High is the probability of classifying a center as having high risk,
given that its ‘true’ classiﬁcation is high. The balance between type I error and
power is determined by the values of the clinical (λ) and statistical (k) tolerance
levels and the distribution of true alternatives, which are ﬁxed here. Details
on the simulation study are given in the Appendix (Section 2.B.1). Results are
shown in Table 2.2 and Figure 2.1, where it can be seen that the power to detect
low risk centers is generally smaller than the power to detect high risk centers.
This is expected because of the lower number of events and closeness to the
boundary for low mortality risk. Because of shrinkage, the normal ME method
has very low power and appears unable to detect many of the low/high risk
centers. Mistakenly classifying centers as low/high mortality risk is equally rare
for these methods.
Interestingly, the clustered normal ME method is not performing better. This
blind clustering, i.e. irrespective of center characteristics, thus requires consid-
erable computing effort with no pay back at the considered sample size. While
similar in terms of power, the doubly robust PS method makes more Type I errors
than the FE method because of the lower coverage of the nevertheless on average
wider conﬁdence intervals. Although the doubly robust PS method has poten-
tial value in realistic settings with strong confounding because of its robustness
against model misspeciﬁcation, conﬁdence intervals with better ﬁnite sample
performance are needed before routine application can be recommended. The
percentage of centers that are correctly classiﬁed is similar for all methods. For
the ME methods, unlike for the other methods, this is the result of classifying
nearly all centers as ‘accepted’ (see Figure 2.1).
In the Appendix (Section 2.B.1) we provide additional simulation results:
Applying the Firth correction did not severely inﬂuence the results of the un-
corrected FE methods, but ensured convergence in the presence of very small
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Figure 2.1: Percentage of correct classiﬁcation against true potential full population
risk for each center and regression method, based on the simulation study mimicking
the setting of the Belgian colorectal cancer register. The vertical gray lines indicate the
clinical decision limits (1−λ)E(Y ) and (1+λ)E(Y ), with λ= 0.20.
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Classical Clustered Firth corrected Firth corrected
normal ME normal ME FE doubly robust PS
Power (%)
to detect High 28.8 31.2 61.5 53.9
to detect Low 12.3 5.4 32.0 39.9
Type I error (%)
Low as High 0.1 0.3 2.4 6.3
Accepted as High 1.2 2.0 8.6 11.8
Type I error (%)
High as Low 0.1 0.1 0.9 2.9
Accepted as Low 3.2 2.1 11.2 19.1
Coverage of 95% CI
for E {Y (c)} (%) 95.4 87.5 93.9 89.0
Classiﬁcation
% High (22%) 7.2 8.0 16.5 17.9
% Low (30%) 6.0 3.0 16.0 22.2
% correct (L-A-H) 59.6 57.7 62.4 58.1
Table 2.2: Center classiﬁcation (Low/High risk or Accepted) based on 1000 simulations
for each regression method. The true percentage of low and high risk centers is respec-
tively 30% and 22%.
centers. Doubling the sample size especially increased the accuracy of the ME
methods. When only one (outcome or PS) model is misspeciﬁed we found some
evidence favouring the doubly robust PS method over the FE method.
2.4.2 Analysis of the Swedish Stroke Register
Riksstroke (http://www.Riksstroke.org) is a national quality register for acute
stroke, collecting data from all 90 Swedish hospitals. It has an estimated coverage
of the total stroke population between 80% and 90%, but there is considerable
variation in coverage between hospitals. The setting is conceptually different
from the cancer register, since acute stroke is treated urgently, mostly at the
nearest center. The register is linked with a socio-economic database at Statistics
Sweden and contains 149 778 patients with ﬁrst stroke between 2001 and 2009.
Centers are compared on 30-day mortality, applying the classical normal ME, the
FE and the doubly robust PS method, without Firth correction as centers are no
longer problematically small.
Because of convergence issues with multinomial models, we build a separate
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logistic regression model P (C = c|L)= expit(L′δc +γc) per center c and estimate
the PS for individual i treated at center c as:
P (Ci = c|Li )∑m
j=1P (Ci = j |Li )
= expit(L
′
iδc +γc)∑m
j=1 expit(L
′
iδ j +γ j )
. (2.16)
The classical ME method is applied separately to the cluster of small (< 1000
patients), medium (1000 to 2000) and large (> 2000) centers, to reduce the effects
of shrinkage and to avoid convergence problems due to the large data size. The
potential full population risk for this method is then based on the cluster-speciﬁc
parameter estimates applied to the total population.
While in general few data are missing, records on education and smoking
are missing for respectively 20.8% and 12.8% of the participants. Certain patient
characteristics, like smoking status, are more likely missing for patients who
were unconscious upon admission and education level is more often unknown
for elderly patients. We ﬁt complete-case regression models as they allow for
missingness in the covariates to depend on the covariates themselves, so long
as there is no residual dependence on the outcome (White and Carlin, 2010);
it moreover avoids the need for modelling the distribution of those covariates.
They will therefore return center effects that are unbiased under fairly minimal
assumptions. Since the proposed estimators standardise these effects to the same
reference population, selective missingness is not expected to distort comparison
of E {Y (c)} between centers, although it may yield underestimates of E {Y (c)} for
each center, as suggested by the comparison of complete cases (n = 101 051)
versus all cases in the Appendix (Section 2.B.2). The Appendix further speciﬁes
the covariates that were included in the PS and outcome regression models.
It shows that in general case-mix does not differ much across centers, except
for considerable variation with respect to treatment for high blood pressure,
education level and time of admission.
The fewer centers classiﬁed as low/high risk by the normal ME method, are
also found by the other methods. This can be seen in Figure 2.2 which displays
the observed center-speciﬁc risk Eˆ (Y |C = c) (which does not depend on the anal-
ysis method) versus the model based potential full population risk Eˆ {Y (c)}. The
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Figure 2.2: The observed center-speciﬁc risk versus the potential full population risk
for all 90 centers of Riksstroke for the FE method, the doubly robust PS method and the
classical normal ME method, distinguishing between low (ﬁlled circle) and high (ﬁlled
triangle) mortality risk.
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Figure 2.3: The potential full population risk and corresponding 50% conﬁdence interval
for all 90 centers of Riksstroke for the FE method, the doubly robust PS method and the
classical normal ME method. The vertical gray lines indicate the clinical decision limits
(1−λ)Eˆ(Y ) and (1+λ)Eˆ(Y ), with λ= 0.20, which are used for classiﬁcation of low and
high (ﬁlled circles) mortality risk centers.
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ME results show the smallest range of potential full population risk with most
attenuation towards the overall risk, i.e. more shrinkage. Both FE methods clas-
sify mostly the same centers as low risk, although the doubly robust PS method
classiﬁes two additional centers as high risk (Figure 2.2). Because these two cen-
ters may be only borderline statistically signiﬁcant, we examine the uncertainty
in terms of a 50% CI on the potential full population risk (Figure 2.3). We found
good discrimination of low and high mortality risk in general, but the 50% CI of
some centers is close to the clinical decision limit where it becomes difﬁcult to
judge. In that case, balanced testing could help to ﬁnd an optimal combination
of the null and the alternative (Moerkerke and Goetghebeur, 2006). Figure 2.3
shows better accuracy of Eˆ {Y (c)} with increasing center size, except for centers
with close to zero events. Surprisingly, high mortality risks are observed mostly
for medium to large centers while low mortality risks are especially detected for
small to medium centers. This may partly be due to selectivity as it is known that
patients dying early are less likely to be recorded in this Riksstroke register which
could potentially happen more frequently in smaller centers. Since size is based
on the number of registered patients, a center with low coverage may come out
as smaller with better performance. This underlines again the importance of
complete coverage.
For the doubly robust method we observe wider conﬁdence intervals espe-
cially for the small centers. This may be related to the generally lower efﬁciency
of this method, but also be more honestly reﬂecting the uncertainty on the po-
tential risk estimates. Unlike the other two methods, the ME method did not
classify any of the very small centers as low risk. This is due to shrinkage to which
especially the smallest centers are very sensitive.
2.5 Discussion
We have proposed and compared approaches to evaluate the performance of
clinical centers via direct standardization. This involves comparing centers in
terms of the potential risk if the full study population were treated at the current
level of care of the given center. A key feature is that the evaluation of all centers
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is based on the same reference population, while each center will have treated
a subset. Especially when centers can be chosen freely, this cuts bias out of the
current center performance. Alternatively, indirect standardization, which is
more widely used (Shahian and Normand, 2008; Austin et al., 2003), evaluates
each center on its own patient population and is of particular relevance when
centers tend to differ in their patient mix. Both standardizations have their
virtues and in future work we will develop similar analysis strategies for indirect
standardization.
We have compared three statistical regression methods for direct standard-
ization based on random or ﬁxed center effects, the latter in combination with
the Firth correction or weighting by the reciprocal of the PS to be treated in the
observed center. Our primary focus on frequentist methods was motivated by
the fact that they are less computer-intensive and avoid the need to specify prior
distributions about which no information was available in our case studies. A cru-
cial and unveriﬁable assumption for all considered methods is that the included
set of baseline patient characteristics is sufﬁcient to adjust for confounding of
the center-outcome effect. This drives the variable selection at the design stage
of disease registers. In case of violations, results will be biased and one may want
to consider other methods such as those using instrumental variables (Hernán
and Robins, 2006a).
In the ﬁrst case study, we found that shrinkage following traditional ME mod-
eling results in substantial power loss compared to the suggested alternatives,
especially for small centers. Although we used direct standardization, these
ﬁndings correspond to those observed for indirect standardization in Austin et al.
(2003). The Firth corrected FE model as well as the doubly robust PS method
recovered power, while maintaining convergence in the presence of very small
centers. In the second case study, shrinkage was still present under the normal
ME model, but disappeared using the Firth correction (see Appendix, Section
2.B.2). As a result, fewer centers were classiﬁed as low/high risk under the ran-
dom compared to the ﬁxed center effects models.
In the simulation study the Firth corrected FE method outperformed the
doubly robust PS method, although differences were relatively minor. While
routine application of the doubly robust PS method in its current form is not
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recommended, it may be of potential interest in settings with strongly differential
case-mix (Shahian and Normand, 2008). In such settings, standard variable
selection procedures for outcome regression models which force the center
effects into the model have a tendency, as a result of multicollinearity, to exclude
patient characteristics that are strongly correlated with center choice so that
their effects get attributed to differences between centers. This may in turn
yield model extrapolation with biased and misleadingly precise center effect
estimates (Vansteelandt et al., 2010). The doubly robust PS method helps to
protect against this. By also modeling the effect of patient characteristics on the
center choice, stronger predictors of center choice are potentially more likely to
be picked up in variable selection procedures (Hocking, 1976). In future work,
it will therefore be of interest to evaluate how the considered methods perform
when combined with variable selection. Double robustness moreover protects
against misspeciﬁcation of the outcome model when the model for center choice
is correct. It thereby lessens the concern for violation of the assumption of equal
covariate effects across centers.
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2.A Technical Appendices
Software in the form of R-code is available at
https://github.com/mmvarewy/Biostatistics_2014.
2.A.1 Firth correction
Maximum likelihood estimation for the parameter θ := (β,ψ) indexing a logistic
regression model amounts to solving the equations
∂(θ)
∂θ
= u(θ)= 0, (2.17)
where (θ)= logL(θ) is the log likelihood function and u(θ) is the score function
for a single observation. Firth (1993) deﬁnes a modiﬁed score function
u∗(θ)= u(θ)− I (θ)b(θ), (2.18)
where I (θ) = −∂u(θ)
∂θ is the Fisher information matrix for a single observation
and b(θ) is the O(n−1) bias of the resulting maximum likelihood estimator θˆ.
Therefore, the solution θF to u∗(θ)= 0 removes theO(n−1) bias of θˆ.
A simple interpretation of equation (2.18) is that it speciﬁes an amount of
bias to be introduced into the score function in order to remove the leading
term in the asymptotic bias of θˆ. The introduced bias function −I (θ)b(θ) isO(1)
as n →∞, an order of magnitude smaller in probability than u(θ) itself (Firth,
1992). The Firth approach eliminates theO(n−1) bias of the maximum likelihood
estimate by adjusting the score function, rather than the estimate itself. An
advantage is that the deﬁnition of the Firth corrected estimates does not depend
on the existence of the non-corrected estimates, of which some components
may be inﬁnite in binomial problems (Firth, 1992).
Simulation studies in different settings for logistic regression in Heinze (2006)
show promising results for the Firth method in case of separated or nearly sep-
arated data. Based on simulations in Kessels et al. (2013), the Firth corrected
multinomial logistic regression outperforms ordinary maximum likelihood as
the Firth corrected method converges in case of data separation, it removes bias
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of the ML estimates and reduces variance.
2.A.2 Fixed effects logistic regression: Asymptotic variance
To simplify notation we denote the vector (L, I (C = 1), . . . , I (C = m)) by X. To
assess the uncertainty on the potential full population risk Eˆ {Y (c)}, note that the
MLE θˆ = (βˆ ′,ψˆ′)′ of θ in
E(Y |X)=U (θ,X)= expit
(
L′β+
m∑
c=1
ψc I (C = c)
)
, (2.19)
satisﬁes the following set of estimating equations
1
n
n∑
i=1
Xi
{
Yi −U (θˆ,Xi )
}= 0. (2.20)
To obtain the asymptotic variance of Eˆ {Y (c)}, we ﬁrst perform a Taylor expansion
of
Eˆ {Y (c)}= 1
n
n∑
i=1
Uc(θˆ,Xi )= 1
n
n∑
i=1
expit
(
L′i βˆ + ψˆc
)
(2.21)
around θ, which results in
1
n
n∑
i=1
Uc(θˆ,Xi )= 1
n
n∑
i=1
Uc(θ,Xi )+E
(
∂Uc
∂θ
(θ,Xi )
)
n(θˆ−θ)+op(1). (2.22)
Second, we perform a Taylor expansion of (2.20) around the true parameter value
θ and obtain 
n(θˆ−θ)= 1
n
n∑
i=1
A−1Ri +op(1), (2.23)
where
Ri = Xi
{
Yi −U (θˆ,Xi )
}
,
A = E
(
∂Ri
∂θ
)
.
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Finally, we combine (2.23) and (2.22) and estimate the variance of Eˆ {Y (c)} via
Var
[
Eˆ {Y (c)}
]= 1
n
Var
{
Uc(θ,Xi )+E
(
∂Uc
∂θ
(θ,Xi )
)
A−1Ri
}
. (2.24)
Conﬁdence interval calculations assume normality of logit Eˆ {Y (c)}, so in our
calculations we have transformed these estimators to the logit scale via the delta
method. This allows us to obtain conﬁdence intervals with boundaries inside
the [0,1] interval.
The above expressions continue to hold when the parameters θ are estimated
according to Firth’s modiﬁed estimating equations (2.18). This is because bias
reduction affects the covariance matrix of the estimates only in theO(n−2) and
higher order terms (Firth, 1993). Note that standard errors of the Firth corrected
estimates may be slightly smaller, since they are evaluated in a different estimate
for θ (Firth, 1992).
2.A.3 Doubly robust PSmethod: Asymptotic variance
We denote the outcome model parameters by θ = (β′,ψ′)′ and the propensity
score parameters by ρ= (γ ′,δ′)′. We estimate E {Y (c)} again as in (2.21), but now
using a weighted regression to ﬁt the FE model (2.19), with weights equal to one
over the propensity score of the observed center g (Ci ,Li ; ρˆ), where
g (c,Li ;ρ) := P (Ci = c|Li )=
⎧⎪⎪⎨
⎪⎪⎩
1
1+∑mj=2 exp(L′iδ j+γ j ) c = 1
exp(L′iδc+γc )
1+∑mj=2 exp(L′iδ j+γ j ) c 	= 1.
(2.25)
The MLE ρˆ of ρ satisﬁes the following set of estimating equations
1
n
n∑
i=1
(
1
Li
){
I (Ci = c)− g (c,Li ; ρˆ)
}= 0, c = 2, . . . ,m. (2.26)
First, we perform a Taylor expansion of (2.26) around ρ and obtain

n(ρˆ−ρ)= 1
n
n∑
i=1
A−11 Ri1+op(1), (2.27)
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where
Ri1 =
(
1
Li
){
I (Ci = c)− g (c,Li ; ρˆ)
}
,
A1 = E
(
∂Ri1
∂ρ
)
.
Analogously, we perform a Taylor expansion of the outcome model estimating
equations
1
n
n∑
i=1
Xi
g (Ci ,Li ; ρˆ)
{
Yi −U (θˆ,Xi )
}= 0 (2.28)
around (θ′,ρ′)′ and obtain

n(θˆ−θ)= 1
n
n∑
i=1
A−12
{
Ri2+E
(
∂Ri2
∂ρ
)
n(ρˆ−ρ)
}
+op(1), (2.29)
where
Ri2 = Xi
g (Ci ,Li ; ρˆ)
{
Yi −U (θˆ,Xi )
}
,
A2 = E
(
∂Ri2
∂θ
)
.
Now, let
Uc(θˆ,Xi )= expit
(
L′i βˆ + ψˆc
)
,
then we deﬁne the estimator for the potential full population risk as follows:
Eˆ {Y (c)}= 1
n
n∑
i=1
Vc(θˆ, ρˆ,Xi ) (2.30)
= 1
n
n∑
i=1
[
Uc(θˆ,Xi )+ I (Ci = c)
g (c,Li ; ρˆ)
{
Yi −Uc(θˆ,Xi )
}]
(2.31)
= 1
n
n∑
i=1
[
I (Ci = c)Yi
g (c,Li ; ρˆ)
+
{
1− I (Ci = c)
g (c,Li ; ρˆ)
}
Uc(θˆ,Xi )
]
. (2.32)
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Combining (2.27) and (2.29), the variance of the estimated potential full popula-
tion risk Eˆ {Y (c)} on the risk scale is estimated via
Var
[
Eˆ {Y (c)}
] = 1
n
Var
[
Vc(θ,ρ,Xi )+E
(
∂Vc
∂ρ
(θ,ρ,Xi )
)
A−11 Ri1
+ E
(
∂Vc
∂θ
(θ,ρ,Xi )
)
A−12
{
Ri2+E
(
∂Ri2
∂ρ
)
A−11 Ri1
}]
.(2.33)
Again, the above expressions can be transformed to the logit scale and con-
tinue to hold when the parameters θ are estimated according to Firth’s modiﬁed
estimating equations (2.18).
2.B Additional Results
An illustration of model extrapolation considering two centers with strongly
differential case-mix is given in Figure 2.4.
2.B.1 Simulation study application: Belgian Colorectal Cancer
register
The ME models were ﬁtted in R using the rjags package (Plummer, 2003) where
we assigned the following independent non-informative hyperpriors:
Classical normal ME model Clustered normal ME model
μψ ∼N (0,25) μk ∼N (0,25) k = 1, . . . ,K
σψ ∼U (0,10) σk ∼U (0,10) k = 1, . . . ,K
β j ∼N (0,102) β j ∼N (0,102) j = 1, . . . ,,
where K = 3 denotes the number of center clusters and  is the length of the
vector of patient characteristics. The Firth corrected FE model was ﬁtted in R
using the brglm package (Kosmidis, 2011). The analysis of 5 simulated datasets
took on average 3 hours for the classical normal ME method and 15 hours for the
clustered analog, as compared to at most 3 minutes for the FE and doubly robust
methods.
First we determine ‘true’ center classiﬁcations based on a large sample of
simulated data for 106 patients in 63 centers. Next, we generate 1000 samples
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Figure 2.4: Artiﬁcial example illustrating extrapolation under outcome regression with
main effects for age and center. It visualizes outcome data for two centers with strongly
differential case-mix and such that smaller outcomes are seen in center 1 (black dots)
than in center 2 (blue triangles) in each patient subgroup. Direct standardization under
seemingly well ﬁtting linear regression models involves strong extrapolation (dashed
line) of the outcome distribution in the given center to what it is expected to achieve on
the full patient population under study. In truth, the observed data carry no information
about E {Y (2)} because no patients in center 2 have age below 60.
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of each 2355 patients under the same models. In this data-generating process,
we ﬁrst generated independent patient characteristics age, gender and initial
disease status cStage based on descriptive statistics in Goetghebeur et al. (2011),
such that age was 67 years on average (SD 9 years), that 61% of the patients
were male and that 13%, 18%, 51%, 14% respectively had cStage I to IV; 4% had
missing cStage. Next, we use the PS and outcome models that were ﬁtted on the
observed data as data-generating models. So, the patients’ center choice and
outcome are generated, mimicking the center-speciﬁc distribution of patients in
the register. Then, based on the large random sample of 106 patients we obtain
precise estimates of E(Y ) and E {Y (c)} as sample averages. Following equations
(2.2) and (2.3) in the main text, this results in the true center classiﬁcation. For
each center this true classiﬁcation is then compared to the classiﬁcation based
on a sample of n = 2355 patients and using one of the regression methods to
estimate Eˆ(Y ) and Eˆ {Y (c)}. In the analysis, we excluded centers treating less
than 10 patients, resulting in a median of 33 registered patients per center and
an average of 53 centers.
About half of the centers are labelled as having low/high risk based on the
initial large sample (see main text Figure 1, ignoring the simulation results for
now) although for many centers the ‘true’ potential full population risk is close
to the decision limits, especially on the low side. Note that results depend highly
on the values of the clinical (λ) and statistical (k) tolerance levels. When early
detection is most important, such as for conﬁdential feedback to clinical centers,
large power is preferred over small type I errors. In contrast, when publishing
results openly, mistakenly classifying a center as high risk may have unduly severe
implications for that center (decrease in number of patients, lower funding)
compared to mistakenly failing to recognize a center as potentially high risk.
Tables 2.3 and 2.4 provide extra results on simulations modelled on the Bel-
gian Colorectal Cancer register when the Firth correction is not applied and
when the sample size is doubled. We performed additional simulations to inves-
tigate the effect of model misspeciﬁcation. We generate data under an outcome
regression model with quadratic centered age effect and a PS model with the
absolute value of centered age effect. Misspeciﬁcation is introduced in the ﬁtted
outcome and/or PS model by estimating a linear centered age effect instead. The
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Fixed effects Doubly robust PS
Power (%)
to detect High 59.6 52.6
to detect Low 38.5 45.3
Type I error (%)
Low as High 1.8 5.5
Accepted as High 7.4 10.5
Type I error (%)
High as Low 1.5 4.2
Accepted as Low 14.9 23.9
Coverage of 95% CI
for E {Y (c)} (%) 94.4 88.5
Classiﬁcation
% High (22%) 15.3 16.9
% Low (30%) 19.6 25.9
% correct (L-A-H) 62.5 57.6
Table 2.3: Center classiﬁcation (Low/High risk or Accepted) based on 1000 simulations
for FE and doubly robust PS method without Firth correction. The true percentage of
low and high risk centers is respectively 30% and 22%.
original population average risk E (Y )= 23% based on Goetghebeur et al. (2011) is
retained. Center effects were multiplied by 2 to obtain a similar spread of E {Y (c)}
values compared to the original simulations. The original age coefﬁcients in
the PS models are multiplied by 2 to obtain more extreme differences in age
distribution and thus stronger extrapolation across centers.
Descriptives under the new and original data generating models for a ran-
dom sample of n = 2355 patients are respectively given in Figures 2.5 and 2.6,
where centers with size smaller than 10 are indicated in red. The quadratic age
effect is quite pronounced while the corresponding estimated linear age effect is
approximately zero (See bottom of Figure 2.5). Comparing the age distribution
under both simulation scenarios, we see more overlap in the age distribution
across centers under the new data generating PS model.
Simulation results in table 2.5 show that the Firth corrected ﬁxed effects and
doubly robust PS methods have similar performance when the regression models
are correctly speciﬁed. We summarize the bias on E {Y (c)} over all centers by
taking the difference of the mean of the squared bias per center and the mean of
the empirical variance of the bias over simulations and next taking the square
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Classical Clustered Firth corrected Firth corrected
normal ME normal ME FE doubly robust PS
Power (%)
to detect High 41.2 40.3 60.6 55.1
to detect Low 22.8 13.4 36.1 39.7
Type I error (%)
Low as High 0.1 0.2 1.2 3.5
Accepted as High 1.0 1.8 6.4 9.4
Type I error (%)
High as Low 0.2 0.2 0.6 1.8
Accepted as Low 4.1 4.4 10.1 16.6
Coverage of 95% CI
for E {Y (c)} (%) 95.8 84.4 94.8 90.6
Classiﬁcation
% High (22%) 9.5 9.8 16.9 17.7
% Low (30%) 9.2 6.5 16.7 21.2
% correct (L-A-H) 62.7 59.0 66.6 61.8
Table 2.4: Center classiﬁcation (Low/High risk or Accepted) based on 1000 simulations,
except for the Bayesian normal ME analyses which were evaluated on 100 simulations,
with double sample size. The true percentage of low and high risk centers is respectively
30% and 22%.
root, that is √√√√Ec [Bias(E {Y (c)})2]−Ec
[
Var
(
Eˆ {Y (c)}
)
S
]
, (2.34)
where S is the number of simulations and Ec is the average over all centers
c = 1, . . . ,m. Note that we correct for the fact that the squared bias also depends
on the variance of the bias. In general the coverage of the 95% CI for E {Y (c)} is
smaller than 95%, but this may be due to extrapolation across centers, which is
also reﬂected in the bias. For bothmethods the power to detect highmortality risk
centers decreases when the outcome model is misspeciﬁed, but the Type I errors
do not decrease accordingly. Here, the doubly robust PS method outperforms the
ﬁxed effects method in terms of coverage of the 95% CI for E {Y (c)}, percentage
of correct classiﬁcation and bias on E {Y (c)}, although it does not gain power to
detect high mortality risk centers. Misspeciﬁcation of the PS model does not
seem to have a large impact on the results in our simulation study, although
this may be different for other data generating models. When both models are
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Both models correct Misspeciﬁcation of
Outcome model PS
model
Both
models
FE DR FE DR DR DR
Power (%)
to detect High 65.4 64.7 54.2 50.1 64.8 50.2
to detect Low 41.6 43.0 40.1 41.8 40.4 47.4
Type I error (%)
Low as High 1.5 4.5 5.3 5.0 4.7 7.0
Accepted as High 5.9 11.0 10.5 10.0 11.6 14.2
Type I error (%)
High as Low 0.7 0.8 1.6 1.6 0.6 5.0
Accepted as Low 11.3 13.5 20.2 14.9 13.6 26.8
Classiﬁcation
% High (19%) 14.8 15.8 18.3 13.4 15.9 18.8
% Low (19%) 15.9 17.7 20.7 16.8 17.7 25.7
% correct (L-A-H) 72.9 70.1 60.3 66.2 70.0 56.8
Bias on E {Y (c)} (×10−2) 1.54 3.62 5.85 5.63 3.52 8.32
MSE of E {Y (c)} (×10−2) 0.330 0.447 0.922 1.01 0.458 1.32
For 95% CI of E {Y (c)}
coverage (%) 88.7 83.2 84.2 90.2 84.2 78.6
median length 0.167 0.167 0.288 0.323 0.167 0.299
Table 2.5: Center classiﬁcation (Low/High risk or Accepted) based on 1000 simulations,
under model misspeciﬁcation. FE = Fixed effects method, DR = Doubly robust PS
method, both with Firth correction. The true percentage of low and high risk centers is
19%.
misspeciﬁed, the doubly robust PS method performs worse than the ﬁxed effects
method with misspeciﬁed outcome model.
2.B.2 Analysis of the Swedish Stroke Register
We give descriptive statistics for both the original and reduced dataset in Table 2.6.
To assess the extent of differential patient case-mix across centers, we perform a
univariate analysis on the complete cases (Figures 2.9 to 2.11). In general case-
mix does not differ much across centers, but we detect considerable variation
with respect to treatment for high blood pressure (Figure 2.7), education level
(Figure 2.8) and time of admission (Figure 2.9). The minimum number of patients
for whom we have records per hospital is 104 (median 1383.5 and max 7260) for
the full data and 49 (median 957.5 and max 4341) for the complete cases. Some
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centers have no records for several years because they no longer treat stroke
patients, have been merged with another center, or only started treating stroke
patients during the study. There are no missing values for the outcome and the
30-day mortality risk is lower for the complete cases (8%) than for the full data
(12%), which is due to the complete cases being generally more healthy as can
be seen from the patient characteristics measured on admission (see Table 2.6).
Figure 2.11 shows lower center-speciﬁc mortality risks for the complete cases
compared to all cases, so results will probably be too optimistic for all centers.
To describe the effect of risk factors on outcome, we report the estimated odds
ratios based on ﬁtting a logistic normal ME model (see Table 2.7).
The analysis is based on a logistic model for the outcome in which we al-
lowed for a piecewise linear spline effect of standardized age (mean age 75 years,
SD = 12 years) with a knot at age 80. Besides the main effects listed in Table
2.7, we include three interactions between patient-speciﬁc covariates which are
of primary interest: education level by age exceeding 80 to account for a differ-
ent effect of education level on 30-day mortality for elderly or young patients,
institution by living alone to account for a different effect of living alone for
patients in an institution or at home, and living alone by gender to account for a
different effect of living alone for men and women. Note that we do not include
interactions with center in the model. The time-dependent PS model includes
the same risk factors, with exception of the interactions, and it does not allow for
a piecewise linear effect of age to avoid model ﬁtting problems. Results for the
analysis of the Swedish Stroke Register when applying the Firth correction to the
outcome model for the FE method and the doubly robust method are given in
Figures 2.12 to 2.14.
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Full data Complete cases
Risk Factor Prevalence (%) Missing (%) Prevalence (%)
Male 50.3 0 53.5
p-ADL dependence (*) 7.2 1.3 4.9
Institutional living (*) 7.0 0.5 4.0
Living alone (*) 48.9 0.7 42.7
Atrial ﬁbrilation (*) 25.3 1.2 21.4
Diabetes (*) 18.9 0.5 19.1
Trt for high blood pressure (*) 50.3 1.4 50.3
Current smoker (*) 16.2 12.8 18.8
Stroke subtype 0
(Intracerebral haemorrhage (I61)) 12.1 11.8
Cerebral infarction (I63) 83.6 84.8
Unspeciﬁed stroke (I64) 4.3 3.4
Consciousness at admission 0.8
(Alert) 82.9 86.8
Drowsy 12.1 9.7
Unconscious 5.0 3.5
Education 20.8
(Primary) 51.9 51.6
Secondary 34.3 34.5
University 13.7 13.8
Adjusted yearly income (in 100 SEK) 0.5
(< 185) 10.0 9.4
815 to 1235 39.0 34.0
1235 to 2241 40.4 44.1
> 2241 10.6 12.5
Year of admission 0
(2001) 9.5 7.4
2002 10.3 8.7
2003 10.8 9.4
2004 11.1 10.6
2005 11.8 11.8
2006 11.6 12.0
2007 11.4 12.2
2008 11.7 13.0
2009 11.8 14.9
Table 2.6: Descriptive percentages of the binary and categorical covariates from the
Swedish Stroke Register, indicating (*) ifmeasured prior to stroke and (reference category)
for analysis. For the full data we calculated percentages for each risk factor not taking
into account missing values for that factor.
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Fixed effects βˆ SE(βˆ) OˆR 95% CI for OR p-value
(Intercept) −2.854 0.084 0.058 0.049 to 0.068 < 0.001
Male 0.163 0.040 1.178 1.088 to 1.275 < 0.001
Age (standardized) 0.513 0.024 1.671 1.594 to 1.751 < 0.001
Age > 80 years 0.441 0.089 1.555 1.306 to 1.851 < 0.001
p-ADL dependence (*) 0.625 0.050 1.869 1.693 to 2.063 < 0.001
Institutional living (*) 0.533 0.123 1.703 1.337 to 2.169 < 0.001
Living alone (*) 0.020 0.043 1.020 0.938 to 1.109 0.639
Atrial ﬁbrilation (*) 0.444 0.030 1.559 1.469 to 1.654 < 0.001
Diabetes (*) 0.205 0.034 1.227 1.149 to 1.311 < 0.001
Trt for high blood pressure (*) −0.026 0.028 0.974 0.922 to 1.030 0.355
Current smoker (*) 0.114 0.040 1.121 1.035 to 1.213 0.005
Stroke subtype
(vs Intracerebral haemorrhage (I61))
Cerebral infarction (I63) −0.933 0.034 0.393 0.368 to 0.421 < 0.001
Unspeciﬁed stroke (I64) −0.419 0.072 0.657 0.571 to 0.757 < 0.001
Consciousness at admission (vs Alert)
Drowsy 1.885 0.031 6.589 6.202 to 7.001 < 0.001
Unconscious 3.445 0.043 31.340 28.827 to 34.072 < 0.001
Education (vs Primary)
Secondary −0.094 0.035 0.910 0.849 to 0.976 0.008
University −0.146 0.053 0.864 0.779 to 0.958 0.005
Adjusted yearly income (in 100 SEK)
(vs < 185)
815 to 1235 0.043 0.049 1.044 0.948 to 1.149 0.381
1235 to 2241 −0.012 0.049 0.988 0.898 to 1.088 0.811
> 2241 −0.146 0.065 0.864 0.760 to 0.982 0.025
Year of admission (vs 2001)
2002 −0.071 0.074 0.931 0.806 to 1.076 0.335
2003 −0.025 0.071 0.975 0.848 to 1.122 0.726
2004 0.081 0.069 1.085 0.948 to 1.241 0.238
2005 0.115 0.068 1.122 0.983 to 1.281 0.089
2006 0.108 0.067 1.114 0.976 to 1.272 0.108
2007 0.104 0.067 1.109 0.972 to 1.266 0.123
2008 0.091 0.067 1.095 0.960 to 1.249 0.177
2009 0.097 0.067 1.101 0.965 to 1.257 0.151
Male × Living alone −0.022 0.057 0.978 0.875 to 1.094 0.701
Institutional living × Living alone 0.030 0.131 1.031 0.797 to 1.333 0.816
Age > 80 years ×
Education (Second. vs Primary) 0.050 0.135 1.051 0.807 to 1.368 0.711
Education (Univ. vs Primary) −0.036 0.213 0.965 0.635 to 1.466 0.867
Random center effects ( ˆVar) 0.069
Table 2.7: Model parameters for a descriptive logistic normal ME model with outcome 30-day
mortality based on the Swedish Stroke Register, indicating (*) if measured prior to stroke and (vs
reference category) for categorical covariates. SE = standard error, OR = odds ratio = exp(β), 95%
CI for OR = 95% conﬁdence interval for odds ratio.
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22.B. Additional Results
Figure 2.5: Age distribution under the new data generating PS model (model misspeciﬁ-
cation), for a random sample of n = 2355 patients. Figure at the bottom: Fitted misspeci-
ﬁed outcome model is a Firth corrected ﬁxed effects model and estimated risks are for
female patients with cStageI.
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Figure 2.6: Age distribution under the data generating PS model based on the Belgian
colorectal cancer register.
64
22.B. Additional Results
Figure 2.7: Prevalence of the binary patient-speciﬁc covariates across centers based on
the complete cases in the Swedish Stroke Register.
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Figure 2.8: Prevalence of stroke subtype, consciousness at admission and education
across centers based on the complete cases in the Swedish Stroke Register.
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Figure 2.9: Boxplot for the distribution of time of patient admission across centers based
on the complete cases in the Swedish Stroke Register.
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Figure 2.10: Boxplots for the distribution of adjusted yearly income (in 100 SEK) with-
/without outliers and age per center based on the complete cases in the Swedish Stroke
Register.
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Figure 2.11: Observed mortality risk per center for all cases and complete cases in the
Swedish Stroke Register. The dashed line represents the ﬁrst bisector and bulb sizes are
proportional to the percentage of patients with missing values in that center.
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Figure 2.12: Center classiﬁcation for the 90 centers in the Swedish Stroke Register, without
and with Firth correction.
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22.B. Additional Results
Figure 2.13: The observed center-speciﬁc risk versus the potential full population risk
for all 90 centers of Riksstroke for the FE method, the doubly robust PS method and the
classical normal ME method, distinguishing between low (blue ﬁlled circles) and high
(red triangles) mortality risk (with Firth correction).
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Figure 2.14: The potential full population risk and corresponding 50% conﬁdence interval
for all 90 centers of Riksstroke for the FE method, the doubly robust PS method and the
classical normal ME method. The vertical gray lines indicate the clinical decision limits
(1−λ)Eˆ(Y ) and (1+λ)Eˆ(Y ), with λ= 0.20, which are used for classiﬁcation of low (blue
ﬁlled circles) and high (red ﬁlled circles) mortality risk centers (with Firth correction).
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3CHAPTER 3
On the Practice of Ignoring Center-Patient Interactions
in Evaluating Hospital Performance
This chapter is based on the following paper: Varewyck, M., Vansteelandt, S.,
Eriksson, M., and Goetghebeur, E. (2015). “On the practice of ignoring center-
patient interactions in evaluating hospital performance," Statistics in Medicine.
Summary
We evaluate the performance of medical centers based on a continuous or bi-
nary patient outcome (e.g. 30-day mortality). Common practice adjusts for
differences in patient mix through outcome regression models which include
patient-speciﬁc baseline covariates (e.g. age, disease stage) besides center effects.
Since a large number of centers may need to be evaluated, the typical model
postulates that the effect of center on outcome is constant over patient charac-
teristics. This may be violated, for example when some centers are specialized
in children or geriatric patients. Including interactions between certain patient
characteristics and the many ﬁxed center effects in the model increases the risk
for overﬁtting however, and could imply a loss of power for detecting centers
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with deviating mortality. Therefore, we assess how the common practice of ig-
noring such interactions impacts the bias and precision of directly and indirectly
standardized risks. The reassuring conclusion is that the common practice of
working with main effects of center has minor impact on hospital evaluation,
unless some centers actually perform substantially better on a speciﬁc group
of patients and there is strong confounding through the corresponding patient
characteristic. The bias is then driven by an interplay of the relative center size,
the overlap between covariate distributions and the magnitude of the interaction
effect. Interestingly, the bias on indirectly standardized risks is smaller than on
directly standardized risks. We illustrate our ﬁndings by simulation and in an
analysis of 30-day mortality on Riksstroke.
3.1 Introduction
Many continuing efforts are made to improve the accuracy of hospital qual-
ity of care assessments (Normand et al., 1997; Shahian et al., 2004). They are
motivated by the major impact of performance evaluations not only on the
improvement of care, but also on the patient’s choice of hospital, or ﬁnancial pay-
per-performance incentives for example. Key aspects of the quality of hospital
performance are commonly evaluated through a binary or continuous outcome
quality indicator via direct or indirect standardization (Shahian and Normand,
2008; Spiegelhalter, 2005a). Direct standardization aims to assess for each center
how the entire study population would have fared under its current level of care.
Indirect standardization contrasts the quality outcome in each center with what
is expected should their patients choose randomly over the level of care across all
centers. Since the choice of standardization technique depends on the research
question, we will report results for both techniques. Traditionally indirect stan-
dardization is used and this is most relevant to judge center performance when
the center’s own population does not substantially change over time. Should
centers vary in approach and one wishes to choose one approach for implemen-
tation across all centers, then direct standardization delivers the most relevant
impact measure.
74
33.1. Introduction
In general, standardized risks are obtained via outcome regression models
that adjust for confounding of the center-outcome effect (DeLong et al., 1997; He
et al., 2013). Adjustment for differential patient mix is necessary, since centers
treating for instance older patients will show a higher mortality risk irrespec-
tive of their actual treatment quality. Interactions between center and patient
characteristics are rarely modelled, however. This is due to the curse of dimen-
sionality which may already show up in the main effects model. One may hit low
information content to estimate the main effects of many centers, resulting in
large ﬁnite sample bias. For this reason we have chosen to use Firth corrected
ﬁxed effects regression instead of standard ﬁxed effects regression (Varewyck
et al., 2014). This method is preferred over standard random effects regression
which may unduly shrink center effects towards the overall mean (Normand
et al., 1997), thereby masking outlying performance of especially the smallest
centers (Varewyck et al., 2014).
In practice, center effectsmay interactwith patient characteristicswhen some
centers perform particularly well on a speciﬁc subgroup of patients (Shahian
et al., 2004; Gatsonis et al., 1993, 1995). In Austin et al. (2003) for instance,
differences in estimated 30-day mortality risk between hospitals were relatively
small for patients with low illness severity but variation increased for patients
with increasing illness severity. This may indicate that high-risk patients receive
more specialized care at some hospitals. Similarly in Normand et al. (1997), the
variation in hospital effect was substantial and depended on patient baseline
severity. In a next step it is important to know which hospitals and why they
show interactions. Evidence suggested that effect differences were sometimes
associated with hospital size, urbanicity and academic afﬁliation, as medium
sized hospitals had slightly weaker effects of baseline severity on the outcome
than large hospitals.
In this article, we will therefore study to what extent bias may enter each of
the standardized risks when modelling constant center effects across patient
proﬁles while interactions between center and patient characteristics are present.
This may justify the common practice of ignoring center-patient interactions,
especially in situations where it is simply prohibitive to allow for effect modiﬁca-
tion because sufﬁcient information is lacking in small centers, for example. In
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Saposnik et al. (2007) ﬁtting problems are overcome by modelling interactions
between patient characteristics and hospital type (teaching status, location), but
this limits evaluations to hospital groups rather than individual hospitals.
3.2 Setting
Throughout the paper, C will denote a random variable indicating in which
center the patient was actually treated (C = 1, . . . ,m) and L denotes the vector of
patient-speciﬁc baseline characteristics such as gender, age and initial disease
status. We focus on the following data-generating outcome regression model:
E(Y |L,C )= g
( m∑
c=1
I (C = c)(L′βc +ψc)
)
, (3.1)
which allows center effects to depend on L. So the expected outcome in center
c is parametrized by ψc for a patient with the reference (L = 0) proﬁle, and by
ψc + l′0βc for a patient with L= l0 proﬁle. Here, g (·) is a known link function, e.g.
the logistic link.
3.2.1 Nature of Interactions
In the outcome regression model (3.1), interactions between center and patient-
speciﬁc characteristics may arise in different ways. We are interested in the
case where some centers perform structurally better on a speciﬁc subgroup.
For example, the difference in care between hospitals is not constant among
age groups when younger patients get very similar care in each center while
older patients receive much better care in some centers compared to others,
perhaps due to special equipment or experience of the hospital staff with geriatric
patients.
In the absence of such structural interactions, center-patient interactions
could still occur due to the scale of the ﬁtted model. While center effects may
not interact with patient characteristics on the scale of the linear predictor in
a logistic regression model, an interaction may be needed if an additive linear
model is used instead (Greenland et al., 1999). Interactions may also manifest
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themselves as a result of unmeasured confounding e.g. due to unknown envi-
ronmental factors. For example, pollution may increase mortality risk in some
regions. If the performance of each center is constant over age but the pollution
especially affects older patients, then it will induce poorer center effects for older
patients in polluted regions. Unmeasured confounders may thus introduce or
hide interactions between center and measured confounders (VanderWeele et al.,
2012). Throughout, we will exclude this possibility as we will assume that there
are no unmeasured confounders, i.e.
Y (c)⊥⊥C |L for all c, (3.2)
where Y (c) indicates the potential outcome for given patient if he/she were
treated at the care level of center c (Hernán and Robins, 2006b).
3.2.2 Direct and Indirect Standardization
We will assess the impact on the directly or indirectly standardized risk of the
practice of ignoring interactions between center and patient characteristics in
evaluating center performance.
Direct standardization aims to infer the potential full population risk for
each center c: the risk that would be realized if all patients under study were
to experience the care level of that given center c, irrespective of where they
were actually treated. We denote this by E {Y (c)}. Under the outcome regression
model in (3.1) and assuming (3.2), this can be estimated by
1
n
n∑
i=1
g (L′i βˆc + ψˆc), (3.3)
for a study population of size n, where βˆc and ψˆc are Firth penalized-likelihood
estimators (Firth, 1993). We can then make pairwise comparisons between the
directly standardized risk of different centers or with the overall mortality risk
E(Y ) estimated by
1
n
n∑
i=1
Yi . (3.4)
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In contrast, indirect standardization focuses on what a center achieves for its
own patient mix. In general, a risk ratio or risk difference is measured between
the observed and expected (e.g. averaged over all care levels) risk in each center
(Shahian et al., 2001). For instance, the excess risk takes the difference between
the center’s observed risk and the expected risk if its patients were randomly
assigned to the care level across the observed distribution of centers, i.e.
Excess risk= E {Y (c)|C = c}− 1
m
m∑
c∗=1
E {Y (c∗)|C = c}. (3.5)
Here, the observed risk in center c, E {Y (c)|C = c}, is estimated by
∑n
i=1Yi I (Ci = c)∑n
i=1 I (Ci = c)
. (3.6)
Under the outcome regression model in (3.1) and assuming (3.2), the expected
risk under the average care level for patients of center c is estimated as:
∑n
i=1m
−1∑m
c∗=1 g
(
L′i βˆc∗ + ψˆc∗
)
I (Ci = c)∑n
i=1 I (Ci = c)
. (3.7)
3.2.3 Ignoring interactions
Below, we will evaluate the bias on estimators (3.3) and (3.7) when the working
outcome model involves a common center effect γc over all patient proﬁles
instead of covariate-speciﬁc center effects:
E(Y |L,C )= g
(
L′β+
m∑
c=1
I (C = c)γc
)
. (3.8)
Here, the effect of center c on patient’s outcome is expressed by the parameter
γc which is now assumed to be the same for each given patient proﬁle.
3.3 Asymptotic Bias Calculation
We calculate the asymptotic bias on the directly and indirectly standardized risk
when imposing a constant center effect among patients instead of allowing for
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center-patient interactions in (3.3) and (3.5). The average of the observed risks in
center c is not model-based when estimated by (3.6) and therefore unbiased. So
we will calculate the bias on the indirectly standardized risk for center c through
the bias on the expected risk when care levels are averaged over all centers,
m−1
∑
c∗ E {Y (c
∗)|C = c}. For simplicity, we focus ﬁrst on linear regression models
including m centers and one patient characteristic L. We ﬁx the number of
centers m in our asymptotic calculations, since we focus on the evaluation of
centers in a setting where m is relatively ﬁxed (e.g. Riksstroke), but patients come
and go. In the Appendix (Section 3.A) we provide details on the calculations,
which are based on a similar principle as in (Liu and Gustafson, 2008).
The asymptotic bias on the directly standardized risk in center c is given by:
{E(L|C = c)−E(L)}
[
βc −
m∑
j=1
P (C = j )Var(L|C = j )
E {Var(L|C )} β j
]
. (3.9)
For the asymptotic bias on the excess risk for center c we obtain:
m−1
m∑
c∗=1
{
E(L|C = c∗)−E(L|C = c)}
[
βc∗ −
m∑
j=1
P (C = j )Var(L|C = j )
E {Var(L|C )} β j
]
.
(3.10)
The ﬁrst factor in these expressions refers to the difference in patient mix be-
tween centers, while the second factor contrasts a center-speciﬁc L-effect with a
weighted average of interaction effects.
Starting with the ﬁrst factor, it is obvious that for both standardized risks the
bias is zero when all centers have exactly the same L-distribution, so in particular
when L is no confounder of the center-outcome effect; in fact it sufﬁces that
the mean of L is equal in all centers. If not, strong confounding by L implies a
small overlap in patient mix between centers or a large ‘extrapolation distance’
of results from one center to the other, and thus may lead to large bias. The
bias increases for a larger deviation of the mean of L in center c from either the
mean in the overall population for direct standardization (3.9) or the mean in any
other center for indirect standardization (3.10). This difference between both
standardization techniques can be explained by different extrapolation, and is
illustrated in Figure 3.1 for two centers. Direct standardization extrapolates the
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Figure 3.1: Extrapolation in the directly and indirectly standardized risk considering 2
centers (small or large center size). The 30-day mortality risk is estimated by a model
with or without interaction between center and patient’s age.
estimated performance at center c to the whole population under study, while
for indirect standardization the performance of any other center is extrapolated
to the patients in center c.
It is clear that the second factor, and thus the bias, is zero when there are
no center-patient interactions because then β1 = . . . = βm . We recognize the
same weighted sum of interaction effects for both standardization techniques.
For a center j the weight P (C = j )Var(L|C = j )E {Var(L|C )}−1 corresponds to the
relative spread of the patient mix in that center compared to the other centers,
where a larger center size or larger variance of the center-speciﬁc L-distribution
will result in a larger weight. The weighted sums are then respectively compared
to the interaction effect in center c for direct standardization or the interaction
effect in any other center than c for indirect standardization. However, in both
cases stronger interactions will result in larger bias.
To get more insight in the difference between the bias for direct and indirect
standardization, we consider m = 2 centers, now coded as c = 0 and c = 1. Then,
the bias on the directly standardized risk for center c (3.9) simpliﬁes to
{E(L|C = c)−E(L)} (βc−β1−c)P (C = 1−c) Var(L|C = 1−c) E {Var(L|C )}−1, (3.11)
80
33.3. Asymptotic Bias Calculation
and for indirect standardization (3.10) to
1
2
{E(L|C = 1− c)−E(L|C = c)} (β1−c −βc)P (C = c) Var(L|C = c) E {Var(L|C )}−1.
(3.12)
For both standardizations we again recognize how the difference in average
covariate levels and the magnitude of the interaction effect inﬂuence the bias.
However, they differ in how the center size and the variance of the center-speciﬁc
L-distribution affect the bias.
Interestingly, for the directly standardized risk the bias will be larger for
relatively small centers, while for the indirectly standardized risk the bias will
be larger for relatively large centers. The different impact of center size for
direct and indirect standardization is due to the different extrapolation. The
largest center contributes most in estimating the working model parameters,
resulting in a smaller bias on the regression line for the largest center (Figure 3.2,
middle panel). Indeed, in Figure 3.1 the working model does not ﬁt well for the
smallest center especially for large values of L (e.g. age) resulting in large bias for
the directly standardized risk for that center. For the large center on the other
hand, we see little bias on the directly standardized risk. In contrast, for indirect
standardization in Figure 3.1 the smallest center extrapolates to a region where
we have good ﬁt, resulting in small bias, while it is the other way around for the
large center. For the small center, the expected risk under its own care level is
approximately correct anyway and the risk for these patients under the care level
of the other center is only slightly biased. So the expected risk (3.7) for this center
also has small bias as we average the expected risks for that center’s patients over
all observed care levels.
The impact of the variance of the center-speciﬁc L-distribution is best under-
stood when looking at two centers (3.11, 3.12). First, the larger the variance in a
center’s patient mix is, the greater this center’s inﬂuence on the estimates of the
working model parameters. Second, when for a given center the patient mix has
large variance, the performance of the other center will be extrapolated to more
extreme values of L for which there may be no good ﬁt (Figure 3.2, left or right
panel). Then, due to different extrapolation, the bias on the directly standardized
risk for a given center increases with smaller variance in its patient distribution
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Figure 3.2: Regression line for the data-generatingmodel (3.1) and for the workingmodel
(3.8) considering 2 centers (center 0 at the bottom and center 1 on top) and a scalar L.
compared to other centers, while for indirect standardization the opposite is
true.
In general, the bias on the indirectly standardized risk will be smaller than
on the directly standardized risk and this difference will be more apparent when
there are many centers. This because for indirect standardization we take an
average over all centers in (3.10), cancelling out positive and negative values, but
not for direct standardization in (3.9).
In summary, when ignoring interactions between center and a patient covari-
ate L we only expect large bias in the presence of large interaction effects and
large differences in the center-speciﬁc mean of L across centers for both stan-
dardization techniques. Moreover, for direct standardization the bias is expected
to be the largest for the smallest centers and centers with small variance of the
center-speciﬁc L-distribution. For indirect standardization, the bias is expected
to be the largest for the largest centers and centers with large variance of the
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center-speciﬁc L-distribution.
In the Appendix (Section 3.A) we investigate whether bias can be reduced
by using model-based estimators for E(Y ) and E {Y (c)|C = c}. We ﬁnd that in
comparisons with the directly standardized risk E {Y (c)} it is not always beneﬁcial
to use the model-based overall mortality. Bias on the indirectly standardized risk
will never be reduced by using the model-based estimator for E {Y (c)|C = c}.
3.4 Simulation Study
We perform a simulation study to assess the impact of ignoring interactions in
logistic regression models. Besides studying the bias, we also examine efﬁciency
in terms of the mean squared error on the standardized risk of interest.
We simulate S = 500 datasets with n = 10000 patients distributed over m = 50
centers and including a scalar patient-speciﬁc covariate L. We ﬁrst generate the
patient characteristic, e.g. scaled age, following a standard normal N (0,1) or
right-skewed Beta(1,6) distribution and assign each patient to a speciﬁc center c ,
following the propensity score model
P (C = c|L)= exp(α0c +α1cL)∑m
j=1 exp(α0 j +α1 j L)
, (3.13)
whereα0c determines the relative center size. Differences in patient mix are large
when we impose strongly varying values of α1c among centers. For this study
population we generate a binary outcome Y , e.g. 30-day mortality, following a
logistic outcome regression model as in (3.1) with the logistic link function. In
the Appendix (Section 3.C) we plot the mortality risk in function of L for each
center to illustrate the magnitude of the interaction effect. There we also describe
the center-speciﬁc distribution of the marginally normal standardized or beta
distributed covariate L with small or large differences across centers for one
simulated dataset.
Bias and precision for the standardized risks are estimated for a working
model which includes interactions between L andC or not. Model parameters
are estimated using Firth corrected maximum likelihood methods. For conve-
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nience, we denote the directly or indirectly standardized risk for center c based
on the data-generating model by fc , based on the ﬁtted working model in simu-
lation run s = 1, . . . ,S by fˆ sc and the average of the latter over all simulation runs
by fˆc . The center-speciﬁc bias on the directly or indirectly standardized risk for
center c is then estimated by
S−1
S∑
s=1
(
fˆ sc − fc
)= fˆc − fc . (3.14)
To prevent that positive bias in some centers is cancelled out by negative bias in
other centers, we square these center-speciﬁc biases before taking the average
over all centers. Then, the overall bias is deﬁned as:
√
m−1
m∑
c=1
(
fˆc − fc
)2−S−1 ˆVar( fˆ sc ), (3.15)
which includes a penalty because the average of the estimated squared bias is
partly inﬂuenced by the imprecision of the estimates. Here, ˆVar( fˆ sc ) denotes the
estimated variance of the center-speciﬁc standardized risk over all simulation
runs. The square root of the overall mean squared error is estimated by:
√√√√m−1 m∑
c=1
S−1
S∑
s=1
(
fˆ sc − fc
)2
. (3.16)
Finally, we measure the variability in patient mix across centers by the variance of
the random intercepts in a random intercept model for L conditional on center.
For normally distributed L the simulation results are similar to the earlier
theoretical ﬁndings in section 3.3 (Figure 3.3a). That is, when there is little
confounding by L, the models with and without interactions give comparable
standardized risks. However, when patient mix differs much across centers,
the overall bias and root mean squared error for the directly standardized risk
E {Y (c)} are large. For indirect standardization the overall bias is not as large as
for direct standardization, as explained above, and the MSE seems insensitive to
excluding the interactions. Here, the variance has by far the largest contribution
in the MSE, so apparently precision on the indirectly standardized risk barely
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changes when ignoring the center-patient interactions. The overall bias following
the model with interactions is sometimes larger than without interactions, which
may be due to small sample bias or overﬁtting problems.
In the Appendix (Section 3.C) we show results for one simulated dataset
and indeed detect most bias when there are large differences in patient mix.
For directly standardized risks the smallest centers suffer most from bias when
ignoring center-patient interactions, while for indirectly standardized risks the
largest centers may still suffer substantial bias. It can also be seen that the
direction of this bias is not necessarily so that it shrinks the estimated outcome
more towards the overall mean or zero, which would mask centers from being
detected as having outlying performance. In practice, we thus do not know
a priori whether the center’s performance is over- or underestimated due to
ignoring the interactions.
Surprisingly, for beta distributed L in Figure 3.3b we see less bias for the
model without interactions than with interactions for indirect standardization. It
is also remarkable that for direct standardization and large variability in patient
mix, the MSE is larger for the model with interactions than for the model without
interactions. Both these ﬁndings are due to ﬁtting problems when modelling
interactions with beta distributed L.
3.5 Data Analysis: Riksstroke, the Swedish National
Quality Register for Stroke Care
Riksstroke (http://www.Riksstroke.org/eng) is a national quality register for acute
stroke, collecting data from all 90 Swedish hospitals. The register contains 249 414
adult patients (≥ 18 years) with ﬁrst registered stroke between 2001 and 2012.
We consider patients diagnosed with ischemic stroke (ICD-10 I63), intracerebral
haemorrhage (ICD-10 I61) or unspeciﬁed acute cerebrovascular event (ICD-10
I64). Centers are compared in terms of directly or indirectly standardized 30-
day mortality risks that correct for the patients’ sex, age, level of consciousness
at arrival (alert, drowsy or unconscious) which is a proxy for baseline severity
and time to hospital (hours between stroke and arrival at hospital). The latter
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Figure 3.3: Estimated bias and precision for direct and indirect standardization are
based on S = 500 simulations. Black dots are used for direct standardization and gray
triangles for indirect, full lines are used for models without interactions and dotted lines
for models with interactions.
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could be an important predictor because brain tissue is rapidly lost as stroke
progresses and the sooner treatment (e.g. thrombolysis) is initiated, the larger
the probability of a favorable outcome (The ATLANTIS, ECASS, and NINDS rt-PA
Study Group Investigators, 2004). The observed time to hospital was more than
24 hours for several patients which are thought to be mistakes in the registration
and therefore truncated at 24 hours. Interactions with patient’s age may arise
when some centers make special efforts for the revalidation of older patients.
Differences in center performance may also differ across groups of time until
hospital arrival depending on differences in prenotiﬁcation systems (Lin et al.,
2012) and time from arrival to thrombolysis treatment. Riksstroke typically
reports directly standardized risks as one aims to compare intrinsic qualities of
the centers. Here, we will estimate directly and indirectly standardized risks as
we aim to provide insight in the bias in the setting studied here, where each of
both standardization techniques could be of interest, depending on the research
question posed.
There are 2 852 records with missing consciousness level and 148910 with
missing time to hospital. We discuss the results of two different approaches to
handle these missing data: (1) We assume that the data are missing completely
at random (MCAR) and perform a complete case analysis. To prevent quasi-
complete separation, we also exclude the 2 smallest centers (center size 5 and
22) with respectively 0 and 1 death within 30 days after admission. This resulted
in a reduction of the dataset to 100207 records and overall 30-day mortality
risk decreased from 13.13% to 12.48%. (2) We assume that the data are missing
at random (MAR) and perform 5 imputations of the missing data using the R-
package MICE (Buuren and Groothuis-Oudshoorn, 2011). A description of the
predictors that were used for the imputation models is given in the Appendix
(Section 3.C). As we need to allow for interactions with center in the outcome
model, we ﬁt separate imputation models per center, with center sizes ranging
from 56 to 11 669 (Median 2324). No outcome values were missing.
Standardized outcomes were based on a Firth corrected ﬁxed effects model,
with or without interactions between center and time to hospital or age. To
suggest a functional form for time to hospital in the outcome regression model
while accounting for the other prognostic factors, we categorized time following
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its 10% quantiles in the model without interactions. We found a good ﬁt for a
loglinear effect of time, and similarly for a linear and quadratic age effect. We
found that for longer time to hospital the 30-day mortality risk decreased for
alert patients, while for drowsy or unconscious patients the risk increased (Figure
3.14 in Appendix). Therefore we will allow for an interaction between time to
hospital and consciousness level in all ﬁtted outcome models. The decreased
risk for alert patients may be due to different baseline severity within this group
of patients: Patients with a less severe stroke have lower mortality risk but it also
takes longer to recognize the symptoms and reach the hospital, while patients
with obvious symptoms arrive earlier but also have a higher mortality risk. For
drowsy or unconscious patients the symptoms are more apparent, and patients
who arrive early will have a lower mortality risk than those who arrive late.
In summary we ﬁt three models, the ﬁrst includes the center where the
patient was treated, patients’ sex, age and quadratic age, level of consciousness
and log transformed time to hospital as main effects and an interaction between
consciousness and time to hospital. The other two models additionally allow the
center effect to depend on the linear effect of age or the loglinear effect of time
to hospital.
An overall Wald test for interactions with center was obtained for age (p-value
0.009 for CC and < 0.001 for MI) and for time to hospital (p-value < 0.001 for CC
and MI). We will now investigate how the standardized risks differ when based on
a model with or without interactions between center and patient’s age or time to
hospital. Results are based on the complete cases (CC) or the multiple imputed
data (MI), where for the latter we report results averaged over 5 imputed datasets
unless otherwise stated.
We see substantial differences in patient mix across centers coming from time
to hospital (Figure 3.4 for MI, Figure 3.12 for CC in Appendix) and only minor
differences are seen for age. We measure the variability in patient mix across
centers as before, i.e. by the variance on the random intercepts in a random
intercept model for L conditional on center, and averaged over the imputed
datasets we obtain 0.022 (CC) or 0.024 (MI) for standardized log time to hospital
compared to 0.017 (CC) or 0.013 (MI) for standardized age. So from previous
theoretical ﬁndings we know that the model ignoring interactions with time
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Figure 3.4: Center-speciﬁc values for the patient’s age and time to hospital (hours) for
one imputed dataset. Bubble size is proportional to center size. Center 47 and 54 have
more than 1% difference in its estimated potential full population risk when ignoring
interactions with time to hospital (MI).
to hospital rather than age may induce larger bias on the standardized risks,
although the bias will be minor for both (Figure 3.3a).
In general, we see negligible differences in standardized risk when based on
a model without or with interactions between center and either age or time to
hospital (Figure 3.5 for MI, Figure 3.13 for CC in Appendix). However, for the
direct standardization we found 2 (CC) or 2 (MI) centers with a difference of
more than 1% in risk when ignoring interactions with time to hospital and 1 (CC)
center when ignoring interactions with age. As expected, these differences are
larger for direct compared to indirect standardization (Table 3.1). In addition,
these differences are larger for time to hospital than for age. So, although for
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Max. difference (%) Average difference (%) No. centers with
difference > 1%
CC MI CC MI CC MI
Direct standardization
Age 1.31 0.63 0.26 0.14 1 0
Time to hospital 1.33 2.83 0.28 0.35 2 2
Indirect standardization
Age 0.22 0.24 0.05 0.04 0 0
Time to hospital 0.37 0.12 0.09 0.03 0 0
Table 3.1: The difference in estimated standardized risk between the model with and
without interactions between center and patient’s age or time to hospital, based on
complete cases (CC) or multiple imputed data (MI). We report the maximum difference,
the average difference (square root of the average of squared differences) and the number
of centers for which the difference in standardized risk exceeds 1%.
some centers we found a strong interaction with age, the standardized risks were
found to be more robust because the age distribution does not differ much across
centers.
3.6 Discussion
We found that if some centers actually perform better on a speciﬁc group of
patients compared to other centers, then ignoring this in the analysis may bias
the directly and indirectly standardized risks when the corresponding patient
characteristic is very differently distributed between centers, but bias is negligible
otherwise. We therefore advise special attention to interactions with covariates
whose distribution differs substantially across centers. When there is no large
variability in patient mix, then the common practice of ignoring center-patient
interactions does not severely impact standardized mortality risks. In general we
notice larger bias for directly standardized compared to indirectly standardized
risks. However, for directly standardized risks the largest bias is seen for centers
with the smallest proportion of registered patients as opposed to the larger
centers for indirectly standardized risks. In our study we found the same trends
for the overall root mean squared error. Of course the interaction effect will need
90
33.6. Discussion
9 10 11 12 13 14 15
0.
00
0.
05
0.
10
0.
15
0.
20
0.
25
sd^(Age|Center)
Ê
{Y
(c
)}
5 6 7 8 9 10
0.
00
0.
05
0.
10
0.
15
0.
20
0.
25
sd^(Time to hospital|Center)
Ê
{Y
(c
)}
9 10 11 12 13 14 15
−0
.1
0
−0
.0
5
0.
00
0.
05
0.
10
0.
15
sd^(Age|Center)
E
st
. e
xc
es
s 
ris
k
5 6 7 8 9 10
−0
.1
0
−0
.0
5
0.
00
0.
05
0.
10
0.
15
sd^(Time to hospital|Center)
E
st
. e
xc
es
s 
ris
k
Figure 3.5: The directly or indirectly standardized risk per center, with or without inter-
actions between center and patient’s age or time to hospital (grey without and black with
interactions), in function of the standard deviation of the center-speciﬁc distribution
of patient’s age or time to hospital for multiple imputation analysis. Bubble size is
proportional to center size and ellipses indicate centers with more than 1% difference in
estimated mortality risk.
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to claim its role when interest lies in prediction of the mortality risk for a speciﬁc
subgroup rather than directly or indirectly standardized risks.
To detect centers with low or high mortality risks, we have applied a similar
center classiﬁcation technique as in (Varewyck et al., 2014) on the simulated
data (See Appendix Section 3.B). A center is classiﬁed as low/high risk if the data
provide sufﬁcient evidence that the standardized risk exceeds a clinical bench-
mark e.g. relative to the population average risk E(Y ). We found that ignoring
center-patient interactions has similar impact on correct center classiﬁcation as
on the bias: the largest differences are seen for direct standardization and large
differences in case mix across centers (See Appendix Section 3.C). Surprisingly,
the power to detect outlying performance is not always decreased by mistakenly
ignoring the interactions, but then we see more centers wrongly classiﬁed as
having outlying performance. Reassuringly, in general the percentage of correct
center classiﬁcation is very similar for the model with and without interactions
and this both for direct and indirect standardization.
We expect that the impact of center-patient interactions on the standardized
risk depends on the considered disease. For example, for a register on a non-
acute surgical procedure we may expect a large impact. First, patient mix may
differ substantially across hospitals when patients can choose the hospital where
they are treated. Moreover, treatment and thus the patient’s mortality risk is
partly based on the surgeons’ decisions and experience, which makes it more
subject to effect modiﬁcation, e.g. when some hospitals are less experienced with
a speciﬁc surgery. On the other hand, for a register on acute stroke, patients are
mostly treated at the nearest hospital so there is less confounding. Furthermore,
well-deﬁned treatment guidelines for this disease result in the same procedure
given in each clinical center, thus we expect the difference in mortality risk
between e.g. old and young patients to be similar across centers.
In practice it is not always possible to estimate all interaction parameters,
especially when the number of patient characteristics is large. One option is to
use prior knowledge on hospital specialization and reduce the factors for which
interactions may be considered. In addition or alternatively a summary measure
for the patient’s baseline severity may reduce the number of parameters to be
estimated, e.g. in the form of propensity scores or prognostic scores (Rubin, 1997;
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Hansen, 2008). We used penalized likelihood estimation, more speciﬁcally the
Firth correction to overcome ﬁtting problems. In this context random effects
models are often used which help to reduce the effective model dimension
when allowing for differential effects of patient characteristics across centers
(Normand et al., 1997; Austin et al., 2003). However, it has been repeatedly shown
that the power for detecting outlying center performance is much lower when
using normal random center effects compared to Firth corrected ﬁxed effects
(Varewyck et al., 2014; Kalbﬂeisch and Wolfe, 2013). In future work it may be
of interest to investigate whether more general regularization methods bring a
solution.
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3.A Asymptotic Bias Calculation
Following a similar principle as in Liu and Gustafson (2008), we calculate the
bias when ignoring interactions between center and one patient characteristic L
in a linear regression model, respectively with (main text, 3.1) and without (main
text, 3.8) interaction between center and L.
We denote the vector of main effects by X= (I (C = 1), . . . , I (C =m))′ and the
vector of interactions by W= (L I (C = 1), . . . ,L I (C =m))′. Let T= (X′,W′)′ be the
random vector of covariates in the data-generating model (main text, 3.1), let
(ψ′,β′)= (ψ1, . . . ,ψm ,β1, . . . ,βm) be the model parameters in the data-generating
model and let S= (L,X′)′ be the covariates in the working model (main text, 3.8)
ignoring the interaction between center and patient characteristic L.
3.A.1 Direct standardization
For the directly standardized risk, we also deﬁne for a given center c the vector
E(S˜c)= (E(L),0, . . . ,1, . . . ,0)′ of length 1+m, where the number 1 occurs at posi-
tion 1+ c . Based on the data-generating model, the potential full population risk
for center c is given by:
E {Y (c)}=ψc +βcE(L).
Let
r = E(L2)−E(LX′)E(XX′)−1E(LX)=
m∑
j=1
P (C = j )Var(L|C = j )= E {Var(L|C )}
V′ = E(L2X′)−E(LX′)E(XX′)−1E(LXX′)
=
(
P (C = 1)Var(L|C = 1) . . . P (C =m)Var(L|C =m)
)
Ignoring the interactions, the estimator for E {Y (c)} has expected value:
Er {Y (c)}= E(S˜′c){E(SS′)}−1E(ST′)
(
ψ
β
)
= (E(L) 0 . . .1 . . .0)
(
E(L2) E(LX′)
E(LX) E(XX′)
)−1 (
E(LX′) E(LW′)
E(XX′) E(XW′)
)(
ψ
β
)
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= (E(L) 0 . . .1 . . .0)
×
(
1
r −1r E(LX′)E(XX′)−1
−1r E(XX′)−1E(LX) E(XX′)−1+ 1r E(XX′)−1E(LX)E(LX′)E(XX′)−1
)
×
(
E(LX′) E(L2X′)
E(XX′) E(LXX′)
)(
ψ
β
)
= (E(L) 0 . . .1 . . .0)
(
0T 1r V
′
Im −1r E(XX′)−1E(LX)V′ +E(XX′)−1E(LXX′)
)(
ψ
β
)
= E(L)1
r
V′β+ψc
+ (0 . . .1 . . .0)
{
−1
r
E(XX′)−1E(LX)V′ +E(XX′)−1E(LXX′)
}
β
= E(L)1
r
V′β+ψc + (0 . . .1 . . .0)
⎧⎪⎪⎨
⎪⎪⎩−
1
r
⎛
⎜⎜⎝
E(L|C = 1)
...
E(L|C =m)
⎞
⎟⎟⎠V′
+
⎛
⎜⎜⎜⎜⎜⎝
E(L|C = 1) 0 · · · 0
0 E(L|C = 2) · · · 0
...
...
. . .
...
0 0 · · · E(L|C =m)
⎞
⎟⎟⎟⎟⎟⎠
⎫⎪⎪⎪⎪⎪⎬
⎪⎪⎪⎪⎪⎭
β
= {E(L)−E(L|C = c)}V
′β
r
+ψc +βcE(L|C = c).
Then bias on the directly standardized risk for center c due to ignoring the center-
patient interaction can be written as:
E [Er {Y (c)}−E {Y (c)}]= {E(L|C = c)−E(L)}
{
βc − V
′β
r
}
= {E(L|C = c)−E(L)}
[
βc −
m∑
j=1
P (C = j )Var(L|C = j )β j
E {Var(L|C )}
]
.
The asymptotic bias on the directly standardized risk for two centers is illustrated
in Figure 3.6.
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Figure 3.6: Asymptotic bias on the directly standardized risk for 2 centers, when ignoring
interaction between center and patient-speciﬁc characteristic, following equation (3.11,
main text) with β1−β0 = 1, E(L|C = 1)−E(L|C = 0)= 1 and Var(L|C = 0)= 1.
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3.A.2 Indirect standardization
For the indirectly standardized risk, we deﬁne for a given center c the vector
E (S˜c )= (E (L|C = c),m−1, . . . ,m−1)′ of length m+1. Knowing the data-generating
model, the center-speciﬁc average of expected outcomes in center c is given by:
m−1
m∑
c∗=1
E {Y (c∗)|C = c}=m−1
m∑
c∗=1
{
ψc∗ +βc∗E(L|C = c)
}
.
However, when ignoring the interactions the ﬁxed effects estimator of the latter
has expected value:
m−1
m∑
c∗=1
Er {Y (c
∗)|C = c}
= E(S˜′c){E(SS′)}−1E(ST′)
(
ψ
β
)
= (E(L|C = c)m−1 . . .m−1)
(
0T 1r V
′
Im −1r E(XX′)−1E(LX)V′ +E(XX′)−1E(LXX′)
)(
ψ
β
)
= E(L|C = c)1
r
V′β+m−1
m∑
c∗=1
ψc∗
+ (m−1 . . .m−1){−1
r
E(XX′)−1E(LX)V′ +E(XX′)−1E(LXX′)
}
β
= E(L|C = c)1
r
V′β+m−1
m∑
c∗=1
ψc∗ +
(
m−1 . . .m−1
)
⎧⎪⎪⎨
⎪⎪⎩−
1
r
⎛
⎜⎜⎝
E(L|C = 1)
...
E(L|C =m)
⎞
⎟⎟⎠V′
+
⎛
⎜⎜⎜⎜⎜⎝
E(L|C = 1) 0 · · · 0
0 E(L|C = 2) · · · 0
...
...
. . .
...
0 0 · · · E(L|C =m)
⎞
⎟⎟⎟⎟⎟⎠
⎫⎪⎪⎪⎪⎪⎬
⎪⎪⎪⎪⎪⎭
β
=
{
E(L|C = c)−m−1
m∑
c∗=1
E(L|C = c∗)
}
V′β
r
+m−1
m∑
c∗=1
{
ψc∗ +βc∗E(L|C = c∗)
}
.
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Figure 3.7: Asymptotic bias on the expected outcome in center c (indirect standardiza-
tion) for 2 centers, when ignoring interaction between center and patient-speciﬁc charac-
teristic, following equation (3.12, main text) with β1−β0 = 1, E (L|C = 1)−E (L|C = 0)= 1
and Var(L|C = 0)= 1.
So, bias on the indirectly standardized risk for center c is
E
[
m−1
m∑
c∗=1
Er {Y (c
∗)|C = c}−m−1
m∑
c∗=1
E {Y (c∗)|C = c}
]
=m−1
m∑
c∗=1
{
E(L|C = c∗)−E(L|C = c)}[βc∗ − V′β
r
]
=m−1
m∑
c∗=1
{
E(L|C = c∗)−E(L|C = c)}
[
βc∗ −
m∑
j=1
P (C = j )Var(L|C = j )β j
E {Var(L|C )}
]
.
The asymptotic bias on the indirectly standardized risk for two centers is illus-
trated in Figure 3.7.
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3.A.3 Model-based estimators when comparing risks
In practice, the directly standardized risk E {Y (c)} is often compared to the overall
mortality. We investigate whether bias is reduced when estimating the latter by
the average of the directly standardized risks over all centers Eˆc [Eˆ {Y (c)}] instead
of Eˆ(Y ). The bias on Ec [E {Y (c)}] due to ignoring center-patient interactions
can be calculated as the average of the bias on E {Y (c)} over all centers. For
two centers, the bias when comparing E {Y (0)} with this model-based overall
mortality is then
Bias(E {Y (0)}−Ec [E {Y (c)}])= 1
2
Bias(E {Y (0)})− 1
2
Bias(E {Y (1)}) , (3.17)
while E(Y ) is unbiased so,
Bias(E {Y (0)}−E(Y ))=Bias(E {Y (0)}) . (3.18)
It is not beneﬁcial to use the model-based overall mortality when the absolute
value of (3.17) is larger than the absolute value of (3.18). This is the case when
Bias(E {Y (1)})> 3 |Bias(E {Y (0)})|
or, equivalently
sign[Bias(E {Y (1)})] = −sign[Bias(E {Y (0)})], and
|Bias(E {Y (1)})| > |Bias(E {Y (0)})|.
We give an example for each case in Table 3.2.
For indirect standardization, the model-based average of observed risks for a
given center c is estimated by:
∑n
i=1 g
(
Li βˆ+ γˆc
)
I (Ci = c)∑n
i=1 I (Ci = c)
. (3.19)
Now, one of the score equations for Firth corrected maximum likelihood estima-
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Bias on E {Y (0)} Bias on E {Y (1)} Bias on E {Y (0)}−Ec [E {Y (c)}]
0.10 0.40 −0.15
−0.10 −0.40 0.15
0.10 −0.20 0.15
−0.10 0.20 −0.15
Table 3.2: Toy example for the cases when it is not beneﬁcial to use the model-based
overall mortality in comparisons with E {Y (0)}.
tion is exactly
n∑
i=1
I (Ci = c)
{
Yi − g
(
Li βˆ+ γˆc
)}= 0.
Then, it follows that the model-based estimator (3.19) for center c is identi-
cal to the average of observed risks (main text, 3.6). So, bias on the indirectly
standardized risk will not be reduced by using this model-based estimator for
E {Y (c)|C = c}.
3.B Decision Criterion for Labelling Centers
For directly standardized risks, a center is classiﬁed as low/high risk if the data
provide sufﬁcient evidence that the potential risk E {Y (c)} exceeds a benchmark
relative to the population average risk E (Y ), it is classiﬁed as accepted otherwise.
So a center is classiﬁed as having low risk if
Eˆ {Y (c)}+ zk × sd
(
Eˆ {Y (c)}
)< (1−λ1) E(Y )
or as high risk if
(1+λ1) E(Y )< Eˆ {Y (c)}− zk × sd
(
Eˆ {Y (c)}
)
.
Here, λ1 expresses a clinically meaningful tolerance level (e.g. 20%) indicating
how much the center-speciﬁc potential risk is allowed to depart from the current
population average risk E(Y ). In practice such envisaged reference is likely to
steer the choice of λ1 once E(Y ) is known or has been estimated. Further, zk
is the k ×100th percentile of the standard normal distribution, so k (e.g. 0.75)
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expresses the degree of statistical evidence required before ﬂagging a center as
low/high risk. In Varewyck et al. (2014) it is explained how sd(Eˆ {Y (c)}) can be
estimated.
Similarly for indirectly standardized risks, we will classify a center as having
low risk if
ˆExcess risk+ zk × sd
(
ˆExcess risk
)<−λ2
or as high risk if
λ2 < ˆExcess risk− zk × sd
(
ˆExcess risk
)
.
Here again λ2 expresses a clinically meaningful tolerance level (e.g. 5%) and k
(e.g. 0.75) is a measure for statistical evidence. To obtain comparable results
between direct and indirect standardization, one can choose λ2 = λ1 ×E(Y )
because then the width for acceptance is the same for both standardizations, i.e.
2×λ2 = 2×λ1×E(Y ).
3.C AdditionalResults onSimulationStudyandData
Analysis
We illustrate the center-speciﬁc distribution of the marginally normal standard-
ized or beta distributed covariate L with small or large differences across centers
for one simulated dataset in Figure 3.8 and 3.9. As discussed in the paper, we
illustrate in Figure 3.10 the mean bias for 1 simulated dataset, for large versus
small differences in patient mix and standardized normal L. Results on correct
center classiﬁcation for the simulated data can be found in Table 3.3 for direct
standardization and in Table 3.4 for indirect standardization.
A univariate descriptive analysis of the Riksstroke data can be found in Table
3.5. Additional results for the multiple imputed analysis are shown in Figure
3.11 and for complete case analysis in Figure 3.12 and 3.13. We also studied the
effect of time to hospital per consciousness level in Figure 3.14. The estimated
interaction effect in the outcome model with interaction between center and
time to hospital or age is illustrated in Figure 3.15.
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tient mix and standardized normal L.
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Figure 3.8: Illustration of center sizes, variability in patient mix and mortality risk high-
lighting 3 speciﬁc centers in black with full line for their range of L (1 simulated dataset).
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Figure 3.9: Illustration of center sizes, variability in patient mix and mortality risk high-
lighting 3 speciﬁc centers in black with full line for their range of L (1 simulated dataset).
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L-distribution N (0,1)
Patient mix Small Medium Large
L×C interaction no yes no yes no yes
Power (%)
to detect High 42 44 33 43 32 34
to detect Low 31 29 33 29 38 28
Type I error (%)
Accepted as Low 3.2 2.8 4.2 2.8 13 6.3
Accepted as High 5.2 5.3 8.8 6.2 18 9.1
Serious type I error (%)
Low as High 0 0 0 0 1.7 0.3
High as Low 0.2 0.1 0.5 0.1 13 2.6
Center classiﬁcation (%)
correct (L-A-H) 81 82 77 81 63 75
L-distribution Beta(1,6)
Patient mix Small Medium Large
L×C interaction no yes no yes no yes
Power (%)
to detect High 47 47 40 44 33 42
to detect Low 59 57 52 54 44 52
Type I error (%)
Accepted as Low 1.0 0.9 2.3 2.8 3.0 6.7
Accepted as High 6.6 6.9 7.8 8.2 7.5 13
Serious type I error (%)
Low as High 0 0 0.4 0 0.1 0.6
High as Low 0 0 0.3 1.3 1.0 3.2
Center classiﬁcation (%)
correct (L-A-H) 74 74 70 71 67 66
Table 3.3: Center classiﬁcation (Low, Accepted or High risk) for direct standardization
with λ1 = 20% and k = 0.75. Results are for an outcome regression model without (no)
or with (yes) interaction between center and patient characteristic L. The ‘Type I error
for Accepted as Low’ for example denotes the estimated probability that a center with a
‘truely’ accepted mortality risk is actually classiﬁed as having low risk.
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L-distribution N (0,1)
Patient mix Small Medium Large
L×C interaction no yes no yes no yes
Power (%)
to detect High 29 27 43 40 70 61
to detect Low 35 37 49 52 68 76
Type I error (%)
Accepted as Low 4.2 4.5 3.9 4.2 6.9 5.6
Accepted as High 2.5 2.4 3.2 2.9 0.9 0.6
Serious type I error (%)
Low as High 0 0 0 0 0.03 0
High as Low 0.25 0.25 0 0 0 0
Center classiﬁcation (%)
correct (L-A-H) 81 81 83 83 83 83
L-distribution Beta(1,6)
Patient mix Small Medium Large
L×C interaction no yes no yes no yes
Power (%)
to detect High 36 35 41 38 38 31
to detect Low 64 65 60 62 59 64
Type I error (%)
Accepted as Low 1.9 1.9 2.5 2.8 3.7 4.5
Accepted as High 4.2 4.1 4.3 3.8 2.9 2.5
Serious type I error (%)
Low as High 0 0 0 0 0 0
High as Low 0 0 0 0.08 0 0
Center classiﬁcation (%)
correct (L-A-H) 76 76 78 78 78 78
Table 3.4: Center classiﬁcation (Low, Accepted or High risk) for indirect standardization
with λ2 = 0.20×E(Y )≈ 4.5% for N (0,1), λ2 = 0.20×E(Y )≈ 5.8% for Beta(1,6) and k =
0.75. Results are for an outcome regression model without (no) or with (yes) interaction
between center and patient characteristic L. The ‘Type I error for Accepted as Low’
for example denotes the estimated probability that a center with a ‘truely’ accepted
mortality risk is actually classiﬁed as having low risk.
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Figure 3.10: Assessing regression to the mean bias for 1 simulated dataset, scenario
with large versus small differences in patient mix and standardized normal L. Direct
standardization on top, indirect standardization at the bottom.
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Complete cases Missing data (%) Imputed data
(n = 83 265) (n = 249 414)
Age 76 (67 to 83) 0 78 (68 to 84)
Women 38 694 (46%) 0 123525 (50%)
Consciousness at admission 1
Alert 70522 (85%) 204621 (82%)
Drowsy 9446 (11%) 31220 (13%)
Unconscious 3297 (4%) 13572 (5%)
Time to hospital (in hours) 2.3 (1.1 to 6.7) 60 3.7 (1.0 to 8.8)
Distance to hospital (in km) 9.6 (2.6 to 23) 1 8.3 (2.5 to 22)
Stroke subtype 0
Intracerebral haemorrhage (I61) 9676 (12%) 29610 (12%)
Cerebral infarction (I63) 70956 (85%) 210421 (84%)
Unspeciﬁed stroke (I64) 2633 (3%) 9383 (4%)
Year of admission 0
2001 5233 (6%) 19890 (8%)
2002 6186 (7%) 20638 (8%)
2003 5834 (7%) 20915 (8%)
2004 6807 (8%) 21003 (8%)
2005 7970 (10%) 21700(9%)
2006 8056 (10%) 20960 (8%)
2007 8001 (10%) 20446 (8%)
2008 7277 (9%) 20591 (8%)
2009 6795 (8%) 20715 (8%)
2010 7106 (9%) 21225 (9%)
2011 7010 (8%) 20899 (8%)
2012 6990 (8%) 20432 (8%)
Education level 4
Primary 43391 (52%) 135467 (54%)
Secondary 28079 (34%) 81431 (33%)
University 11795 (14%) 32515 (13%)
Country of birth 1
Sweden 75200 (90%) 222275 (89%)
Other Nordic 4083 (5%) 12757 (5%)
Other Europe 2835 (3%) 10080 (4%)
Other 1147 (1%) 4301 (2%)
Adjusted yearly income (in 100 SEK) 1
< 861 8326 (10%) 24864 (10%)
861 to 1334 30497 (37%) 99792 (40%)
2490 34771 (42%) 25058 (40%)
> 2490 9671 (12%) 99700 (10%)
Institutional living 5264 (6%) 1 21769 (9%)
Living alone 34660 (42%) 1 123790 (50%)
Activities of daily living, before admission 6303 (8%) 2 24834 (10%)
Atrial ﬁbrilation 21379 (26%) 2 66661 (27%)
Diabetes 15481 (19%) 1 49658 (20%)
Trt for high blood pressure, before admission 44742 (54%) 2 134526 (54%)
Current smoker 12461 (15%) 13 38422 (15%)
CT-scan after admission 82242 (99%) 0.4 244744 (98%)
Thrombolytic treatment 6323 (8%) 2 8869 (4%)
30-day mortality risk 8571 (10%) 0 32738 (13%)
Table 3.5: Descriptives of the predictors used in the imputation models, based on complete
cases or the average over 5 imputed datasets. For continuous variables the median with 1st and
3rd quartile are given and for categorical variables the number of patients (%) are given.
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Figure 3.11: Center-speciﬁc values for the proportion of female patients and proportion
of unconscious or drowsy patients for one imputed dataset. Bubble size is proportional
to center size. Center 47 and 54 have more than 1% difference in its estimated potential
full population risk when ignoring interactions with time to hospital (MI).
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Figure 3.12: Center-speciﬁc values for the proportion of female patients, proportion of
unconscious or drowsy patients, patient’s age and time to hospital (hours) for complete
cases. Bubble size is proportional to center size. Center 55 has more than 1% difference
in its estimated potential full population risk when ignoring interactions with age, center
65 and 85 for interactions with time.
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Figure 3.13: The directly or indirectly standardized risk per center, with or without
interactions between center and patient’s age or time to hospital (grey without and
black with interactions), in function of the standard deviation of the center-speciﬁc
distribution of patient’s age or time to hospital for complete case analysis. Bubble size
is proportional to center size and ellipses indicate centers with more than 1% difference
in estimated risk.
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Figure 3.14: The estimated 30-day mortality risk when allowing for a different effect of
time to hospital (hours) per consciousness level, considering male patients with mean
age and treated at the reference hospital. Time to hospital categories are based on its 10%
percentiles (dots) and ﬁtted lines assume a loglinear effect of time on 30-day mortality
risk.
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Figure 3.15: Estimated interaction effect in outcome model with interaction between
center and time to hospital or age, based on complete cases and for a reference patient
(Left: male patient, alert and 0 hours until admission; Right: male patient with mean
age).
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4CHAPTER 4
Cost-eﬃcient Variable Selection for Clinical Registers
with Missing Covariate Values
Summary
Clinical registers have expanded enormously and, with that, the hope to capture
the important confounders for health-care evaluations and learn more about
causal treatment effects. However, more covariates are not always better, because
they imply higher measurement costs, possibly less precise and more missing
data. We provide a frequentist approach for cost-efﬁcient selection of variables
which may be incompletely measured.
We estimate individual mortality risks as well as directly standardized mor-
tality risks based on logistic regression models incorporating patient-speciﬁc
baseline covariates and added hospital effects. Missing covariate values are han-
dled by complete case analysis or multiple imputation. We search for the subset
of patient covariates that suits the budget and minimizes the error on estimated
risks. This subset can be approximated by stochastic search algorithms (basic
hill-climber or parallel tempering), possibly preceded by the generalized LASSO.
For a case study with 83 covariates we found a subset with smaller error than
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the Bayesian population RJMCMC approach within a fraction of its search time.
For the Swedish register Riksstroke, intrinsically different subsets were found for
30-day mortality prediction versus hospital quality assessment. Analytical and
empirical results favored adding consciousness over the more comprehensive
but incomplete measure NIHSS of baseline disease severity.
4.1 Introduction
Whether the purpose is personalized medicine or monitoring quality of care,
medical registers are rapidly gaining ground. Linkage with existing national
registers avoids duplication efforts while maintaining a rich information basis
per patient. This in turn enables accurate prediction for (groups of) patients,
for example, clinical biomarkers are used to predict which patient populations
are more likely to beneﬁt or experience an adverse reaction in response to a
given therapy (Trusheim et al., 2007). There are limits however to what can be
gained from these additional covariates. The idea that more measured patient
characteristics automatically yield better results, not only hits against statistical
limitations but also against constraints of measurement costs and human effort
involved in registration. First, measurement costs can be lowered by recording
fewer characteristics per patient (group). The time and medical infrastructure
needed for certain measurements contribute to this cost as well as the poten-
tial burden on the patients themselves. Measurement costs should be weighed
against the incremental value, on top of predictors that are readily available. Sec-
ondly, by reducing the number of predictors one may improve the completeness
and accurateness of registration, a recognized weakness of registers (Shahian
et al., 2007). The more expensive sickness indicators are thereby expected to
be missing more frequently, while basic predictors such as age and gender are
accessible for all patients. From a statistical point of view, a full model, including
all measured covariates, may suffer overﬁtting when sample size is limited.
In this paper we search for the subset of covariates that minimizes the error
on the predicted individual outcome or on standardized risks for multicenter
data, while the total covariate cost is restricted. We estimate these risks based on
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logistic regression models that incorporate patient-speciﬁc baseline covariates
plus hospital effects. Missing data complicate model building, because includ-
ing patient covariates with missing data may induce selection bias, in view of
which the analysis becomes conditional on unveriﬁable assumptions on the
unobserved data. We will consider both complete case analysis and multiple
imputation to handle missing data, comparing current practice and statistical
preference (Little, 1992). The statistical challenge is even more formidable when
evaluating hospital performance, because important confounders of the center-
outcome effect should then be selected to avoid confounding bias (Normand
et al., 1997; Brookhart et al., 2010). Indeed, if age is for example not accounted
for, centers treating mostly older patients will likely show a higher mortality risk,
irrespective of their actual care level.
When many covariates are measured, selection is routinely based on auto-
matic forward or backward selection procedures (van der Heijden et al., 2006;
Wood et al., 2008), which select variables purely based on statistical signiﬁcance
without taking clinical relevance or measurement costs into account. Instead, we
target small prediction errors or accurate performance estimates, depending on
the outcome of interest. A characteristic is not only selected for its added value,
but also for its low registration cost. We therefore restrict our search to those
covariate subsets that respect a predeﬁned (average) budget per patient. Enu-
merating, not to say evaluating all possible candidate covariate combinations is
not manageable even with a modest number of covariates. Therefore, stochastic
search algorithms have been suggested in a Bayesian framework (George and
McCulloch, 1993), which prove useful in a frequentist context with an adapted
deﬁnition of a ‘better’ subset. We deﬁne a subset to be better if it yields a smaller
cross-validated error on individual predictions or directly standardized risks. We
focus on the following two search algorithms: basic stochastic hill-climber and a
parallel tempering algorithm (Glover and Kochenberger, 2010).
We apply this variable selection approach to predict 30-day mortality for
patients with pneumonia in U.S. hospitals based on data from the RAND corpo-
ration (Kahn et al., 1990) and compare results with those reported in Fouskakis
et al. (2009). To evaluate hospital performance based on the national register
Riksstroke for acute stroke treatment in Swedish hospitals (Asplund et al., 2011),
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selection is more complicated as we need to balance the inclusion of confounders
needed to avoid confounding bias with the occurrence of missing values which
may induce selection bias.
4.2 Methods
4.2.1 Deﬁning the error functions
Let L be the (n×p) matrix of p patient-speciﬁc baseline characteristics such as
gender, age and initial disease status for all n patients. We wish to select a subset
L(S) where S refers to the vector of inclusion indicators (S1, . . . ,Sp) such that S j is
1 if the j -th patient characteristic is included in the outcome regression model
and 0 otherwise ( j = 1, . . . ,p). Let C be a random variable indicating in which
center, out of m centers, the patient was actually treated. In general, we consider
the following regression model for outcome Y , e.g. 30-day mortality:
E
(
Y |L(S),C ;β(S),ψ(S)
)= g (L(S) β(S)+ m∑
c=1
ψc,(S)I (C = c)
)
, (4.1)
where β(S) is an unknown parameter with the dimension of L(S), ψ(S) = (ψ1,(S),
. . . ,ψm,(S))T are the residual center effects and g (·) is a known link function,
e.g. the logistic link. The model parameters (βT(S),ψ
T
(S)) will be estimated using
the Firth penalized-likelihood method (Firth, 1993), which has been shown to
be preferable in this setting (Varewyck et al., 2014), because it avoids undue
shrinkage and maintains convergence in the presence of small centers.
We aim to ﬁnd a subset of patient characteristics, identiﬁed by S, that respects
the total allowed cost A:
p∑
j=1
I (S j = 1)aj ≤ A, (4.2)
where aj ≥ 0 is the cost for measuring and registering covariate j ( j = 1, . . . ,p).
For the ﬁrst outcome of interest, the given subset has to minimize the error on
the predicted individual outcome, which is deﬁned as:
ER1(S)= E
[{
E
(
Y |L∗(S),C∗;βˆ(S),ψˆ(S)
)−Y ∗}2]1/2 . (4.3)
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For a given S, we will ﬁrst estimate the model parameters (βT(S),ψ
T
(S)) as (βˆ
T
(S),ψˆ
T
(S))
on 80% of the data (Y ,L(S),C ) and then, given the obtained estimates, the pre-
diction error is evaluated on the remaining 20% of the data (Y ∗,L∗(S),C
∗). Using
cross-validation techniques, we randomly partition the dataV = 5 times into two
such complementary subsets (Y ,L(S),C ) and (Y ∗,L∗(S),C
∗), which are assumed
to have the same distribution. Note that estimating the prediction error using
cross-validation may give overly pessimistic results, due to a reduced sample size
for parameter estimation (Steyerberg et al., 2001).
In the context of hospital performance, we aim to minimize the error on the
estimated directly standardized risks. As the hospital performance measure is
intended to represent the causal effect of the given care level, it is important
to adjust for confounding (Brookhart et al., 2010). Otherwise, higher mortality
risks may be unfairly attributed to a worse care level while they were actually
due to differences in patient mix across centers (e.g. initial disease severity
status, age). So, let Y (c) indicate the potential outcome for a given patient if
treated at the care level of center c. The directly standardized risk, denoted by
E {Y (c)}, encodes the potential full population risk under the care of center c:
the risk that would be realized if all patients under study were to experience the
care level of that given center c, irrespective of where they were actually treated,
e.g. Varewyck et al. (2014). Throughout, we assume that the patient-speciﬁc
covariates L are sufﬁcient to adjust for confounding of the center-outcome effect,
so that Y (c)⊥⊥C |L for all c (Hernán and Robins, 2006b). Under this assumption,
we have that E {Y (c)} = E {E(Y |L,C = c)}. Having selected a subset of patient
characteristics S, the error at hospital level is deﬁned as:
ER2(S,c)= E
[(
Eˆ(S)
{
Y ∗(c);βˆ∗(S),ψˆ
∗
(S)
}− Eˆ {Y (c);βˆ,ψˆ})2]1/2 , (4.4)
where the gold standard E {Y (c)} is not known and therefore replaced by the
estimated directly standardized risk Eˆ {Y (c);βˆ,ψˆ} based on half of the data and
including all measured covariates. The remaining half of the data is used to
estimate the model parameters as (βˆ∗T(S) ,ψˆ
∗T
(S) ) and for a given choice of S:
Eˆ(S)
{
Y ∗(c);βˆ∗(S),ψˆ
∗
(S)
}= Eˆ {E (Y |L∗(S),C = c;βˆ∗(S),ψˆ∗(S))} .
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This strategy makes sure that estimation of the model parameters and standard-
ization are performed on the same subset of the data, which is common practice
for direct standardization. Whilst this approach may result in underestimation
of the error ER2(S,c) because the gold standard is replaced by the model-based
Eˆ {Y (c);βˆ,ψˆ}, it is not expected to change which subset has the smallest error,
because the relative ranking of the errors is preserved under the assumption
that the estimate of the gold standard is consistent (Brookhart and van der Laan,
2006). We then aim to ﬁnd the subset S that meets the cost constraint (4.2) and
minimizes:
ER2(S)= E {ER2(S,c)}, (4.5)
where the average gives equal weight to all centers.
4.2.2 Searchmethods for cost-efﬁcient variable selection
The complexity of the search strongly differs for the two targeted risks. For
individual prediction, we aim to select those covariates that strongly impact indi-
vidual outcomes, as we target minimization of the prediction error. When interest
lies in accurately estimating directly standardized risks, we also need to select the
confounders of the center-outcome effect, which is especially important to avoid
confounding bias and thus to make fair evaluations of hospital performance. Our
methods may fail to select confounders that are strongly correlated with the cen-
ter choice and only moderately with the outcome. Therefore we suggest to ﬁrst
assess how patient mix differs across centers before the variables are selected.
Alternative selection procedures that are better targeted towards the selection
of confounders have been suggested in e.g. van der Laan and Gruber (2010);
Wilson and Reich (2014); Wang et al. (2012); Vansteelandt et al. (2010), but these
do not restrict the total covariate cost. Moreover, in contrast to prediction, risk
standardization requires that the regression model is correctly speciﬁed, because
the ﬁtted model is used to extrapolate results outside the observed covariate
range, which is especially the case if patient mix differs strongly across centers.
In that case, selecting the subset of confounders that minimizes the error on the
directly standardized risks is not sufﬁcient, but one also needs to assume that
there is no uncertainty about the structural properties of the outcome regression
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model, such as the link function and functional form of the covariates.
In this paper we will consider two stochastic search algorithms to approxi-
mate the subset of covariates S that minimizes the error functions ER1(S) and
ER2(S). Notice that we only consider suitable 0/1 combinations for S, e.g. in-
cluding a categorical covariate with dummy coding will change several values of
S at a time. The basic stochastic hill-climber (Glover and Kochenberger, 2010)
starts with a random subset of covariates that meets the covariate cost constraint.
In each step of the algorithm, a new neighbor-subset is created by randomly
adding, removing or swapping one covariate from the previously accepted sub-
set. It is ﬁrst checked whether the covariate cost of this new subset exceeds the
predeﬁned cost constraint. If so, this subset is not further considered and a new
neighbor-subset is created from the last accepted subset. If the cost constraint
is met, the outcome model is ﬁtted and the error on the predicted individual
outcome or the standardized risk is estimated. If this error is smaller than the
currently accepted subset, this new subset is accepted as current subset. If not,
the algorithm generates a new neighbor starting from the last accepted subset.
This strategy is similar to the reversible jump Markov chain Monte Carlo (RJM-
CMC) algorithm which allows the number of included covariates to vary during
the search (Green, 1995). As the basic hill-climber may be trapped in a local
optimum, the procedure is repeated for 10 initial subsets and the best solution
over all restarts is chosen. This does not affect the total computation time if these
10 independent restarts are executed on parallel cores of the computer.
Alternatively, we consider the parallel tempering search algorithm, which
is superior to the basic stochastic hill-climber as it is able to escape from a
local optimum by sometimes accepting subsets whose error is larger than for
the current subset solution. For example, when evaluating prediction of the
individual’s outcome, the probability to accept a new subset solution Snew over
the current solution Scurrent, for a given temperature t , is:
P (accept Snew)=
{
1 if ˆER1(Snew)≤ ˆER1(Scurrent)
exp
{
− ˆER1(Snew)− ˆER1(Scurrent)t
}
if ˆER1(Snew)> ˆER1(Scurrent),
(4.6)
and similarly for ER2(S). The search algorithm runs multiple chains, each with
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a given temperature, and exchanges subset solutions between them. Chains
with a high temperature thereby allow a lot of freedom to escape from local
optima, while those with lower temperatures ease convergence towards an opti-
mum. In our case, the parallel tempering algorithm will concurrently run 5 such
Metropolis searches with different temperatures. Solutions are then exchanged
to converge to one single best solution. It is advised to perform several Metropo-
lis searches in advance, each with a given temperature, to set the minimum
and maximum temperature for the parallel tempering algorithm. In a Bayesian
framework, this search strategy has been explored by means of the population-
based trans-dimensional RJMCMC algorithm in Fouskakis et al. (2009), which
combines ideas from the population-based MCMC and simulated tempering
algorithms.
These search algorithms do not terminate internally, so that we have to
specify a stopping criterion. Here, we limit the maximum time without ﬁnding a
better subset. Given the time it takes to evaluate the error for one given subset S,
one can calculate the maximum amount of time needed to evaluate all possible
neighbors of a given subset solution, which may help to set realistic values for
the stopping criterion. The latter may be large if the number of candidate subsets
is large or when evaluating the error function for one given subset takes already
a considerable amount of time.
In view of computation time, we also investigate the use of the generalized
LASSO (Tibshirani and Taylor, 2011), which can serve as a ﬁrst raw exploration
of the variable space. Indeed, the cost constraint in (4.2) suggests the use of a
weighted penalty function for LASSO regression. Then, the generalized LASSO
estimates are deﬁned by:
argmin
(β,ψ)∈Rp+m
[
n∑
i=1
{
Yi −E(Yi |L= Li ,C =Ci ;β,ψ)
}2+λ
(
p∑
j=1
aj |β j |+
m∑
c=1
bc |ψc |
)]
,
(4.7)
where λ≥ 0 is a tuning parameter and the subscript (S= 1) is omitted as naturally
all covariates are considered here. In particular, the center effects have penalty
factors (b1, . . . ,bm), which can all be set at 1 to penalize the center effects follow-
ing ordinary LASSO for individual prediction, or close to zero for hospital quality
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Figure 4.1: The shaded area is the constraint region for equal penalty factors (|β1|+|β2| ≤
2, i.e. ordinary LASSO), and the gray colored area for a penalty of β2 that is twice that
of β1 (2/3|β1|+4/3|β2| ≤ 2, generalized LASSO). The ellipses are the contours of least
squares error functions which intersect with the constraint regions in the red dots.
assessment so that the center effects are hardly penalized and thus forced into
the model. The penalty factors aj ≥ 0 for the patient characteristics increase for
larger measurement costs. In this way, covariates with a larger cost are intended
to be penalized more than cheap ones, reﬂecting that we are only willing to
pay an extra cost if the beneﬁt in terms of smaller errors is substantial. Before
estimating the parameters, the penalty factors are internally rescaled to sum to
the number of considered model parameters (p+m). The generalized LASSO
method is also illustrated in Figure 4.1, where compared to the ordinary LASSO,
the effect of an expensive covariate is shrunken more and sometimes set to zero
while the opposite may be true for the cheaper covariate. We will perform cross-
validated (default V = 10) generalized LASSO to ﬁnd the optimal value of λ, i.e.
the value that minimizes the mean-squared error on outcome predictions. This
value corresponds with a given subset of covariates that not necessarily respects
the total cost constraint. Once this subset is known, we will reﬁt the outcome
model using Firth corrected maximum likelihood estimation and estimate the
cross-validated error, which will allow us to compare the performance of this
method with the results from the stochastic search algorithms.
When some covariate values are missing or measured with error, our cost-
efﬁcient variable selection approach becomes especially relevant. It allows to
evaluate the added value of such a covariate while penalizing it by the cost to
ﬁll in missing values or obtain more accurate measurements. Although multiple
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imputation has been recommended over complete case analysis (van der Hei-
jden et al., 2006), a combination with variable selection is not straightforward
(Wood et al., 2008; Musoro et al., 2014). The completed data sets may result in
different best subsets, which are often combined using ad-hoc methods such
as retaining those covariates that were selected in at least 50% of the imputa-
tions (Vergouwe et al., 2010). In this article, we will obtain one ﬁnal subset as
follows: Given a subset suggested by the search algorithm, we ﬁt the outcome
model on each imputed data set. Then, predicted outcomes or standardized
risks are averaged across the imputed data sets before the error is evaluated and
the suggested subset is retained or rejected. This approach has previously been
recommended by Wood et al. (2008), where it is shown that under the ‘missing
at random assumption’ as stated in Little (1992), the obtained Type I error of
wrongly including a given variable which has no predictive value, is comparable
to what would be achieved if there were no missing data. We have now made
this approach computationally feasible, even for large data sets and numerous
variables, by using stochastic search algorithms to select the best subset. For the
generalized LASSO, we suggest to take the union of the selected subsets over the
multiple imputed data.
The search algorithms are run in Java version 1.8.0 using the JAMES frame-
work (De Beukelaer et al., 2015). Statistical analyses are performed in R version
3.1.2.
4.3 Two Case Studies
4.3.1 Subset selection for RAND data
The RAND data contain a representative sample of n = 2532 elderly American
patients hospitalized in the period 1980-86 with pneumonia, taken from the
RAND study (Kahn et al., 1990). An overview of the full set of 83 variables, together
with the minutes of abstraction time, ranging from 30 seconds to 10 minutes
is given in the Appendix (Table 4.2, taken from Fouskakis et al. (2009)). We will
use the basic stochastic hill-climber and the parallel tempering search algorithm
to ﬁnd the subset of covariates that minimizes the error on 30-day mortality
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predictions and compare their performance with the population RJMCMC and
the generalized LASSO. The data set has no missing values and no information on
the center where patients were treated. The estimated average 30-day mortality
risk is 15.8%. We perform V = 5 cross-validations with 80%+ 20% data split,
where the selected subjects differ only over the V data splits, but are re-used
for each subset selection S or (restart of the) search algorithm. Calculations are
performed on a machine with 3.40 GHz of CPU speed and 8 Gbyte RAM, unless
speciﬁed otherwise.
The full model, including all 83 covariates has a total cost of 103 and its
cross-validated prediction error was estimated to be 0.3162. The computation
time to ﬁt this model was only 7.3 seconds. The subset suggested by the RAND
committee was based on medical knowledge and includes 14 covariates with
total cost 30.5 and ˆER1(S) = 0.3126. Variable selection for the RAND data has
extensively been studied in Fouskakis et al. (2009). For example, when the total
cost is allowed to be at most 10, the population RJMCMC method in Fouskakis
et al. (2009) selected 8 covariates as best subset with estimated prediction error
0.3179. This search took about 3.3 days, on a machine with 3.66 GHz of CPU
speed and 1 Gbyte RAM (Fouskakis et al., 2009). Although differences in predic-
tion error turn out to be negligible, substantial differences in computation time
and covariate cost are detected. Clearly, the full model is not preferred as it has a
huge covariate cost while its prediction error is not the smallest. Results on the
selected subsets are summarized in Table 4.1 and their included covariates are
compared in Figure 4.4 (see Appendix).
We aim to reduce the computation time and prediction error compared to
the population RJMCMC by selecting covariates with different stochastic search
algorithms or the generalized LASSO. We constrain the total covariate cost to
10. The maximum time without ﬁnding a better subset is set at 10 minutes for
the stochastic hill-climber (and descriptive Metropolis searches), while for the
parallel tempering algorithm, which is more time-consuming, we double the
time to 20 minutes. We performed 100 Metropolis searches to deﬁne the mini-
mum (0) and maximum (0.003) temperature for the parallel tempering algorithm
(Figure 4.5 in Appendix). The stochastic hill-climber and the parallel tempering
search algorithm selected the same subset of 13 covariates as the subset with the
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Table 4.1: Comparison of the variable selection methods on the RAND data. Computa-
tion time is for a machine with 3.40 GHz of CPU speed and 8 Gbyte RAM, except for * it
was 3.66 GHz of CPU speed and 1 Gbyte RAM.
Selection method Prediction error Total cost Computation Selected
ˆER1(S) (constraint) time covariates
Full model 0.3162 103 (-) 7.3 secs 83
RAND committee 0.3126 30.5 (-) 0.7 secs 14
Population RJMCMC 0.3179 10 (10) 3.3 days* 8
Basic stochastic hill-climber 0.3039 10 (10) 38 mins 13
Parallel tempering 0.3039 10 (10) 2.2 hrs 13
Generalized LASSO
with cost constraint 0.3218 9 (10) 9.6 secs 15
at λmin +SEmin 0.3189 13 (-) 9.6 secs 20
smallest estimated prediction error of 0.3039 over 10 restarts. The longest com-
putation time over the 10 independent restarts was 38 minutes for the stochastic
hill-climber and 2.2 hours for the parallel tempering algorithm. Our best sub-
set was found only once for the stochastic hill-climber (Figure 4.6 in Appendix)
although enough time was given to evaluate all neighbor subset solutions, so
that the other restarts were probably trapped in a local optimum. For the parallel
tempering algorithm this best subset was found twice, because the algorithm
is partially protected against being trapped in a local optimum by concurrently
running chains with different temperature. The generalized LASSO with cost con-
straint selected 15 covariates within a drastically reduced computation time of
9.6 seconds. This subset has an estimated root mean-squared error of 0.4626 and
was selected after evaluating 500 values for λwith 10-fold cross-validations. The
estimated prediction error for this subset based on Firth corrected ﬁxed effects
regression is ˆER1(S)= 0.3218. Without cost constraint, it can be seen in Figure 4.2
that the subset corresponding with λ=λmin +SEmin has an estimated average
mean-squared error (MSE) which exceeds the minimum MSE by only one time
its estimated standard error (SEmin) and still approximates the cost constraint.
This subset solution has a total covariate cost of 13 and ˆER1(S)= 0.3189, so it is
certainly preferred over the one with the smallest mean-squared error, because
the latter has a total covariate cost of 67.5.
In summary, the stochastic hill-climber is the preferred method here, be-
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Figure 4.2: Generalized LASSO regression for a range of tuning parameter values λ, for
the RAND data. The shaded part meets the total cost constraint. λmin is the tuning
parameter corresponding with the minimum mean-squared error and SEmin is the
estimated standard error of its mean-squared error.
cause it ﬁnds the subset with the smallest prediction error that meets the cost
constraint, within a relatively short time span. The best subset we found has
a slightly smaller error than the subset suggested by the RAND committee and
costs only a third. All subsets from the 10 restarts of our stochastic search al-
gorithms have a smaller ˆER1(S) than the best subset in Fouskakis et al. (2009)
(Figure 4.6 in Appendix) and although the reduction in prediction error is at
most 1.7%, the reduction in computation time is huge (3.3 days compared to 38
minutes). The smaller prediction error may be explained by the use of a differ-
ent selection criterion in Fouskakis et al. (2009), namely the Bayesian posterior
model probability. Estimating that probability is also very time consuming be-
cause 500 000 iterations of the population RJMCMC had to be performed. The
generalized LASSO further reduced the computation time, but did not result in
smaller prediction errors and did not necessarily meet the total cost constraint.
The worse prediction errors may be due to undue shrinkage of the parameter
estimates in the ﬁtted model for variable selection while our selection criterion,
the cross-validated prediction error, was based on Firth corrected ﬁxed effects
regression. If the computation time for the stochastic hill-climber is problemat-
ically large, we suggest to ﬁrst perform a raw exploration of the variable space
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with the generalized LASSO. Then in a second phase, the stochastic hill-climber
can be applied to further reduce the number of included covariates so that the
total cost constraint is met.
4.3.2 Subset selection for Riksstroke
Riksstroke is the Swedish quality register for stroke care which aims to monitor
and improve hospital performance and ultimately to ensure the best possible
care for stroke patients. We consider 124 308 adult patients (≥ 18 years) with
ﬁrst registered stroke between 2007 and 2012 who were treated in one of 80
Swedish hospitals. The number of registered patients ranges from 103 to 5 832
per hospital. We consider patients diagnosed with ischemic stroke (ICD-10 I63),
intracerebral haemorrhage (ICD-10 I61) or unspeciﬁed acute cerebrovascular
event (ICD-10 I64) and we focus on 30-day mortality as the quality indicator,
which is never missing. We focus subsequently on minimizing the error at the
patient level ER1(S) and at the hospital level ER2(S). In total, 18 baseline patient
characteristics are considered, of which some may be incompletely measured
(Table 4.3 in Appendix). For example, the covariate NIHSS (National Institutes
of Health Stroke Scale) is a comprehensive measure (42 levels) for baseline dis-
ease severity but is missing for two-thirds of patients. In contrast, the patient’s
consciousness level at admission (alert, drowsy or unconscious) is registered for
almost all patients.
When some of the included covariates have missing values, the error will
be based on either the complete cases (CC) or the multiple imputed (MI) data.
For the ﬁrst method we assume that the missingness indicator R ⊥⊥ Y |L,C , i.e.
the outcome distribution of all data and the complete cases do not differ, given
the center and patient characteristics. For the directly standardized risks, we
moreover assume that R ⊥⊥ L, because the average over the distribution of L is
taken and otherwise the intended performance measure would differ for the
complete cases and all data. Depending on the included set of covariates, the
complete cases left a sample size of at least 41 798 complete records with lower
average 30-day mortality risk (8.0% versus 13.1%). To prevent lack of information
and quasi-complete separation, we excluded centers with less than 20 registered
126
44.3. Two Case Studies
patients to ﬁt the model (max. 6 and 9 excluded centers, respectively at patient
and hospital level). For the second method, assuming missingness at random
we performed 5 imputations of the missing covariate data using the R-package
MICE (Buuren and Groothuis-Oudshoorn, 2011). Missing values were imputed
using Bayesian linear regression models for continuous covariates, logistic regres-
sion for binary covariates and polytomous regression for unordered categorical
covariates. Each imputation model includes the 30-day mortality outcome and
all baseline covariates, except the one that is imputed. The data are thus multi-
ply imputed before the variable selection procedure is performed. For a given
subset S, we combine the outcome predictions and the directly standardized
risks for each center c (c = 1, . . . ,m) over the 5 imputations using Rubin’s rules
(Little, 1992). To obtain a consistent estimate for the gold standard, we always
estimate Eˆ {Y (c);βˆ,ψˆ} in (4.4) based on MI data, while Eˆ(S){Y ∗(c);βˆ∗(S),ψˆ
∗
(S)} may
be based on CC or MI data. We presume that problems of residual confounding
pose no major concern here, because patient mix has been shown not to differ
substantially across centers for Riksstroke (Varewyck et al., 2014, 2015).
We aim to ﬁnd the subset of covariates that results in the smallest error ER1(S)
or ER2(S). For these stochastic searches we only consider multiple imputation to
handle missing values, because it has repeatedly been shown to be superior over
a complete case analysis (van der Heijden et al., 2006; Little, 1992) although also
the more challenging method in combination with variable selection (Wood et al.,
2008). Our patient covariate cost is determined by the proportion of missing
values: 1 (no missing values), 1.5 (up to 5% missing values), 2 (up to 50% missing
values) or 3 (more than 50% missing values) and we constrain the total allowed
cost to 7 (Table 4.3 in Appendix). Higher covariate costs then reﬂect the effort it
would take to ﬁll in the missing values after the data were collected. Evaluating
all 218 ≈ 2.6×105 possible combinations is infeasible, because evaluating the
error for one given subset is already computationally demanding and may take
up to 6 minutes. Therefore we use a stochastic hill-climber with 10 restarts that
each stop after 2 hours without improvement, although 9 hours are needed to
evaluate all possible neighbors of a given subset. For this time-consuming search,
we perform only one cross-validation split. When splitting the multiple imputed
data, we ﬁx the selected subjects over the imputations. We will use standardized
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age and log-transformed NIHSS as we found a good ﬁt for a loglinear effect of
NIHSS on 30-day mortality risk (Figure 4.10 in Appendix).
The subset of patient characteristics with the smallest error at patient level
is S1: stroketype, age, consciousness level and NIHSS, with total cost 6.5 and
ˆER1(S1) = 0.2787. This subset includes NIHSS which has the largest covariate
cost and one covariate which is measured prior to stroke, namely age. As this
subset with the costly NIHSS is selected only once over the 10 restarts (Figure 4.7
in Appendix), it is likely that the search algorithm was trapped in a suboptimal
solution for the other restarts or not given enough time to ﬁnd a better neighbor.
We found a different best subset of patient characteristics when minimizing
the error on the directly standardized risks, S2: year of admission, patient’s
ADL-dependence, consciousness level and NIHSS, with total cost 7 and average
error over the centers ˆER2(S2)= 0.0161 (Figure 4.8 in Appendix). Comparing the
subsets S1 and S2, the predictors stroketype and age were replaced by year of
admission and patient’s ADL-dependence in the context of health care evalua-
tions. Indeed, hospital performance is very likely to be confounded by the year
of admission and by the degree of patients’ dependence or thus how strongly
patients rely on the provided care level.
As the best subsets S1 and S2 include both consciousness and NIHSS, which
are different measures for the same patient’s baseline disease severity, we now
aim to investigate whether consciousness is a good surrogate for NIHSS.
4.4 Analytical Reﬂections on the Inclusion of Covari-
ates
We compare the error change when including a covariate with missing values (e.g.
NIHSS) versus a surrogate which is completely, but imprecisely measured (e.g.
consciousness). These comparisons will be made for the prediction error (4.3)
and the error on the directly standardized risk of a given center c (4.4); details
on the calculations can be found in the Appendix, Section 4.A. We will consider
the simple setting of a linear regression model for a continuous outcome Y ,
including two patient characteristics and two centers. Such model is equivalent
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with a model including mean-centered covariates:
Y =β1L1+β2L2+ψ1I (C = 1)+ψ2I (C = 2)+ε, (4.8)
where ε is a random variable with mean zero and variance σ2ε conditional on
(L1,L2,C ) and E(L1)= E(L2)= 0. As before, using cross-validation, we randomly
split the data into two complementary parts, {(Yi ;L1i ,L2i ,Ci ), i = 1, . . . ,n} and
{(Y ∗i ;L
∗
1i ,L
∗
2i ,C
∗
i ), i = 1, . . . ,n∗}, which are assumed to have the same distribution.
Let L1 be a surrogate for L2, so that L1 contains no other information on Y
than what is available in L2. More formally, we assume that L1 = L2 +U with
E(U |L2,C )= 0 and that Y is conditionally independent of L1 given L2 andC , so
that β1 = 0 in the regression model (4.8).
4.4.1 A covariate withmeasurement error
First, we consider the working outcome regression model including only the
surrogate L1:
Y =α1L1+α2I (C = 1)+α3I (C = 2)+εs , (4.9)
where εs has mean zero and variance σ2s conditional on (L1,C ). The residual
variance of this regression is (Carroll et al., 2006):
σ2s =σ2ε+
β22σ
2
uσ
2
2
σ2u +σ22
, (4.10)
where σ2u =Var(U |L2,C ) and σ22 =Var(L2|C ). Let (αˆ1, αˆ2, αˆ3) be the least squares
estimates of the model parameters (α1,α2,α3). As shown by equation (4.20) in
the Appendix, the expected prediction error for a ‘new’ patient with characteristic
L∗1 and treated at centerC
∗, is:
E
[{
Y ∗− (αˆ1L∗1 + αˆ2I (C∗ = 1)+ αˆ3I (C∗ = 2))
}2]=σ2s (1+ pn
)
, (4.11)
where p = 3 is the number of model parameters. From (4.10) it is clear that σ2s
will never be smaller than σ2ε, which conﬁrms the intuition that the residual
variance increases by regressing Y on the ‘less-informative’ surrogate L1 instead
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of on L1 and L2. Moreover, σ2s and thus the prediction error will increase for a
stronger predictive value of L2 on the outcome, as determined by β2, or with
larger measurement error.
For the standardized risks, estimation of the model parameters and the di-
rectly standardized risks are both based on (Y ∗;L∗1 ,L
∗
2 ,C
∗). Therefore, notation
will be simpliﬁed by omitting the star superscript in the notation below for the
directly standardized risks. Under the assumption that the patient covariates are
mean-centered, the directly standardized risk at center c is simplyψc , (c = 1,2).
As shown by equation (4.22) in the Appendix, the expected error on the directly
standardized risk for center 1 is then:
E
{
(ψˆ1−ψ1)2
}= σ2s
n
{
1
P (C = 1) +
E(L1|C = 1)2
E(L21)
}
. (4.12)
If there is no difference in patient-mix across centers, then E (L1)= E (L1|C = 1)=
E(L1|C = 2) = 0, so that the error simpliﬁes to σ2s {nP (C = 1)}−1, showing that
larger centers will have a smaller error on their directly standardized risk, which
corresponds to previous ﬁndings in Varewyck et al. (2015).
4.4.2 A covariate withmissing values
Suppose now that we include the more precise, but incomplete measure L2
instead of its surrogate L1. Let R = (R1, . . . ,Rn)T where Rj = 1 if L2 is observed
and Rj = 0 if L2 is missing for the j -th subject ( j = 1, . . . ,n). We assume that
R ⊥⊥ Y |L1,L2,C and perform a complete case analysis. Moreover, we assume
that the covariate L2 is mean-centered given the complete cases, E (L2|R = 1)= 0,
and that (L∗2 ,C
∗) is a random sample from the complete cases. Let (βˆ2,ψˆ1,ψˆ2) be
the least squares estimates of the model parameters (β2,ψ1,ψ2) in (4.8), based
on the complete cases. If the distributions of (L2,C ) in the complete cases and
(L∗2 ,C
∗) are equal, the expected prediction error is:
E
[{
Y ∗− (βˆ2L∗2 + ψˆ1I (C∗ = 1)+ ψˆ2I (C∗ = 2))
}2]=σ2ε
{
1+ p
nP (R = 1)
}
, (4.13)
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where p = 3 is again the number of model parameters. It is clear that the pre-
diction error for a complete case analysis with a model including only L2 will be
smaller than for the model including only the completely measured surrogate L1
if,
σ2s
σ2ε
> 1+ 1−P (R = 1)
P (R = 1)
(
1+ np
) , (4.14)
or e.g. if there are many observations in the data set for parameter estimation
(n ), few missing values and thus P (R = 1) ≈ 1 or if the measurement error
is large σ2s  σ2ε. Let λ express which fraction of the variability in L1 is due to
measurement error in the sense that λ=Var(U |C )Var(L1|C )−1. Then it is shown
by equation (4.23) in the Appendix that (4.14) is equivalent with:
(
1+ n
p
)
λ
R2L2|C
1−R2L2|C
> odds(R = 0), (4.15)
where R2L2|C is the coefﬁcient of partial determination between Y and L2 givenC .
This may help to decide for which percentage of missing values it is still beneﬁcial
to include the more informative variable L2 when there is a completely measured
surrogate L1 available, as will be illustrated in Section 4.4.3.
When regressing Y on L2, the directly standardized risk for center c (c = 1,2)
is again expressed by ψc , under the additional assumption that the observed
distribution of L2 is the same as in the study population, R ⊥⊥ L2. Then, the
expected error on the directly standardized risk for center 1 is:
E
{
(ψˆ1−ψ1)2
} = σ2ε
nP (R = 1)
{
1
P (C = 1|R = 1) +
E(L2|C = 1,R = 1)2
E(L22|R = 1)
}
= σ
2
ε
nP (R = 1)P (C = 1|R = 1) , (4.16)
where the last equality is only justiﬁed if there is no difference in patient-mix
across centers for the complete cases. Here again, the largest centers will have
the smallest error on their directly standardized risk. Under the assumption of
equal patient-mix across centers, the error on the directly standardized risk for
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center 1 is smaller when regressing Y on L2 instead of its surrogate L1, if:
σ2s
σ2ε
> P (C = 1)
P (R = 1)P (C = 1|R = 1) , (4.17)
which is most probable if there are few missing values or the measurement error
is large. As shown by equation (4.24) in the Appendix, the error on the averaged
directly standardized risks, giving equal weight to each center, then becomes:
1+λ
R2L2|C
1−R2L2|C
>
∑m
c=1
1
P (C=c|R=1)
P (R = 1)∑mc=1 1P (C=c) . (4.18)
If R ⊥⊥C , the latter simpliﬁes to:
λ
R2L2|C
1−R2L2|C
> odds(R = 0), (4.19)
which is less likely to be fulﬁlled than the similar criterion at patient level (4.15).
So, even when the variance of the surrogate would be much larger than for L2 (e.g.
λ= 50%) and this more precise measure would be hardly missing (e.g. odds(R =
0)= 10%), the relative reduction in residual error by additionally including L2 on
top ofC has to be substantial (e.g. R2L2|C = 20%) in order to favor the inclusion of
L2 instead of L1 (see also equation (4.25) in Appendix).
In conclusion, measurement errors have a direct adverse effect on the accu-
rateness of predicted outcomes, so that in most settings the analytical results
favored the inclusion of the most accurate measure instead of its surrogate, even
when the former is often missing. This will however reduce for which patients pre-
dictions can be obtained. On the other hand, when the aim is to assess hospital
performance, more observations will improve the accurateness of the estimated
center effects, even when the included confounders are measured with some
error. So, in this case missing values have a bigger impact than measurement
error, and consequently the inclusion of the available surrogate was favored in
most settings. Notice that these analytic results only hold for a complete case
analysis and that a similar derivation for multiple imputed data is much more
complicated.
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4.4.3 Comparing the added value of consciousness and NIHSS
For Riksstroke, we aim to assess the beneﬁt of NIHSS over consciousness as mea-
sure of baseline disease severity in the prognostic score via the error at patient
or hospital level. We will study differences in the error analytically and by per-
forming V = 5 cross-validations to evaluate the errors ER1(S) and ER2(S) for all
possible subsets of the baseline covariates log NIHSS, consciousness, sex and age.
The latter three patient characteristics are chosen because national reports on
Riksstroke traditionally adjust the outcome for those (Stroke Board Team, 2011).
We found that NIHSS values tend to be larger for drowsy or unconscious patients
than for alert patients (Figure 4.9 in Appendix), suggesting that consciousness
may be a surrogate for NIHSS.
Based on the analytical results in Sections 4.4.1 and 4.4.2, we can ﬁrst get
some intuition on whether to best include consciousness or NIHSS without
explicitly estimating the error. We simplify the setting by excluding 1338 patients
with missing consciousness level, which left a sample of 122 970 patients of
which 41 798 (Pˆ (R = 1) = 33%) patients have observed NIHSS. Based on the
data,
∑m
c=1 1/Pˆ (C = c|R = 1) = 36726, and
∑m
c=1 1/Pˆ (C = c) = 11790. With p =
m+1 = 81 and n = 122970×0.8, where 0.8 is the proportion of data used for
parameter estimation following cross-validation, equation (4.14) states that the
model including NIHSS will have a smaller prediction error than the model
including consciousness if σˆ2s > (1+0.0013) σˆ2ε, which is highly likely. In contrast,
for the directly standardized risk, this is most unlikely, unless σˆ2s > 3×3.12 σˆ2ε.
For the MI data we found a smaller error, both at patient and hospital level,
when including consciousness rather than NIHSS, in addition to sex and age
(Figure 4.3). This is surprising, because NIHSS is a more comprehensive measure
for baseline disease severity, but unconsciousness appears to be the stronger pre-
dictor of death following a univariate regression model (Table 4.3 in Appendix).
For CC the smallest prediction error is obtained when including NIHSS, which
was often missing, instead of consciousness. However, this is a misleading result
as the error is evaluated on the selective subset of patients with observed NIHSS.
Therefore in Figure 4.3a we additionally show the estimated prediction errors for
ﬁtting the models on CC while evaluating the prediction error on MI data and
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Figure 4.3: Estimated errors for null model or combination of patient characteristics sex
(S), age (A), consciousness (C) and NIHSS (N). We highlight three covariate combinations
that are of special interest for comparison.
found a smaller prediction error for the model including consciousness com-
pared to the model including NIHSS, besides sex and age. The error at hospital
level is remarkably large for models including NIHSS under a CC analysis, which
was already clear from the analytic results but may also partly be due to estimat-
ing the gold standard as the full population average, hence based on MI data. In
either case, the smallest errors were obtained for the model including sex, age,
consciousness and NIHSS, although the additional error reduction compared to
the model excluding NIHSS is negligible. For this reason and to avoid selection
bias, we prefer not to include NIHSS on top of consciousness.
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4.5 Discussion
Electronic health registers have expanded enormously in the last years. Their
size and measurement cost are expected to increase even further e.g. when
biomarkers are more routinely measured. For individual patient management
and treatment decisions, physicians are interested in those risk factors that best
predict mortality while limiting the overall workload and measurement cost.
When initial measurements for disease severity point towards an aggressive
cancer variant, one may additionally perform more expensive measurements
that can guide ﬁnding the most effective targeted treatment (Spahn et al., 2015).
In that case, values are missing for a selective group of patients and we have
assessed whether the added predictive value then weighs against the average
additional measurement cost. When the aim is to compare hospital performance,
it is important to adjust for differences in patient mix that induce confounding
and thus the interest lies primarily in those predictors of mortality that are also
differentially distributed between centers. Here again, the number of covariates
that can be measured may be restricted by the budget. In this paper, we suggested
a simple and efﬁcient approach to determine an appropriate subset of covariates
to include for each of the settings. We illustrated results on the RAND data, which
included a large number of patient characteristics, and the Swedish register
Riksstroke, that allowed for comparisons of hospital performance. For the latter
we focused on direct standardization, but our approach can similarly be applied
to indirect standardization such as the excess risk, which contrasts the quality
outcome in each center with what is expected if its patients were randomly
assigned over the level of care across all centers (Goetghebeur et al., 2011).
Both the deﬁnition of the error function and the options for the search al-
gorithm are very ﬂexible. In this paper, we used a strict maximum budget, so
that we rejected any model with total cost larger than the upper bound. Rather
than spending any money - as long as it stays below the maximum budget - one
may require a minimum beneﬁt per ‘dollar’ invested. The search methods we
used can indeed incorporate a penalty that accepts 1 unit cost increase provided
the error is decreased by at least x units. Another option of the search algo-
rithms is to increase the beneﬁt per dollar required when the current subset’s
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cost approaches the budget constraint. In the literature, costs and prediction
gain are sometimes placed on a common scale, trading one against the other,
and optimization then occurs on that scale (Fouskakis and Draper, 2008).
The deﬁnition of the error function may vary depending on the speciﬁc
context and does not fundamentally affect the search algorithm strategies. We
considered one speciﬁc error function at the patient level (4.3) and one at the hos-
pital level (4.4), which all give equal weight to ‘positive’ or ‘negative’ errors. The
situation is not necessarily symmetric however. For example, when the difference
between ‘true’ and estimated standardized risk is positive, we underestimate the
risk at that hospital and high mortality may be masked. A different weighting
factor for positive and negative differences can be obtained by a simple change
in the deﬁnition of the error function. Although it is unclear how the errors on
the directly standardized risks are best averaged over hospitals, we gave equal
weight to each hospital but alternatively weights proportional to the number of
registered patients could be given and one could minimize the mean absolute
rather than squared error. Our regression model contained main effects only. In
a second step, one may investigate interaction effects among those main effects.
This step would no longer be constrained by the budget for registration.
Stochastic search algorithms were used to approximate the best subset selec-
tion within a reasonable time. The basic stochastic hill-climber performed very
well as long as we allowed a sufﬁciently long computation time and restarted
the procedure with a number of randomly chosen initial subsets. However, the
stopping criterion is rather arbitrary and highly dependent on the speciﬁc setting,
so that better solutions may be missed when it is set too strict. Therefore it may
be interesting to monitor convergence during the search and stop the algorithm
as soon as convergence is reached, for example by examining the error reduction
relative to the amount of search time to ﬁnd this better subset. To reduce the
total search time, one may also consider to ﬁrst perform a generalized LASSO
regression, weighting covariates by their cost but not restricting the total cost.
Given the best subset found via this procedure, the subset can be further reduced
to meet the total cost constraint via the stochastic hill-climber.
When performing a complete case analysis the end user must be warned for
misleading results when covariates are selected based on the estimated error.
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This because including a covariate which is often missing, changes the subset of
patients on which the error can be evaluated. A smaller prediction error may then
not necessarily yield a better prediction model on the full study population. In
practice, individual predictions for patients with missing covariate values will be
based on their available patient characteristics and a separate model will be ﬁt for
each set of observed patient characteristics. Unfortunately, for the standardized
risks this is no longer possible as estimation and standardization have to be
performed on the same set of subjects. Comparing the predictive value of NIHSS
and consciousness surprisingly favored the latter. Moreover, when including both
in a model with sex and age, the added value of NIHSS on top of consciousness
was limited. So, we have several reasons to prefer consciousness over NIHSS
here: NIHSS is more absent, which is an important deﬁciency for a predictor
and it also forced us to make assumptions on the reasons for missingness. Then,
even if we assumed that values for NIHSS were missing at random, it did not
beat the predictive value of consciousness. When NIHSS would get measured
for more patients in the future, this may be reassessed before drawing general
conclusions.
In all, we believe that the ﬂexibility in deﬁning the error function as well as
the options of the search algorithms form a major advantage over other vari-
able selection methods. Moreover, they can be combined with a cost-efﬁcient
generalized LASSO to further reduce the computation time. Some R packages
implement these or similar search algorithms, such as in ‘caret’ (Kuhn, 2008) but
lack the wealth of ﬂexible options of the JAMES framework (De Beukelaer et al.,
2015).
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4.A Analytical Reﬂections on the Inclusion of Covari-
ates
In Section 4.4 we compare the error change when including a covariate with
missing values versus its surrogate which is completely, but imprecisely mea-
sured. Here, we provide extra results on the calculations, building on the as-
sumptions and notation introduced in Section 4.4. The outcome regression
model in (4.8) can be written as Y = Xγ + ε, where γ = (β1,β2,ψ1,ψ2)T and
X= (L1,L2, I (C = 1), I (C = 2)). Let Xn be the (n×4) design matrix for n individu-
als, with row i : (L1i ,L2i , I (Ci = 1), I (Ci = 2)), i = 1, . . . ,n. Least squares estimation
for γ then results in:
γˆ−γ = (XnTXn)−1XnT (Y−Xnγ)= (XnTXn)−1XnTε,
where Y= (Y1, . . . ,Yn)T and ε= (ε1, . . . ,εn)T .
In general, the expected prediction error for a ‘new’ patient with characteris-
tics X∗ = (L∗1 ,L∗2 , I (C∗ = 1), I (C∗ = 2)), is:
E
{
(Y ∗−X∗γˆ)2} = E {(Y ∗−X∗γ)2}+E {(X∗(γ− γˆ))2}
= σ2ε+E
(
X∗(XnTXn)−1XnTεεTXn(XnTXn)−1X∗T
)
= σ2ε+σ2εE
(
X∗E(XnTXn)−1X∗T
)
= σ2ε
[
1+n−1E {X∗E(XTX)−1X∗T }]
= σ2ε
{
1+n−1E (XTX)−1E (X∗X∗T )}
= σ2ε
(
1+ p
n
)
, (4.20)
where p is the number of model parameters and the last equality is justiﬁed under
the assumption that (Y ;L1,L2,C ) and (Y ∗;L∗1 ,L
∗
2 ,C
∗) are equally distributed. In
the case of mean-centered patient covariates, the directly standardized risk at
center c is simplyψc , (c = 1,2). The expected error for center 1 is then:
E
{
(ψˆ1−ψ1)2
} = E {(0,0,1,0)(γˆ−γ)(γˆ−γ)T (0,0,1,0)T }
= E {(0,0,1,0)(XnTXn)−1XnTεεTXn(XnTXn)−1(0,0,1,0)T }
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= σ
2
ε
n
(0,0,1,0)E(XTX)−1(0,0,1,0)T . (4.21)
For the ﬁrst setting, the outcome regression model includes only L1, which is
the surrogate for L2. In this case, the expected error on the directly standardized
risk for center 1 in (4.12) is calculated as:
E
{
(ψˆ1−ψ1)2
}
= σ
2
s
n
(0,1,0)⎛
⎜⎜⎝
E(L21) P (C = 1)E(L1|C = 1) P (C = 2)E(L1|C = 2)
P (C = 1)E(L1|C = 1) P (C = 1) 0
P (C = 2)E(L1|C = 2) 0 P (C = 2)
⎞
⎟⎟⎠
−1
(0,1,0)T
= σ
2
s
n
{
1
P (C = 1) +
E(L1|C = 1)2
E(L21)
}
. (4.22)
When L2 is incompletely measured, we assume that R ⊥⊥ Y |X and perform a
complete case analysis, so that the following identities hold,
E(Y |R = 1,X)= E(Y |X) and Var(Y |R = 1,X)=Var(Y |X)=σ2ε.
Let diag(R) be an (n×n) diagonal matrix with diagonal R. Using complete case
analysis, we estimate γ by solving the equations XnT diag(R)(Y−Xnγˆ) = 0, so
that γˆ−γ = (XnT diag(R)Xn)−1XnT diag(R)ε. We ﬁrst show that:
E
{
Xn
T diag(R)Xn
} = E(XnTXn|R = 1)P (R = 1)
= nP (R = 1)E (XTX|R = 1) .
Using this result, the expected prediction error in (4.13) and the expected error
on the directly standardized risk for center 1 in (4.16) can be calculated as before.
The prediction error for a complete case analysis with a model including only
L2 will be smaller than for the model including only the completely measured
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surrogate L1, if:
σ2s
σ2ε
>
{
1+ p
nP (R = 1)
}(
1+ p
n
)−1
1+ β
2
2σ
2
uσ
2
2
σ2ε(σ
2
u +σ22)
> 1+ 1−P (R = 1)
P (R = 1)(n/p+1)
1+λβ22
σ22
σ2ε
> 1+ odds(R = 0)
n/p+1
(1+n/p)λ
R2L2|·
1−R2L2|·
> odds(R = 0). (4.23)
where R2L2|· is the coefﬁcient of partial determination between Y and L2 given
the other covariates in the outcome regression model (4.8). The average error on
the directly standardized risks is smaller when regressing Y on L2 instead of the
surrogate L1, if:
m∑
c=1
σ2ε
nP (R = 1)P (C = c|R = 1) <
m∑
c=1
σ2s
n P (C = c)
σ2s
σ2ε
>
∑m
c=1
1
P (C=c|R=1)
P (R = 1)∑mc=1 1P (C=c)
1+λβ22
σ22
σ2ε
>
∑m
c=1
1
P (C=c|R=1)
P (R = 1)∑mc=1 1P (C=c)
1+λ
R2L2|·
1−R2L2|·
>
∑m
c=1
1
P (C=c|R=1)
P (R = 1)∑mc=1 1P (C=c) . (4.24)
If R ⊥⊥C , the latter simpliﬁes to:
λ
R2L2|·
1−R2L2|·
> odds(R = 0)
1
1−R2L2|·
> odds(R = 0)
λ
+1
R2L2|· >
odds(R = 0)
λ+odds(R = 0) . (4.25)
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4.B Additional Figures and Tables
Variable
Index Name Cost
1 Systolic blood pressure score 0.5
2 Age 0.5
3 Blood urea nitrogen 1.5
4 APACHE II coma score 2.5
5 Shortness of breath day 1 1.0
6 Serum albumin score 1.5
7 Respiratory distress 1.0
8 Septic complications 3.0
9 Prior respiratory failure 2.0
10 Recently hospitalized 2.0
11 Racbilateral process score 1.5
12 Initial temperature 0.5
13 Heart rate day 1 0.5
14 Chest pain day 1 0.5
15 Cardiomegaly score 1.5
16 Plural effusion score 1.5
17 Chest X-ray congestive heart failure score 2.5
18 Ambulatory score 2.5
19 Endocarditis at admission 1.5
20 Creatine phosphokinase score 2.0
21 Prior antibiotics 0.5
22 Prior interstitial lung disease 0.5
23 Home oxygen use 1.0
24 Prior pneumonectomy 0.5
25 Prior tracheostomy 0.5
26 Prior aminophylline score 0.5
27 Haematologic history score 1.5
28 Cancer score 1.5
29 APACHE heart rate score 1.5
30 Corodaker score 1.0
31 Disease of thorax 1.0
32 Multiple myeloma 0.5
33 Immunocompromised 0.5
34 Residence score 1.0
35 Hepatobiliary history 0.5
36 Renal history score 1.0
37 APACHE respiratory rate score 1.0
38 New lung score 1.0
39 Comorbid aspiration score 0.5
40 APACHE sodium score 2.0
41 APACHE haematocrit score 1.5
42 APACHE white blood cell score 1.5
43 APACHE oxygenation score 1.5
44 Cardiovascular accident score 1.0
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45 APACHE potassium score 1.0
46 Admission systolic blood pressure 0.5
47 Congestive heart failure chest X-ray score 2.5
48 Total APACHE II score 10.0
49 Respiratory rate day 1 0.5
50 Diastolic blood pressure day 1 0.5
51 Confusion day 1 0.5
52 Pulmonary vascular congestion score 0.5
53 APACHE venous bicarbonate score 1.5
54 Pulmonary of oedema score 0.5
55 Sum of congestive heart failure components 5.5
56 Inﬂuenza score 0.5
57 Arrest in emergency room score 0.5
58 Biliribin score 1.5
59 Positive blood culture 0.5
60 Positive urine culture 0.5
61 Wheezing at admission 0.5
62 Body system count 2.5
63 Morbid prior chronic obstructive pulmonary disease score 0.5
64 Morbid pulmonary hospitalization score 0.5
65 Comorbid cirrhosis score 0.5
66 Comorbid congestive heart failure score 0.5
67 Comorbid arrhythmias score 0.5
68 Comorbid smoking score 0.5
69 Comorbid alcoholism score 0.5
70 APACHE acidity score 1.0
71 Comorbid nasogastric tubes score 0.5
72 Comorbid steroids score 0.5
73 Morbid + comorbid score 7.5
74 Cardiac history score 0.5
75 Neurologic history score 0.5
76 Oncologic history score 0.5
77 Immunologic history score 0.5
78 Musculoskeletal score 0.5
79 APACHE temperature score 1.0
80 APACHE mean blood pressure score 1.0
81 APACHE creatinine score 1.0
82 Diagnoses score 1.0
83 Sex of patient 0.5
Table 4.2: Full set of 83 variables for the RAND data set, together with their covariate
cost per patient. In bold we indicate the variables that minimized the error on pa-
tient’s predicted 30-day mortality, using the basic stochastic hill-climber and the parallel
tempering algorithm, given a cost constraint of 10.
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Generalized LASSO
at  λmin + SEmin
Generalized LASSO 
 with cost constraint
Parallel tempering
Stochastic hill−climber
Population RJMCMC
RAND committee
Full model
1 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 83
Variable index
Figure 4.4: The selected subsets of covariates for each of the variable selection methods
on the RAND data.
0.000 0.002 0.004 0.006 0.008 0.010
0.305
0.310
0.315
0.320
Estimated prediction error
Temperature
Figure 4.5: The estimated prediction error for the ﬁnal best subset when performing
100 Metropolis searches with given temperature between 0 and 0.010. The maximum
temperature for the parallel tempering algorithm is then set at 0.003.
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(a) Stochastic hill-climber
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(b) Parallel Tempering
Figure 4.6: For 10 restarts we report the selected subset of patient characteristics for
the RAND data and compare the selected subset with the one found in Fouskakis et al.
(2009).
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Prevalence Missing Cost Univariate analysis
(%) (%) Odds ratio p-value
Male * 50.9 0 1 1.40 < 0.001
Age (in years) * (Mean & sd) 75.3 (12.4) 0 1 1.06 < 0.001
Consciousness at admission 1.1 1.5 < 0.001
(Alert) 82.6
Drowsy 12.1 8.6
Unconscious 5.3 38.71
NIHSS (Mean & sd) 7.1 (8.8) 66.2 3 1.09 0.018
log NIHSS (Mean & sd) 1.6 (1.0) 66.2 3 2.92 0.052
p-ADL dependence * 10.0 1.8 1.5 3.98 < 0.001
Institutional living * 8.5 0.5 1.5 4.41 < 0.001
Living alone * 49.8 0.7 1.5 1.85 < 0.001
Atrial ﬁbrilation * 27.2 1 1.5 2.11 < 0.001
Diabetes * 19.6 0.7 1.5 1.09 < 0.001
Trt for high blood pressure * 57.4 1.2 1.5 1.13 < 0.001
Current smoker * 14.8 9.8 2 0.54 < 0.001
CT scan 98.4 0.2 1.5 0.19 < 0.001
Thrombolysis 5.3 0.7 1.5 0.57 < 0.001
Stroke subtype 0 1 < 0.001
(Intracerebral haemorrhage (I61)) 11.8
Cerebral infarction (I63) 85.7 0.29
Unspeciﬁed stroke (I64) 2.5 0.96
Education * 3 1.5 < 0.001
(Primary) 49.9
Secondary 35.1 0.68
University 14.9 0.55
Country of birth * 0.8 1.5 < 0.001
Sweden 88.1
Other Nordic 5.4 0.83
Other Europe 4.4 0.87
Other 2.1 0.62
Adjusted yearly income (in 100 SEK) * 0.8 1.5 < 0.001
(< 861) 9.3
861 to 1330 31.1 0.97
1330 to 2490 45.6 0.61
> 2490 14.0 1.30
Year of admission 0 1 0.012
(2007) 16.4
2008 16.6 1.03
2009 16.7 1.02
2010 17.1 1.01
2011 16.8 0.99
2012 16.4 0.93
30-day mortality 13.1 0 - - -
Distribution of 30-day mortality risk (%) over CC (based on SACN model) MI
Centers (Mean and range) 8.0 0.0 to 30.8 12.8 6.7 to 19.1
Consciousness level: Alert 4.4 6.1
Drowsy 28.8 35.8
Unconscious 58.5 71.6
NIHSS (quartiles): 0 to 1 1.3 2.8
2 to 4 2.5 6.2
5 to 9 5.8 12.3
10 to 42 24.9 33.2
Table 4.3: Patient characteristics and outcome in Riksstroke, indicating * if measured prior to
stroke; reference category for regression model between brackets. Results are averaged over the
5 imputed data sets for Riksstroke, except for CC results and missing (%). CC are the complete
cases considering sex (S), age (A), consciousness (C) and NIHSS (N) and MI are multiple imputed
data.
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Figure 4.7: The selected subset of patient characteristics when minimizing the error
at patient level ˆER1(S) following stochastic hill-climber on multiple imputed data for
Riksstroke. The longest computation time for the 10 independent restarts is 5.6 hours.
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Figure 4.8: The selected subset of patient characteristics when minimizing the error
at hospital level ˆER2(S) following stochastic hill-climber on multiple imputed data for
Riksstroke. The longest computation time for the 10 independent restarts is 7.1 hours.
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No. of observations: 36492 (36%) 4545 (31%) 761 (12%)
Figure 4.9: Measured NIHSS values over consciousness levels (restricted to patients with
both observed), at the bottom indicating the number (and percentage) of patients with
measured NIHSS values.
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Figure 4.10: 30-day mortality risk in function of NIHSS per consciousness level for male
patients with mean age treated at the reference hospital. Dots are estimated risks based
on a model including 10% percentile categories for NIHSS and lines assume a loglinear
effect of NIHSS.
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Figure 4.11: Estimated errors per combination of patient characteristics sex (S), age (A),
consciousness (C) and NIHSS (N). Distribution of ˆER2(S,c) over all centers, averaged
over 5 cross-validations - log scale; in pairs of CC analysis on the left and MI analysis on
the right.
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The R package RiskStandard
5.1 Introduction
This R package implements statistical methods for benchmarking clinical care
centers based on a binary quality indicator such as 30-day mortality. For each
center we provide directly or indirectly standardized risks based on ﬁxed cen-
ter effects in a logistic regression model that also incorporates patient-speciﬁc
baseline covariates to adjust for differential case-mix. The user can choose to
apply the Firth correction (Firth, 1993) to the logistic outcome model to maintain
convergence in the presence of very small centers.
The package includes three example datasets: ‘smallCaseMix’, with small
differences in patient mix across centers, ‘largeCaseMix’ with large differences
in patient mix across centers, and ‘largeCaseMix_missing’ which is based on
largeCaseMix but where the consciousness level is missing for some patients.
Input data must contain for each patient (1) patient-speciﬁc covariates to adjust
for in the analysis e.g. age, baseline disease severity, (2) a hospital code where
the patient was treated and (3) a binary quality outcome e.g. 30-day mortality. In
this document we will illustrate how center performance can be assessed using
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the implemented R-functions.
We refer the user to Varewyck et al. (2014) for the theory behind the imple-
mented R-functions. The R package is freely available at www.cvstat.ugent.be.
5.2 Implemented R-Functions
In this section we illustrate the two summary functions and three plot functions
of the package. First, install and load the package ‘RiskStandard’:
> install.packages("./RiskStandard_0.0.6.tar.gz",
repos = NULL, type = "source")
> library(RiskStandard)
The dataset largeCaseMix contains for the n = 50 000 patients treated in one
of the m = 50 centers:
• patient-speciﬁc covariates: age (continuous), sex (binary) and conscious-
ness level at admission (1=alert, 2=drowsy, 3=unconscious)
• hospital code: center (1 to m)
• binary quality outcome: 30-day mortality (0=alive, 1=dead)
Before assessing center performance, we recommend to make some descriptives
of the dataset to get an impression of the distribution of patient characteristics
across centers (Figure 5.1).
> str(largeCaseMix)
 data.frame : 50000 obs. of 5 variables:
$ age : int 65 74 64 69 76 87 61 75 51 71 ...
$ sex : int 0 0 0 1 0 0 0 1 1 1 ...
$ cons : Factor w/ 3 levels "1","2","3": 1 1 1 1 2 1 1 1 1 1 ...
$ center : int 25 50 24 1 25 24 16 24 50 32 ...
$ outcome: int 0 0 1 0 1 0 0 0 0 0 ...
> m <- length(unique(largeCaseMix$center))
> n <- dim(largeCaseMix)[1]
> centerSize <- as.vector(table(largeCaseMix$center))
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> layout(matrix(1:4))
> # Age
> with(largeCaseMix,
plot(1:m, tapply(age, center, mean), pch = 19,
cex = centerSize/n*m, cex.lab = 1.2, ylim = c(60,80),
xlab = "Center", ylab = "", main = "Mean age per center"))
> with(largeCaseMix,
boxplot(age ~ center, xlab = "Center", ylab = "Age distribution",
cex.lab = 1.2))
> # Sex
> with(largeCaseMix,
plot(1:m, tapply(sex, center, mean), pch = 19, cex=centerSize/n*m,
cex.lab = 1.2, ylim = c(0,1), xlab =  Center , ylab = "",
main= "Percentage women per center"))
> # Consciousness
> with(largeCaseMix,
plot(1:m, tapply((cons==1), center, mean), pch = 21,
cex = centerSize/n*m, cex.lab = 1.2, ylim = c(0,1.1),
xlab= Center , ylab = "",
main="Distribution of consciousness level per center"))
> with(largeCaseMix,
points(c(1:m), tapply((cons %in% c(1,2)), center, mean), pch = 19,
cex = centerSize/n*m))
> legend("bottomleft", pch = c(21,19), bty= n ,
legend = c("Alert", "Alert or drowsy"), cex=1.2)
5.2.1 standardizeRisks()
This function estimates the standardized mortality risks. Necessary parameters
are:
• patientCovariates: design matrix for the patient-speciﬁc covariates. Please
make sure that categorical covariates are passed as factor, otherwise a
linear effect will be assumed in the ﬁtted outcome model (p covariate
values for each of the n patients, giving an n×p data frame)
• center: hospital code (1 value out of m for each of the n patients)
• Y: binary quality outcome (0 or 1 for each of the n patients)
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Figure 5.1: Descriptive plots for patient case-mix across centers. The size of the plot
symbol is proportional to the center size.
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The input for the parameter ‘center’ can be a character vector with the hospital
names which will automatically be used in the output. The other function param-
eters have default values, but can be changed by the user (see documentation in
R). By default, a Firth corrected outcome regression model is ﬁtted. By default,
no summary of the ﬁtted model is printed, but it can be asked by adding the
argument trace = TRUE. This summary can be useful e.g. to check whether
each of the covariates was passed in the correct format.
> indirectRisks <- standardizeRisks(
patientCovariates = largeCaseMix[,c( age , sex , cons )],
center = largeCaseMix[, center ],
Y = largeCaseMix[, outcome ])
> head(indirectRisks)
centerName centerSize standardizedRisk varStandardizedRisk lowerCI
1 1 386 -0.023367272 0.0003162722 -0.05822335
2 2 61 -0.007509684 0.0019252936 -0.09350931
3 3 984 -0.016308775 0.0001421959 -0.03968055
4 4 448 -0.075252885 0.0002203354 -0.10434600
5 5 2111 0.033703502 0.0001061479 0.01351036
6 6 141 -0.032481875 0.0006909590 -0.08400168
upperCI observedRisk
1 0.011488811 0.1658031
2 0.078489944 0.1803279
3 0.007062996 0.1636179
4 -0.046159770 0.1093750
5 0.053896643 0.2676457
6 0.019037931 0.1347518
Similarly for direct standardization:
> directRisks <- standardizeRisks(
patientCovariates = largeCaseMix[,c( age , sex , cons )],
center = largeCaseMix[, center ],
Y = largeCaseMix[, outcome ],
method= direct )
When some patients have missing values for a categorical patient covari-
ate such as consciousness level, we offer two ways to handle the missingness.
The option missing=‘completeCase’ (default) performs a complete case anal-
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ysis, excluding all patients who have missing consciousness. The option miss-
ing=‘dummyCategory’ adds a separate category to the ﬁtted outcome model,
allowing for a missing value effect. When some patients have missing values for
a continuous patient covariate such as age, the function will by default perform
a complete case analysis, excluding all patients who have missing age. Alterna-
tively, multiple imputation can be considered to handle missingness. Although
this method is currently not implemented in the standardizeRisks() function, the
user can pass each of the imputed datasets separately to the function and after-
ward average the estimated standardized risks over the different imputations.
The variance on the standardized risks can then be obtained by combining the
within and between imputation variance as explained in Schafer (1999). The
number of observations (n) that was used for the analysis can be extracted as an
attribute from the function.
> indirectRisks2 <- standardizeRisks(
patientCovariates = largeCaseMix_missing[,c( age , sex , cons )],
center = largeCaseMix_missing[, center ],
Y = largeCaseMix_missing[, outcome ],
method= indirect , missing= completeCase )
> attr(indirectRisks2, "n")
[1] 38345
5.2.2 labelCenters()
The output from the standardizeRisks() function can then be used to classify
the centers as having ‘low’, ‘accepted’ or ‘high’ mortality risk.
> labeledCenters <- labelCenters(standardizedRisks = indirectRisks)
> head(labeledCenters)
centerName centerLabel lowerCI upperCI
1 1 A -0.03536243 -0.011372117
2 2 A -0.03710506 0.022085690
3 3 A -0.02435179 -0.008265759
4 4 L -0.08526481 -0.065240962
5 5 A 0.02675436 0.040652643
6 6 A -0.05021158 -0.014752171
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By default, for indirect standardization, centers are classiﬁed as having low
mortality if the (upper bound of the) 50% conﬁdence interval on the standardized
risk is smaller than a consensus value. This clinically relevant boundary is by
default set at −0.05. Analogously, centers are classiﬁed as having high mortality
if the (lower bound of the) 50% conﬁdence interval on the standardized risk is
larger than the clinically relevant boundary of 0.05. For direct standardization
the consensus value is by default 0.8 Eˆ (Y ) for low mortality risks and 1.2 Eˆ (Y ) for
high mortality risks. Note that the function labelCenters() returns by default
50% conﬁdence intervals in the output, while the function standardizeRisks()
gives 95% conﬁdence intervals by default.
The clinically relevant boundaries can be adapted by providing speciﬁc values
for the parameter lambda in the labelCenters() function. When lambda is a vector
of two elements, the ﬁrst value determines the consensus value before classifying
centers as having low mortality risk, while for high mortality it is the second value.
For example, we can implement a consensus value of −0.06 for low mortality
risks and 0.02 for high mortality risks as follows:
> labeledCenters2 <- labelCenters(standardizedRisks = indirectRisks,
lambda=c(low = -0.06, high = 0.02))
> head(labeledCenters2)
centerName centerLabel lowerCI upperCI
1 1 A -0.03536243 -0.011372117
2 2 A -0.03710506 0.022085690
3 3 A -0.02435179 -0.008265759
4 4 L -0.08526481 -0.065240962
5 5 H 0.02675436 0.040652643
6 6 A -0.05021158 -0.014752171
5.2.3 plotRisks()
For indirectly standardized outcomes, the function plotRisks() generates a de-
scriptive scatterplot of the observed against the expected risk under the average
care level for patients of that center (Figure 5.2).
> plotRisks(standardizedRisks = indirectRisks,
labeledCenters = labeledCenters)
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Figure 5.2: Indirect standardization: Plot the observed versus the expected risk under
the average care level for patients of that center. The full line represents the best local ﬁt
through the points (loess() function in R), the dashed line represents the ﬁrst bisector
and ‘M’ denotes the estimated overall mortality risk Eˆ(Y ).
It illustrates how much the observed risk in each center deviates from the
expected risk under the average care level for patients of that center. Large
deviation is expected when differences in patient mix are large among centers
and is visualised by large deviations from the ﬁrst bisector. The character ‘M’
denotes the estimated overall mortality risk Eˆ(Y ).
For directly standardized outcomes, this function generates a descriptive
scatterplot of the observed against the estimated directly standardized risk for
each center under study.
5.2.4 plotCenterLabels()
Center performance classiﬁcation can be visualised using the estimated stan-
dardized risk and variance per center from the output of standardizeRisks()
and classiﬁcation labels from labelCenters() (Figure 5.3).
> plotCenterLabels(standardizedRisks = indirectRisks,
labeledCenters = labeledCenters)
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Figure 5.3: Plot the estimated indirectly standardized risk with 50% conﬁdence limits
per center.
Centers that are classiﬁed as having low mortality risk are indicated by green
triangles (on the left) and their conﬁdence interval (by default 50%) lies com-
pletely below the clinically relevant boundary. Similarly, centers classiﬁed with
high mortality risk are indicated by red triangles (on the right) and have their
conﬁdence interval lying completely above the clinically relevant boundary. Of
course, larger centers have narrower estimated conﬁdence intervals than smaller
centers.
5.2.5 funnelPlot()
The funnelplot is an internationally recommended plot for comparing institu-
tional performance (Spiegelhalter, 2005a) (Figure 5.4). The estimated standard-
ized risks are plotted against a measure of precision (default is center size). Care
centers with an estimated standardized risk lying outside the 95% control limits
are ﬂagged as outlying centers. A horizontal line is drawn at the displayed value,
for indirect standardization this is at the average of the indirectly standardized
excess risks over all centers while for direct standardization this is at the overall
mortality risk Eˆ(Y ).
157
Chapter 5. The R package RiskStandard
5
0 2000 4000 6000−
0.
10
−0
.0
5
0.
00
0.
05
0.
10
Center size
S
ta
nd
ar
di
ze
d 
ris
k
95% CL
99% CL
−0.003
Figure 5.4: Funnelplot for the estimated indirectly standardized risk per center. The
horizontal line represents the average over all centers of the indirectly standardized risks.
> funnelPlot(standardizedRisks = indirectRisks)
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6CHAPTER 6
Conclusion and Future Research
6.1 Conclusion
Quantifying the quality of hospital care has been fascinating people for several
decades (Iezzoni, 2003). Still, the analysis of quality registers faces several sta-
tistical challenges, e.g. when some hospitals have a small number of registered
patients or when the number and completeness of patient characteristic mea-
surements is limited by the budget. In this thesis, we discussed new statistical
methods to handle these limitations and compared their performance with that
of current alternatives. Thereby we avoided making ad-hoc adaptations as it may
harm conﬁdence in the ﬁnal reporting and complicate comparisons with earlier
study results.
Normal mixed effects models that include ﬁxed effects for patient covariates
and random center effects, are commonly used but may lack power to detect
small centers with deviating performance due to unintended shrinkage (Nor-
mand et al., 1997). In Chapter 2 we have shown that a Firth corrected ﬁxed
effects model only slightly shrinks the ﬁxed center effects towards the overall
mean. This approach is thus especially valuable in the presence of small centers
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as convergence of the estimation strategy improved over ordinary ﬁxed effects
models and more power was retained compared to normal mixed effects models.
Weighting observations by the reciprocal of the so-called propensity score, i.e.
the probability to be treated in the observed center, may warn the user for undue
model extrapolation if patient mix strongly differs across centers. We have inves-
tigated the use of an estimator with inverse probability weighting which is doubly
robust. It was shown analytically and by simulation that the resulting estimator
for the directly standardized risk is indeed doubly robust. So, unbiased estimates
of the standardized risks are obtained if either the outcome model or the model
for center choice is correctly speciﬁed, but not necessarily both (Robins et al.,
2007). The model for center choice does not face the issue of extrapolation, so
when some centers have only few registered patients the doubly robust estimates
may more honestly reﬂect the uncertainty on the obtained results through wider
conﬁdence intervals. Although promising, the doubly robust method was not
considered for routine application in its current form due to convergence prob-
lems. In summary, we recommended the Firth corrected ﬁxed effects method
and used it in all subsequent analysis.
It is known that some centers may perform better on a speciﬁc group of
patients compared to other centers (Nicholl et al., 2013; Mohammed et al., 2009),
for example due to specialized care for the elderly. In Chapter 3 we found that
if this is ignored in the outcome regression model, the directly and indirectly
standardized risks are biased when that patient characteristic is very differently
distributed between centers, but bias is negligible otherwise. We have also shown
that misspeciﬁcation of the outcome regression model mostly induces bias for
the smallest centers for directly standardized risks as opposed to the larger
centers for indirectly standardized risks. Given these ﬁndings, we can now assess
(e.g. via propensity score overlap, which will be explained in Section 6.2) for a
clinical register whether common practice of ignoring center-patient interactions
is justiﬁed and how it will impact the estimated directly or indirectly standardized
risks. Justiﬁcation of including main center effects only, is especially valuable
in settings where ﬁtting interactions is simply prohibited by low information
content. Still, if including main center effects only is not justiﬁed, the question
remains how interactions are best included in the outcome model so that the
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power to detect deviating performance is preserved and convergence of the
estimation strategies is guaranteed.
Of course, high-quality data is most desirable, but in practice it is known to
be hindered by budget, personnel or time constraints. Measuring and registering
a wide variety of patient characteristics does not only imply a big effort in terms
of time and money, but may also damage the quality of registers when more
values are missing or incorrect (Shahian et al., 2007). In Chapter 4 we tackled
the problem of selecting the subset of patient covariates that best explains differ-
ences in 30-day mortality risks or directly standardized risks and respects a total
cost constraint. The stochastic search algorithms allowed for relatively fast and
cost-efﬁcient variable selection and could easily handle multiple imputed data
sets when some measurements were missing. The ﬂexibility in deﬁning the error
function and the options for the search algorithm were a major advantage over
other variable selection methods such as the generalized LASSO. These features
allow for easy implementation of the stakeholder’s preferences and facilitate
automated variable selection. Inspection of the selected subset may for example
give a clear understanding of which risk factors have a large impact on patient’s
mortality. One could also decide to restrict future registration to those covari-
ates that resulted in the smallest error on the individual predictions or hospital
performance measures. Analytic guidelines were given to evaluate for which
proportion of missing values it may be beneﬁcial to include an incompletely
measured covariate instead of its surrogate that is less precise but has no missing
values. This may either encourage or discourage more complete registration
of an expensive covariate depending on whether the expected beneﬁt in error
reduction balances the extra registration cost.
We believe that the discussed methodology in this thesis is not only valuable
for many clinical registers, but also for school registers or other performance
registers. To make the statistical methods available for data analysts in a user-
friendly way, we have started building the R package RiskStandard. Given the
data, this package estimates, with one click of the mouse, the directly or indirectly
standardized risks based on (Firth corrected) logistic outcome regression models
that include ﬁxed center and patient-speciﬁc effects. Next, the centers with
outlying performance can be highlighted, corresponding to the user-deﬁned
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values for statistical and clinical signiﬁcance levels, which depend on whether
the user’s purpose is public or private reporting. All these results can easily be
visualized, using the basic plotting functions documented in Chapter 5.
Each of the covered topics were motivated by speciﬁc research questions on
quantifying quality of care for stroke patients in Sweden (Asplund et al., 2011)
or for patients with rectal cancer in a Belgian pilot project (Goetghebeur et al.,
2011). The applicability of the developed statistical methods, however, is much
wider. On one hand, it is expected that monitoring quality of care based on
recorded data will be performed in an increasing range of disease areas. The
methods developed here will be directly relevant for that. On the other hand, the
interest in monitoring quality of performance is also growing in other ﬁelds such
as education, where these methods will also allow to evaluate quality in a clearly
understandable way and to compare performance between institutions.
6.2 Future Research
6.2.1 Instrumental variable analysis
One of the principal issues when assessing hospital performance is confounding.
In this thesis we have studied the use of a multivariate outcome regression model
or a doubly robust propensity score model to adjust for confounding (Chapter
2). However, a crucial and unveriﬁable assumption for these causal inference
methods is that the included set of patient covariates is sufﬁcient to adjust for
confounding of the center-outcome effect (Hernán and Robins, 2006b). We
considered this assumption to be reasonable for Riksstroke because differences
in patient mix across hospitals were minimal and a rich set of patient baseline
characteristics was measured. Of course, this is certainly not the case for all
clinical registers. The plausibility of this assumption both depends on whether
the important confounders have been measured and how acute treatment of the
disease is. For example, mental illness and cancer are not always treated at the
closest center to the patient so that registers for such diseases are expected to
show more substantial differences in patient mix than for more acute diseases
such as stroke or heart failure. When some important confounders U are not
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patient mix L
centerC 30-day mortality Yinstrument I
unmeasured confounders U
Figure 6.1: A possible instrumental variable setting.
measured (e.g. patient’s socio-economic status or geographical pollution levels)
the estimated center performance may be biased. In that case, one may consider
alternative methods that do not rely on this assumption, such as those using
instrumental variables (Hernán and Robins, 2006a).
An instrument is a variable which (i) is, preferably strongly, associated with
the center choice and (ii) only affects the 30-day mortality risk via pathways that
go through C in Figure 6.1. For example, a vector I = (I1, . . . , Im) of differential
distances to all centers under study has been suggested (Newhouse and McClel-
lan, 1998; Gowrisankaran and Town, 1999), where for a given patient we deﬁne I j
as the additional distance to center j , beyond the distance to the nearest center.
Naturally, this instrument satisﬁes the ﬁrst property as patients are mostly treated
at (one of) the nearest hospital(s). The second property, however, assumes that
distance to center is not associated with the outcome except through the center
choice itself. The latter may be violated if for example some geographical regions
have a population with low socio-economic status U which is not measured
and clearly associated with a higher mortality risk, while these poor regions do
not have many hospitals nearby (extra arrow from U to I in Figure 6.1). So, the
differential distances I for patients from poor regions will be much larger than
for patients from more wealthy regions. If this is the case, one may still not
obtain consistent estimates for the causal center effects (Brookhart et al., 2010;
Gowrisankaran and Town, 1999).
In Gowrisankaran and Town (1999) a two-stage linear model for the instru-
mental variable approach is suggested. In our case it could be postulated as:
C∗c = P (C = c|I,L) =
expit(γcL+δcI)∑m
j=1 expit(γ jL+δ j I)
c = 1, . . . ,m (6.1)
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P (Y = 1|C∗,L) = expit(αL+βC∗)
where C∗ = (C∗1 , . . . ,C∗m) and approximate estimates for the model parameters
can be obtained using two-stage estimation methods (Burgess, 2013). Hospitals
are then compared based on the estimated effects βˆ which are assumed to
reﬂect the given care level. In (6.1) we suggest to ﬁt a separate logistic regression
model for each hospital instead of a multinomial model, because we experienced
convergence issues when ﬁtting the hospital-speciﬁc propensity score models in
Chapter 2. Future work may thus investigate how for a binary outcome, the causal
center effect is best estimated when a good instrument is available, because two-
stage least squares estimation yields only approximate estimates for the model
parameters (Vansteelandt et al., 2011). Moreover, it would be interesting to
compare both approaches, either relying on the no unmeasured confounders
assumption or on the existence of a good instrumental variable. We suggest
to make such comparisons based on hospital quality classiﬁcation because
standardized risks cannot easily be obtained using the instrumental variable
approach. We also suggest then to study the extent to which there is empirical
support for the assumptions given the clinical register and how much results (are
expected to) differ between both approaches.
6.2.2 On themethods in this thesis
Doubly robust propensity score methods have been suggested to be promis-
ing in Chapter 2, especially in settings where patient mix differs substantially
across centers or where the outcome regression model may be misspeciﬁed.
However, small centers resulted in problematically small estimated PS values,
especially when its patient case-mix was very different from that of other large
centers. Therefore we made an ad-hoc adaptation by stabilizing the vector of
propensity scores for each patient by dividing it by the proportion of registered
patients at that center. Moreover, for the Riksstroke data convergence issues with
multinomial models forced us to build a separate logistic regression model per
center. New doubly robust methods, such as the machine learning technique
for outcome regression in van der Laan and Gruber (2010) and methods that
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are more robust against misspecifaction of both the outcome and PS model, e.g.
in Vermeulen and Vansteelandt (2014), show great promise. The construction
of conﬁdence intervals with better ﬁnite sample performance is an interesting
topic for future research.
In Chapter 3 we have suggested further research on modelling center-patient
interactions, when they are necessary. For a small number of hospitals (m = 4),
a logistic regression model including interaction terms for each hospital and
case mix variable in turn, was investigated in Mohammed et al. (2009). When
the number of hospitals is large and interactions with many case mix variables
together are included, we expect that Firth corrected maximum likelihood es-
timation may suffer from convergence problems. Even so when the inclusion
of interactions induces complete separation, e.g. some hospitals only treated
female patients. We believe that a combination of Firth corrected ﬁxed main
effects and random interaction effects may reduce the effective model dimension
while maintaining power to detect outlying center performance. Thereby it has
to be assessed whether assuming a normal distribution for the interaction effects
is indeed more plausible than for the main center effects. To our knowledge
estimation methods for this combination are not yet investigated. Alternatively,
doubly robust models may protect against violation of the assumption of equal
covariate effects across centers if the model for center choice is correctly spec-
iﬁed. Interactions between center and patient characteristics may also show
up due to measurement errors (Nicholl et al., 2013). Blood pressure measure-
ments for example, depend on when and where they are measured. If this is
done systematically different in each center, then a patients’ blood pressure
may be classiﬁed as high in one center while in another center it would have
been classiﬁed as acceptable. Ignoring this, may yield unreliable performance
measures.
The stochastic search algorithms in Chapter 4 focused on minimizing the
error function of the patients’ individual mortality risk or the directly standard-
ized risk. For the latter, we have discussed that minimizing the error may lack to
select confounders of the center-outcome effect. Especially confounders that
are strongly related with center choice and weakly with mortality risk may be
missed, because covariates were selected based on their predictive value in esti-
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mating the mortality risk. Alternative procedures that focus on the selection of
confounders are available, such as C-TMLE in van der Laan and Gruber (2010),
which does not include a covariate if it blows up the variance on the treatment
(i.e. center) effect. On the other hand, in Wilson and Reich (2014) two models
are simultaneously penalized: an outcome regression model and a model for the
center choice in function of all potential confounders. However, it has not been
investigated how covariate costs can be included in these selection procedures.
The R package RiskStandard 0.0.6 implements only a limited number of R
functions which in its current version make rather stringent assumptions on the
structure of the clinical register, such as covariate values to be missing completely
at random. A ﬁrst step towards a more broadly applicable package would be to
make the output for the base function standardizeRisks() more generic, so
that it can be wrapped in or built on existing R functions. The previously men-
tioned techniques can then more easily be implemented, such as the stochastic
search algorithms for cost-efﬁcient variable selection or multiple imputation of
missing covariate values based on the R package MICE (Buuren and Groothuis-
Oudshoorn, 2011).
6.2.3 Assessing differences in patient-mix
Throughout this thesis the importance of determining how patient mix differs
between centers has been emphasized: to warn the user for unwanted model
extrapolation, to conﬁrm the need for modeling center-patient interactions
or to identify potential confounders before automatic variable selection. In
Chapter 2 we have visually compared the center-speciﬁc distribution of each
patient characteristic across the centers under study and summarized overlap
in patient mix via propensity scores. In Chapter 3 we have also measured the
variability of a continuous covariate across centers by the variance of the random
intercepts in a random intercept model for L conditional on center. Still, in
practice it is rarely checked how patient mix differs across centers. We believe
that this can be encouraged when methods are implemented that allow for easily
and clearly doing so, for example as a function in the R package RiskStandard.
Especially, multivariate overlap in patient mix should be assessed more routinely.
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Figure 6.2: The patient’s age and body mass index (BMI) for two centers.
Indeed, a univariate overlap does not guarantee that there is also an overlap for
combinations of covariates across centers. For example in Figure 6.2, patients at
center A andB are clearly not similarwhen considering age andBMI, although the
age distributions for center A and B do overlap, as well as the BMI distributions.
In Shahian and Normand (2008) the distribution of propensity scores was used
to compare the patient mix for each hospital with that of the pool of patients at
the remaining hospitals as well as for selected pairwise comparisons. Although
such visual comparisons are very insightful, they may form a subjective criterion
and elaborate investigation is needed when there are many hospitals. Future
research may focus on developing a statistical test for accordance in patient mix
across hospitals.
6.2.4 Longitudinal analysis
We have been monitoring quality of care over a given time period e.g. for Swedish
stroke patients treated between 2001 and 2012. Interest may however be in
monitoring how the performance of hospitals evolves over time e.g. via annual
evaluations (Parry et al., 1998; Campbell et al., 2012). A hospital with deterio-
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rating performance over time should evidently receive more attention than a
hospital with ameliorating performance. Most of the developed methods can
still be applied on an annual subset of the data, although this certainly has con-
sequences. First, the sample size will drop, and especially for small hospitals
the size may become problematically small. If the Firth corrected maximum
likelihood estimation does not converge, a separate normal random effects distri-
bution per group of centers (e.g. urban/rural hospitals, university/non-university
hospitals) or another distribution than the normal distribution for the random
center effects may provide an alternative (Ash et al., 2012). A second concern is
that measures of hospital performance should not blindly be compared between
different time periods: It has to be kept in mind that the reference population
may be shifted. For a given hospital, estimated differences in DSRs or ISRs over
years may be explained by a shift in the overall population under study for DSRs
or the center-speciﬁc population for ISRs. A more stable reference for DSRs
could for example be obtained by taking a 5-year window of treated patients
as reference population. More interesting however would be to make direct
comparisons of center performance between several years. This requires taking
into account the correlation between performance measures on successive time
points. For example, given 4 successive time points, a continuous outcome Yi j
for a patient i at time point j can be modeled as:
Yi j = βLi +
m∑
c=1
ψc I (Ci = c)+εi j i = 1, . . . ,n; j = 1, . . . ,4 (6.2)
ψc ∼ N (μ,σ2ψ) c = 1, . . . ,m
εi ∼ N (0,σ2εV) i = 1, . . . ,n
V =
⎛
⎜⎜⎜⎜⎜⎝
1 ρ ρ2 ρ3
ρ 1 ρ ρ2
ρ2 ρ 1 ρ
ρ3 ρ2 ρ 1
⎞
⎟⎟⎟⎟⎟⎠ ,
where (ψ1, . . . ,ψm) and εi = (εi1, . . . ,εi4) are independent and a ﬁrst-order auto-
regressive structure for the variance matrix V is assumed (Fitzmaurice et al.,
2004). Pairwise comparisons between two years may then help to examine how
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the correlation actually decreases when the period between two time points
increases.
6.2.5 Mediation analysis
Identifying the reasons for different care levels between hospitals plays an im-
portant role in improving quality of care. Some differences may be explained by
hospital characteristics, such as its size or medical infrastructure (Goldstein et al.,
2002; Saposnik et al., 2007; Tung et al., 2015). In a causal inference framework
these hospital attributes can be seen as mediators M of the center-outcome
effect.
patient mix L
centerC 30-day mortality Y
mediator M
Including the hospital attributes in the logistic regression model can be based on
advanced methodology for mediation analysis (VanderWeele and Vansteelandt,
2010). The natural direct and indirect effect can distinguish between the effect
of the given care level and the effect of the mediator on the mortality risk, but
much less is known on how the measures for hospital performance are then best
deﬁned. For example, for the indirectly standardized risks for a given center, the
mediator value could be set at the value that would be observed under the care
level for that center. The ISR for center c would then compare the observed and
expected risk while the mediator value is as observed in center c.
To conclude, in this thesis we have provided some statistical tools to guide the
analysis of clinical registers. We have shown how and when they may facilitate
quantifying the quality of care by analyzing the Riksstroke data. However, it is
clear that there is still much more to learn about this interesting topic.
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Samenvatting
In deze thesis onderzoeken we hoe de analyse van uitkomsten, zoals overleving
vanpatiëntenmet een beroerte, kan helpen omde kwaliteit van de zorg te vergelij-
ken tussen ziekenhuizen. Naar analogie met de buurlanden, groeit de vraag naar
kwaliteitscontrole in ziekenhuizen maar ook bijvoorbeeld in woonzorgcentra
en scholen, en dit zowel vanuit de overheid en de patiënten als de centra zelf.
Gezien de mogelijks grote impact van gerapporteerde resultaten vraagt dit om
een zorgvuldige statistische analyse van de beschikbare data, zoals besproken in
Hoofdstuk 1. Om het oorzakelijk (i.e. causaal) effect van de zorgkwaliteit in een
ziekenhuis op de gekozen uitkomst te kunnen schatten, moet er gecorrigeerd
worden voor patiëntkenmerken, zoals leeftijd en ernst van de ziekte. Dit is
nodig omdat ze de uitkomst kunnen beïnvloeden en mogelijks verschillend
verdeeld zijn over de ziekenhuizen. Zonder die correctie kan een ziekenhuis
dat vooral oudere patiënten behandelt een hoger sterftecijfer vertonen, ook
al is de zorgkwaliteit er uitstekend. De onderzoeksvragen in deze thesis zijn
voornamelijk geïnspireerd vanuit de analyse van het Zweedse kwaliteitsregister
voor acute beroertes, Riksstroke (http://www.riksstroke.org/eng/), maar
de ontwikkeldemethodes zijn uiteraardmeer algemeen toepasbaar. Om rekening
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te houden met patiëntkenmerken zullen, afhankelijk van de onderzoeksvraag,
direct of indirect gestandaardiseerde risico’s gebruikt worden als maat voor de
performantie.
Het is bewezen dat het schatten van gestandaardiseerde risico’s met behulp
van het populaire normal mixed effects model, de geschatte kwaliteit van zieken-
huizen richting het gemiddelde kan trekken, waardoor afwijkende performantie
vaak niet gedetecteerd wordt (Normand et al., 1997; Ash et al., 2012). In Hoofd-
stuk 2 onderzochten we daarom het gebruik van een Firth gecorrigeerd ﬁxed
effects model en vonden daarbij slechts lichte krimping van de centrumeffecten
richting het globale gemiddelde. Deze aanpak is dus bijzonder nuttig wan-
neer sommige ziekenhuizen een klein aantal patiënten hebben geregistreerd,
aangezien de convergentie van de schattingsstrategie beter is dan voor ﬁxed
effects modellen en er een betere detectie van afwijkende performantie is dan
voor normal mixed effects modellen. Een tweede aspect dat we behandelen
is onbewuste model-extrapolatie bij het schatten van bijvoorbeeld direct ge-
standaardiseerde risico’s, vooral wanneer de patiëntenmix sterk verschilt tussen
ziekenhuizen. Extrapolatie in combinatie met het gebruik van foute statistische
modellen kan vertekende resultaten opleveren met een onderschatte onzeker-
heid. Daarom onderzochten we een methode die observaties weegt met het
omgekeerde van de zogenaamde propensity score, d.w.z. de kans om in het
geobserveerde ziekenhuis behandeld te worden (Shahian and Normand, 2008).
De onderzochte dubbel robuuste methode is meer beschermd tegen het gebruik
van foute modellen (Robins et al., 2007) en zal, als de propensity score zeer klein
is, de gebruiker waarschuwen voor extrapolatie via opgeblazen variantieschat-
tingen. Hoewel veelbelovend, raden we op basis van de bekomen resultaten de
Firth gecorrigeerde ﬁxed effects methode aan.
Gemeenschappelijke correcties voor verschillen in patiëntenmix veronder-
stellen doorgaans dat het effect van zorgniveau op de uitkomst constant is over
patiëntkenmerken (Ohlssen et al., 2007b; Shahian and Normand, 2008). In de
praktijk is dit echter niet altijd het geval, bijvoorbeeld door gespecialiseerde
zorg voor ouderen (Nicholl et al., 2013; Mohammed et al., 2009). Als er in dat
geval geen interacties tussen centrum en patiënt in het uitkomst regressiemodel
worden opgenomen, dan vonden we in Hoofdstuk 3 dat de direct en indirect
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7gestandaardiseerde risico’s enkel vertekend zijn indien de verdeling van het be-
treffende patiëntkenmerk sterk verschilt over de centra, anders is de vertekening
verwaarloosbaar. Het kunnen rechtvaardigen van de gangbare praktijk is vooral
belangrijk in situaties waarbij het simpelweg onmogelijk is om deze interacties
in het model te schatten, omdat er onvoldoende informatie beschikbaar is in
kleine ziekenhuizen, zie bijvoorbeeld Ash et al. (2012).
InHoofdstuk 4 onderzochten we ook hoe het aantal (dure, genetische) metin-
gen - en dus de kost per patiënt - kan beperkt worden wanneer we de uitkomst
willen voorspellen voor individuele patiënten of voor het gestandaardiseerde
risico bij het meten van ziekenhuiskwaliteit. Stochastische zoekalgoritmes laten
toe om een relatief snelle en kost-efﬁciënte variabelenselectie uit te voeren en
ze kunnen gemakkelijk overweg met meervoudig geïmputeerde datasets wan-
neer sommige metingen ontbreken. We hebben bovendien geïllustreerd hoe de
rekentijd verder gereduceerd kan worden door voorafgaand een kost-gebaseerd
generalized LASSO algoritme uit te voeren.
Omdat we geloven in de brede toepasbaarheid van de statistische methodes
in deze thesis, stellen we ze beschikbaar via het R-pakket RiskStandard (www.
cvstat.ugent.be), zoals gedocumenteerd in Hoofdstuk 5.
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8CHAPTER 8
Summary
In this thesis, we examine how the analysis of quality outcomes, such as 30-day
mortality for patients with acute stroke, can help compare the quality of care
between hospitals. As in the neighboring countries, the demand for quality
control in hospitals is growing but also, for example for residential care centers
and schools, both by government and patients as well as centers themselves.
Given the potentially large impact of reported results, this requires a careful
statistical analysis of the available data, as discussed in Chapter 1. To estimate
the causal effect of the quality of care on the outcome of interest, we have to
control for differences between patients on admission, such as age and initial
disease severity. This is necessary because they may inﬂuence the outcome
and they are possibly distributed differently across centers. Otherwise, hos-
pitals treating mostly elderly patients may show higher mortality risks, even
though the given care is excellent. The research questions in this thesis were
mostly inspired by the analysis of the Swedish register for acute stroke care,
Riksstroke (http://www.riksstroke.org/eng/), but the discussed methods
are more generally applicable. To account for measured patient characteristics
we will use, depending on the research question, directly or indirectly standard-
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ized risks as performance measure.
It has been proven that when standardized risks are estimated based on
the popular normal mixed effects model, the estimated quality of care may be
shrunken towards the average, often masking outlying performance of hospitals
(Normand et al., 1997; Ash et al., 2012). In Chapter 2 we therefore investigated
the use of a Firth corrected ﬁxed effects model and found little shrinkage of
the center effects towards the overall mean. This approach is thus particularly
valuable when some centers have a small number of registered patients since the
convergence of this estimation strategy is better than for ﬁxed effects models and
a better detection of outlying performance is obtained than for normal mixed
effects models. Secondly, we investigate undue model extrapolation when esti-
mating for example, directly standardized risks, especially if patient mix differs
substantially between hospitals. Extrapolation in combination with the use of
misspeciﬁed statistical models can yield biased results with an underestimated
uncertainty. Therefore, we examined a method that weights observations by the
inverse of the so-called propensity score, i.e. the probability to be treated in the
observed center (Shahian and Normand, 2008). The investigated doubly robust
method is protected against model misspeciﬁcation (Robins et al., 2007) and, if
the propensity score is very small, the user will be warned for extrapolation via
inﬂated variance estimates. Although promising, the obtained results suggested
to use the Firth corrected ﬁxed effects method.
Common adjustments for differences in patient mix generally assume that
the effect of the given care level on the outcome is constant across patient groups
(Ohlssen et al., 2007b; Shahian and Normand, 2008). In practice, however, this
may be violated when some centers are for example specialized in care for the
elderly (Nicholl et al., 2013; Mohammed et al., 2009). If then no center-patient
interactions are included in the outcome regression model, we found in Chapter
3 that the directly and indirectly standardized risks will only be biased if the
distribution of that patient characteristic differs substantially across centers,
otherwise bias is negligible. Being able to justify common practice is especially
important in settings where it is simply impossible to estimate these interactions
in the model, because insufﬁcient information is available in small hospitals, for
example see Ash et al. (2012).
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8In Chapter 4 we also examined how the number of (expensive, genetic) mea-
surements - and thus the cost per patient - can be reduced when predicting
individual patient outcomes or estimating standardized risks for hospital quality
evaluation. Stochastic search algorithms allow for a relatively quick and cost-
efﬁcient variable selection and they can easily handle multiple imputed datasets
when some measurements are missing. We have also illustrated how the search
time can be further reduced by a priori performing a cost-efﬁcient generalized
LASSO search.
Because we believe in the broad applicability of the statistical methods in
this thesis, we have made them available via the R-package RiskStandard (www.
cvstat.ugent.be), as documented in Chapter 5.
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